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ABSTRACT 
The general focus of this dissertation is the role of infectious agents in 
pregnancy wastage in swine. The manuscript was written in four parts. Part I reports 
the results of an epidemiologic field investigation designed to measure the effects of 
encephalomyocarditis virus, porcine parvovirus, Leptospira interrogans, swine influenza 
virus, pseudorabies virus, or Toxoplasma gondii on reproductive performance in gilts 
in commercial swine herds. Parts II through IV are ancillary studies intended to 
augment and broaden the findings in Part I. 
Part I reports the results of a field study monitoring the course of 210 gilts 
entering the breeding pool in 15 different herds. Surveillance was maintained through 
a combination of production records, breeding records, and periodic serologic sampling. 
Prevalence of 6 infectious agents associated with reproductive failure was estimated in 
in the sow and finisher populations in each herd. Antibody titers were monitored in 
each gilt either until the animal left the breeding pool or farrowed. Statistically 
meaningful associations were observed between significant rises in antibody titers and 
farrowing 3 or more stillborns, farrowing 3 or more mummies, or giving birth to fewer 
than 7 live pigs. 
As discussed in Part II, the microtitration serum neutralization (SN) test has 
been routinely used to serologically diagnose encephalomyocarditis virus (EMCV) 
infection in swine. The utility of the SN test as a diagnostic tool has been 
compromised because an antibody titer that confirms EMCV infection has not been 
established. Therefore, interpretation of test results has been uncertain. In the study 
described in Part II, antibodies were measured in experimentally infected swine to 
determine the minimum titer that confirms infection and to estimate sensitivity and 
specificity for the test. 
Eleven animals were injected intramuscularly with 1.78 x 10^ TCID^Q of NVSL 
strain (a.k.a. Florida strain) EMCV. Three sentinel swine were commingled with the 
exposed animals. Animals were bled at approximately 7-day intervals, beginning 36 
days prior to exposure and continuing through post-inoculation day (PID) 126. It was 
found that SN antibody titers of 1:8 were highly suggestive of infection, with an 
estimated 97.8 percent sensitivity and 95.7 percent specificity at this dilution. 
Antibody titers of 1:16 or greater were conclusive for EMCV infection, based on a test 
specificity of 100.0 percent at these dilutions. 
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population in Iowa. A total of 2,614 animals from 104 herds located throughout the 
state were tested for antibodies against EMCV by the SN test. The sample was 
composed of 587 sows and gilts and 2,027 finishing animals. A statistically significant 
difference (P<0.002) was observed between the prevalence in sows and gilts (17.2 %) 
vs. finishing animals (12.2 %). Breeding swine maintained in total confinement 
(20.5 %) showed a significantly higher prevalence (P=0.04) than breeders maintained in 
other types of housing (12.1 %), while the prevalence in finishing animals raised in 
total confinement (6.4 %) was significantly lower (P=0.02) than finishers not raised in 
total confinement (13.6 %). No association was detected between prevalence and herd 
size, or prevalence and season of the year. Adjusting for test specificity and 
sensitivity, the true prevalence of EMCV in Iowa swine was estimated to be 13.8 
percent in breeding stock and 8.5 percent in finishing animals. On a herd basis, 89.4 
percent (93/104) of the herds had one or more EMCV-positive animals using 1:8 as the 
positive threshold. 
In Part IV, a second serosurvey measured the prevalence of Toxoplasma gondii 
in the Iowa swine population. A total of 2,616 animals from 104 herds were tested for 
the presence of antibodies against Toxoplasma gondii by the enzyme-linked 
immunosorbent assay (ELISA). Data were analyzed by animal type, herd size, facility 
type, and season. The true prevalence of toxoplasmosis was estimated as 5.4 percent 
among finishing swine and 11.4 percent among sows and gilts. Herds with fewer than 
100 breeders were significantly more likely to be infected than herds with 100 or more 
breeders (P<0.05). Within infected herds, seroprevalence in breeding stock was 
approximately the same, regardless of herd size. Finishers in total confinement were as 
likely to be infected as finishers in other types of facilities, but infected herds with 
finishers in confinement appeared to have a lower in-herd prevalence than herds with 
other types of facilities (P=0.09). No seasonal effects were observed and prevalence 
remained relatively constant throughout the year. The prevalence of porcine 
toxoplasmosis in Iowa was markedly lower than other areas of the United States 
surveyed within the past decade. 
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INTRODUCTION 
Explanation of Dissertation Format 
This dissertation was written in the alternate format. It begins with an abstract 
of the opus followed by a general introduction to the subject area and a statement of 
the problem. Parts I through IV present the experimental work performed. Each of 
these parts addresses specific issues related to the general theme of the dissertation. 
The doctoral candidate is the primary investigator and first author of each of these 
parts and is responsible for their contents. The dissertation concludes with a general 
discussion of the issues and suggestions for further areas of investigation, additional 
references, and acknowledgements. 
Literature Review 
Herd reproductive performance continues to play a pivotal role in the economic 
success of swine operations. An analysis of the 1988 Iowa State University Swine 
Enterprise Records Program participants found that the 99 highest profit herds 
averaged 0.3 more live pigs per litter farrowed than the 99 lowest profit herds. 
Superior reproductive performance was identified as one of the important factors that 
was responsible for the difference in profitability between the 2 groups of herds 
(Stevermer, 1989). 
Many factors influence herd reproductive performance, including environment, 
nutrition, stress, genetics, management, seasonal effects, and disease (BeVier and Dial, 
1983; Hurtgen, 1980). Infectious agents account for 30 to 40 percent of abortions, 
mummies and stillbirths (Straw, 1986). Diagnosis of specific infectious agents causing 
these losses, and research in this area, is complicated by the fact that 1) numerous 
infectious agents are capable of causing reproductive failure, 2) the diagnosis of the 
cause of reproductive losses is often difficult, or impossible, at the time the loss is 
discovered (Straw, 1986), and 3) losses are usually the result of the interaction of 
multiple factors, such as time of gestation, immune status, and stress, rather than the 
direct effect of a single infection. 
This work focused on six infectious agents and their effects on reproduction in 
swine. These agents are: encephalomyocarditis virus, porcine parvovirus, Leptospira 
interrogans, swine influenza virus, pseudorabies virus, and Toxoplasma gondii. 
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Encephalomvocarditis virus Encephalomyocarditis virus (EMCV) is 
classified in the family Picornaviridae, genus Cardiovirus (Matthews, 1982a). Unusual 
for a picornavirus, EMCV has a broad host range. Infections acquired under natural 
conditions have been described in humans (Adamcova and Bardos, 1959; Bardos, 1957; 
Jungeblut and Bautista, 1954; Tesh, 1978; Tesh and Wallace, 1978; Verlinde and van 
Tongeren, 1953), other primates (Dick, 1948; Dick, 1953; Dick et al., 1948; Dshikidse 
et al., 1974; Dzhikidze et al., 1982; Gainer, 1967; Helwig and Schmidt, 1945; Heredia et 
al., 1982; Kissling, 1956; Ramos et al., 1983; Roca-Garcia and Sanmartin-Barberi, 
1957; Verlinde et al., 1950; Wells and Gutter, 1986), many species of rodents (Causey 
et al., 1962; Dick, 1953; Gainer and Bigler, 1967; Ghosh and Rajagopalan, 1973; 
Heredia et al., 1982; Kilham et al., 1956; Kissling, 1956; Paul et al., 1968; Pope, 1959; 
Vizoso and Hay, 1964), marsupials (Pope and Scott, 1960; Causey et al., 1962; 
Tiggleman-Van Krugten and Collier, 1955; Gaskin et al., 1980), mongoose species 
(Dick et al., 1948; Tesh and Wallace, 1978), a raccoon (Gainer, 1967), and several 
species of birds (Causey et al., 1962; Gresikova et al., 1978; Tesh and Wallace, 1978). 
Clinical outbreaks in zoological parks with death losses in elephants, primates, and 
artiodactyls have also been reported (Gaskin et al., 1980; Simpson et al., 1977; Wells 
and Gutter, 1986). Among the domesticated species, horses (Adamcova and Bardos, 
1959; Bardos, 1957; Causey et al., 1962; Gainer et al., 1968; Pope and Scott, 1960), 
cattle (Adamcova and Bardos, 1959; Alcolado and Gomez, 1982; Ramos et al., 1983; 
Spradbrow and Chung, 1970; Tesh and Wallace, 1978), swine (Murnane et al., 1960), 
dogs (Tiggleman-Van Krugten and Collier, 1955), and cats (Tesh and Wallace, 1978) 
are susceptible to EMCV. 
Although EMCV is commonly thought of as occurring in subtropical or tropical 
areas, infections in swine have been reported throughout the world: Australia (Acland 
et al., 1970; Acland and Littlejohns, 1975; Glastonbury, 1977; Hill et al., 1985; Links et 
al., 1986; Littlejohns, 1984; Mercy et al., 1988), Brazil (Roehe et al., 1985), Britain 
(Sangar et al., 1977), Canada (Sanford et al., 1985; Sanford et al., 1989), Cuba (Gomez 
et al., 1982; Ramos et al., 1982), Czechoslovakia (Adamcova and Bardos, 1959), Greece 
(Tsangaris et al., 1989), Guatemala (Kovatch et al., 1969), Italy (Gualandi et al., 1989), 
New Zealand (Sutherland, 1977), Panama (Murnane et al., 1960), Puerto Rico (D. R. 
Jutting, National Veterinary Services Laboratories, Ames, lA, personal communication, 
1989), and South Africa (Williams, 1981). In the United States, EMCV has been 
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isolated from swine in Florida (Gainer and Murchison, 1961), Georgia (R. F. Solorzano, 
Diagnostic Laboratory, College of Veterinary Medicine, University of Missouri, 
Columbia, MO, personal communication, 1990), Hawaii (D. R. Jutting, National 
Veterinary Services Laboratories, Ames, lA, personal communication, 1989), Maryland 
(J. C. M. Huang, Animal Health Laboratory, Maryland Department of Agriculture, 
College Park, MD, personal communication, 1989), and Minnesota (Joo et al., 1988; J. 
L Kresse (retired). National Veterinary Services Laboratories, Ames, lA, personal 
communication, 1989). If species other than swine are included, the geographic 
distribution of EMCV may be further expanded. 
Current understanding of the epidemiology of EMCV is far from complete. 
Transmission of the virus is assumed to be fecal-oral, but studies of transmission from 
infected animals to uninfected commingled animals have shown that transmission by 
contact with infected animals and contaminated environments is not particularly 
efficient. In a study utilizing mice, only 2 of 18 uninfected female mice placed in 
contact with 204 infected female mice in highly overcrowded conditions became 
infected. Exposure of 18 uninfected male mice to 198 infected male mice resulted in 
13 infected animals. The higher incidence in the males was credited to fighting and 
cannibalism in the group (Dick, 1948). In a similar experiment in swine, transmission 
by contact was attempted in 2 groups of 4 pigs each (Littlejohns and Acland, 1975). 
Two animals in each group were orally exposed to EMCV. None of the contact 
animals became infected. On the other hand, it has been shown that EMCV can be 
transmitted from sows to their nursing offspring, although whether transmission 
occurred via the milk or via fecal contamination was not determined (Boulton, 1984). 
A reservoir host for EMCV has not been identified. Rodents, especially Rattus 
species, are occasionally cited as reservoir hosts or assumed to be the source of EMCV 
in clinical outbreaks (Acland and Littlejohns, 1986; Boulton, 1984; Merchant and 
Earner, 1964). Support for this point of view comes from the fact that serologic 
surveys frequently identify EMCV-infected populations of wild rodents, and Rattus 
species in particular (Adamcova and Bardos, 1959; Bardos, 1957; Dick, 1953; Ghosh 
and Rajagopalan, 1973; Jonkers, 1961; Pope, 1959; Pope and Scott, 1960; Tesh and 
Wallace, 1978; Warren et al., 1949). Also, infected rats and mice are often found in 
association with clinical outbreaks (Acland et al., 1970; Boulton, 1984; Gainer et al., 
1968; Ramos et al., 1983; Seaman et al., 1986; Wells and Gutter, 1986). However, it 
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would be expected that the reservoir host would establish a chronic intestinal carrier 
state, as is the case in the closely related poliomyelitis virus in humans or porcine 
enteroviruses in swine.- This is not the case for Rattus species or any other species 
known to be susceptible to EMCV infection. In experimentally exposed Rattus rattus, 
R. novegicus and Mus musculus, EMCV was recovered from feces only within the first 
24 hours after exposure (Tesh and Wallace, 1978). The bulk of the experimental 
evidence supports the hypothesis that seropositive rodents are indicative of EMCV 
activity in the natural setting, not reservoir hosts (Kilham et al., 1956; Ramos et al., 
1983; Tesh and Wallace, 1978). 
Unique among picornaviruses, EMCV has been isolated from a wide variety of 
wild-caught arthropods. EMCV has been isolated from mosquitoes in Brazil, Uganda, 
and Madagascar (Causey et al., 1962; Dick et al., 1948; Dick, 1953; Fontenille, 1989). 
In each case, these isolations were serendipitous findings made in conjunction with 
yellow fever or other arbovirus research and surveillance projects. In Brazil, EMCV 
was isolated from Aedes aborealis, A. fulvithorax, A. senatus, A. taeniorhynchus, Culex 
species, Mansonia arribazagae, and M. venezuelensis mosquitoes (Causey et al., 1962). 
In Madagascar, EMCV was isolated from Aedes cartroni, A. masoalensis. Anopheles 
gambiae, Culex univittatus, and Eretmapodites quinquevittatus mosquitoes (Fontenille, 
1989), and in Uganda from Coquillettidia fuscopemata (Dick et al., 1948; Dick, 1953). 
The recovery of EMCV from wild-caught ticks has also been reported (Paul et 
al., 1968). In India, this virus was isolated from 80 Ixodes petauristae larvae and 5 I. 
petauristae nymphs collected from captured Rattus rattus wroughtoni and one Ixodes 
petauristae nymph from Rattus blanfordi. The virus was also isolated from 
Haemaphysalis spinigera nymphs collected from the forest floor. It was demonstrated 
that EMCV could pass transstadially in ticks from larval to nymphal stages. 
Ramos et al. (1983) very succinctly reported the recovery of EMCV from a 
batch of wild house flies (Musca domestica), without giving further details. 
Apparently, this isolation was made in Cuba in association with a clinical outbreak of 
EMCV in a swine herd. 
What role arthropods fulfill, if any, in the maintenance and transmission of 
EMCV in nature is not known. The weight of the evidence does not support a 
hypothesis of arthropod transmission. If EMCV were arthropod borne, it would most 
likely be either mechanically transmitted by flies or hematophagous arthropods, or 
7 
both. In any case, arthropod transmission does occur remains to be proven. 
The potential for transmission of EMCV is augmented by the ability of the 
virus to persist in the environment. Indeed, EMCV has been isolated from standing 
water assayed during the course of investigating an outbreak in a swine herd (Gainer et 
al., 1968). Saline solutions containing an initial titer of 6.6 log^Q per milliliter were 
held at various temperatures (Dick, 1948). At 37 C, virus was still detectable on day 
25, as was the virus maintained at "room temperature" on day 102. Held at 2 - 10 C 
(refrigerator temperature), on day 117 the concentration of the virus was still 2.0 logjQ 
per milliliter. Virus suspensions containing brain or serum persisted much longer 
(Dick, 1948). Luya et al. (1979) reported shorter virus persistence: 10 days at 37 C, 21 
days at 25 C, and more than 73 days at 4 C. These results are not necessarily 
contradictory with those of Dick, As discussed by Bryan et al. (1990), comparisons are 
more easily made when such studies are reported in terms of virus half-life rather than 
absolute recovery times. EMCV is also highly resistant to changes in pH in the range 
of 3 - 13 (Luya et al., 1979; Schatz and Plager, 1948). 
The first evidence that EMCV could induce reproductive disease in pigs was 
the isolation of the virus from a sow and one of her fetuses (Gomez et al., 1982). 
EMCV was recovered from the hearts of both animals. Reinforcing the evidence that 
infection could occur in utero, Littlejohns (1984) reported the isolation of EMCV from 
partially mummified, parvovirus-negative, stillborn pigs. Links et al. (1986) reported 
the first outbreak implicating EMCV as a cause of significant fetal mortality. Twenty-
three of 135 sows that farrowed produced 69 mummified fetuses and 12 nearly full-
term dead pigs. The fetuses died at various gestational ages. EMCV was isolated from 
the pigs that died late in gestation but not from mummified fetuses. Mercy et al. 
( 1 9 8 8 )  a l s o  d e s c r i b e d  a n  o u t b r e a k  c h a r a c t e r i z e d  b y  s u d d e n  d e a t h  i n  p i g s  a g e d  3 - 1 7  
days and an increased incidence of mummies and stillbirths. Joo et al. (1988) used 
serology on fetal sera or thoracic fluids to detect the presence of antibody to EMCV. 
Among mummified or stillborn pigs, 48/233 (20.6 %) had detectable immunoglobulin. 
Among the 48 with detectable antibody, 12 were positive for antibody against EMCV 
and 21 were positive for porcine parvovirus. Furthermore, the presence of fetal 
antibodies against EMCV was associated with clinical herd history of increased 
mummification, stillbirth and neonatal death (Joo et al., 1988). 
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Leptospira interroeans Leptospirosis is present on all continents of the 
world (Hanson and Tripathy, 1986). Leptospira probably originated in southeast Asia 
and was disseminated by the well-traveled Rattus norvégiens in the early 18th century 
(Gsell, 1984). Spreading across western Asia and into Europe, infected rats reached 
England's harbors around 1730 and from there the rest of the globe. 
Inada and Ido are generally given credit for first describing the organism 
(Spirochaeta icterohaemorrhagiae) in the year 1915, although a number of their 
contemporaries, working independently, made critical contributions as well (Gsell, 
1984). Noguchi (1918), incorrectly believing Spirochaeta icterohaemorrhagiae to be the 
cause of yellow fever, found it morphologically different from all known genera of 
spirochetes and assigned it to a new genus, Leptospira. 
Leptospira is the only genus in the family Leptospiraceae. Leptospires are 
motile, rod-shaped bacteria, coiled in shape, with one or both ends hooked. They are 
obligate aerobes. The genus consists of two species: L. interrogans and L. biflexa 
(Johnson and Faine, 1984). L. interrogans contains the majority of parasitic and 
pathogenic serovars. L. biflexa contains all saprophytic serovars, although several 
serovars in L. biflexa are parasitic (Torten, 1979). 
The genus Leptospira is divided into serogroups and subdivided into serovars on 
the basis of two-way cross absorption-agglutination serologic reactions. Serovars 
within a serogroup share common antigens; within a serogroup, two strains are 
considered to belong to different serovars if more than ten percent of the homologous 
antibody titer remains in both antisera after cross absorption-agglutination (Torten, 
1979). L. interrogans currently consists of 23 serogroups and 214 serovars (Miller, 
1989). Restriction endonuclease analysis has recently been used to identify and classify 
leptospires to the genotype level (Thiermann and Le Febvre, 1983; Thiermann et al., 
1985). 
L. interrogans is infectious for at least 181 species of animals (Torten, 1979). 
Multiple species of animals may be susceptible to the same serovar or even genotype. 
For example, L. interrogans serovar bratislava genotype B2a has been isolated from 11 
different animal species, and pigs, dogs, hedgehogs, and horses all probably serve as 
reservoir hosts for this genotype (Ellis, 1988). 
At least 21 serovars from 12 serogroups (Andamana, Australis, Autumnalis, 
Ballum, Bufonis, Grippotyphosa, Hebdomadis, Icterohemorrhagia, Javanica, Pomona, 
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Pyrogenes, and Tarassovi) have been isolated from swine (Torten, 1979). Within the 
United States, 7 serovars have been isolated from swine: bratislava (Ellis and 
Thiermann, 1986), canicola (Ward et al., 1956), copenhageni (Miller, 1989), 
grippotyphosa (Hanson et al., 1971), icteohaemorrhagiae (Schnurrenberger et al., 1970), 
kemewicki (Thiermann et al., 1985) and pomona (Gochenour et al., 1952). 
Serologic surveys indicate that leptospirosis in swine is common. In Ireland, 82 
percent of sows were estimated to have been infected (McErlean, 1972). Surveys in 
Poland, 1948 through 1970, showed the prevalence of leptospirosis to be between 8 and 
30 percent (Zwierzchowski, 1984), while in Scotland, 42 percent of market hogs were 
serologically positive for leptospirosis (Michna and Campbell, 1969). In the United 
States, the prevalence of leptospirosis in swine has been estimated at 33 percent in 
Georgia (Cole et al., 1983), IS percent in Illinois (Bryan, 1954), and 10 percent in Iowa 
(Morter, 1960). 
Leptospirosis is also present in feral swine (Sus scrofa) populations. In 
California, blood samples collected from wild hogs in four areas of California showed 
118/136 (87 %) positive for agglutinating antibodies against Leptospira interrogans 
(Clark et al., 1983), and in Texas, 43/120 (36 %) feral swine were seropositive (Corn et 
al., 1986). 
No single serovar is most common in all swine populations. Different serovars 
predominate in swine populations in different geographic regions: icterohaemorrhagiae 
in Poland (Zwierzchowski, 1984) and canicola in Scotland (Michna and Campbell, 
1969), for example. Pomona has historically been considered the predominant serovar 
in the U.S. swine population (Inzana and Dawe, 1979), whereas pomona is unimportant 
in the Netherlands (Hill and Weenink-Van Loon, 1976). 
Within a population, the relative prevalence of specific serovars may change 
over time. For instance, during the period from 1969 to 1974, a survey of 6,348 swine 
in the Netherlands showed that 22 percent were Leptospira positive, with serotypes 
icterohaemorrhagiae and tarassovi most common (Hill and Weenink-Van Loon, 1976). 
A second survey of swine in the Netherlands (1975 to 1980) found a nearly identical 
prevalence (21 %), but bratislava had become the most common serovar, followed by 
tarassovi, ballum, and icterohaemorrhagiae (Bercovich et al., 1983). 
Leptospires are discharged into the environment in the urine of infected 
animals (or humans). Transmission occurs when a susceptible individual comes into 
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direct contact with leptospires, either in urine or in Leptospira-coMànAnzied streams, 
surface waters, ponds, or marshy areas. Not infrequently, leptospires have been 
isolated from the environment in association with clinical outbreaks of leptospirosis 
(Gillespie et al., 1957; Kingscote, 1986). 
Once introduced into the biosphere, leptospires persist for a period of time 
dependent on the interaction of temperature, pH, composition of soil or suspension 
fluid, and the presence of other microorganisms in the microenvironment. Okazaki and 
Ringen (1957) reported the survival of Leptospira pomona to be as short as 30 minutes 
in dry soil and as long as 183 days in soil supersaturated with water. The temperature 
range for survival was between 7 C and 36 C, and the range of pH tolerance was 6.0 to 
8.4. Under simulated "natural" conditions, leptospires were recovered for less than 7 
days. 
Leptospires are able to penetrate abraded skin or mucous membranes (Ferguson 
and Powers, 1956). Transmission can also occur through ingestion of tissue infected 
with leptospires, such as consuming infected rodents, or through copulation (Hanson, 
1972). It is hypothesized that venereal transmission may occur routinely with Australis 
serogroup serovars, as opposed to the traditional association of transmission with 
exposure to urine (Ellis et al., 1985). 
The period of leptospiruria in swine appears to be serovar-dependent, to some 
degree. Leptospiruria in swine experimentally infected with L. pomona was shown to 
peak approximately 20 to 30 days after exposure and persist in excess of 122 days 
(Morse et al., 1958). In contrast, bratislava is excreted in small numbers for a short 
period of time (Ellis, 1988). While not rigorously quantified, excretion of copenhageni 
and muenchen seem to be somewhere between pomona and bratislava in quantity and 
time (Hathaway et al., 1983). 
The majority of Leptospira infections, regardless of species infected, are 
subclinical (Hanson and Tripathy, 1986; Torten, 1979). It was poetically consistent 
with this scenario that the first porcine isolation of Leptospira in the United States was 
made from a clinically healthy pig (Gochenour et al., 1952). Frequently, even 
experimental exposure will produce no clinically significant signs of infection (Fish et 
al., 1963; Inzana and Dawe, 1979; Morse et al., 1958). 
When observed, clinical signs often present a puzzling and diagnostically 
challenging picture. Anorexia, conjunctivitis, convulsions, depression, diarrhea, fever. 
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hematuria, and jaundice have all been described in association with acute leptospirosis 
(Hanson and Tripathy, 1986; Torten, 1979). Diagnosis is further complicated by the 
fact that leptospires are sometimes isolated from serologically negative individuals 
(Kirkbride and McAdaragh, 1978; Morse, 1960), or isolation may fail in known cases 
of exposure (Inzana and Dawe, 1979). 
The most conspicuous and consistent clinical feature of leptospirosis in 
commercial swine herds is reproductive loss, including abortions, stillbirths, and the 
birth of weak, nonviable pigs (Boyer, 1952; Bryan et al., 1953; Fennestad and Borg-
Petersen, 1966; Kingscote, 1986; McErlean, 1964; Michna, 1962; Powers et al., 1956). 
Abortion usually occurs in the last third of pregnancy and is often the only clinical 
sign observed. Experimentally, it has been shown that exposure to leptospires prior to 
day 32 of gestation will produce no effects and result in the birth of normal litters 
(Kemenes, 1984). Exposure after day 32 of gestation will cause abortion between 19 
and 73 days after inoculation of the pregnant animal (Fennestad and Borg-Petersen, 
1966; Kemenes, 1984). Exposure in late pregnancy will result in a higher proportion 
of stillborn and weak pigs, which usually die within 48 hours of birth (Michna, 1962). 
Once infected, individuals are refractive to re-infection with the same serovar. 
Thus, the immunity produced by exposure to pomona will protect pregnant sows and 
their fetuses against challenge with a virulent strain of pomona (Morter et al., 1960) 
and antibodies passed to pigs via colostrum of infected mothers are able to confer a 
high degree of resistance to challenge by the same serotype (Michna, 1965). But 
immunity against one serovar will not protect against infection by other serovars. It 
has been reported that, in herds with two serovars, both serotypes can simultaneously 
or alternately infect sows (Kemenes and Suveges, 1976). 
Currently of special interest is serogroup Australis and its role as a possible 
pathogen of swine. Serogroup Australis contains 12 serovars (Pritchard et ai., 1985). 
Serovars either isolated from swine or detected serologically are bratislava (Ellis et al., 
1985; Ellis et al., 1986a; Ellis et al., 1986b; Ellis et al., 1986c; Ellis and Thiermann, 
1986; Bolin and Cassells, 1990), muenchen (Hathaway et al., 1982; Ellis et al., 1986c), 
and lora (Hartman et al., 1975). 
The data regarding serogroup Australis are suggestive of a dynamically evolving 
host-parasite relationship: 1) a survey of 695 finishing swine in Scotland found no 
Australis serogroup titers (Michna and Campbell, 1969), 2) the prevalence of antibody 
12 
titers to serovar bralislava were observed to increase in Europe in the i970's (Bercovich 
et ai., 1983; Weber and Fenske, 1978), 3) bralislava titers are now common in 
domestic swine populations: Canada - 32 percent (Baker et al., 1989), England - 12 
percent (Hathaway and Little, 1981a), Sweden - 18 percent (Sandstedt and Engvall, 
1985), Illinois - 15 percent (Hanson, 1987), and Iowa - 42 percent (Miller et al., 1990). 
It is not clear if serogroup Australis infections are clinically and/or 
economically significant. Of importance in assessing the significance of Australis 
infections are 3 basic points: 1) association of serogroup Australis serovars with 
clinical disease, 2) ability of these serovars to produce disease in experimental settings, 
and 3) a statistical association between the presence of these serovars and disease. 
Although the significance of Australis serovars in swine herds is uncertain, 
Australis serovars have been isolated from herds experiencing clinical reproductive 
disease. Serovar bralislava was isolated from placentas, stillborn pigs and weak pigs 
(Bolin and Cassells, 1990). Serovars lora, muenchen, and bralislava were recovered 
from the kidneys and genital tracts of sows that aborted (Hartman et al., 1975; 
Hathaway et al., 1982; Ellis et al., 1986b). In herds in western Canada, bralislava was 
recovered from kidneys, uteruses, and placentas of sows that had farrowed weak pigs 
or aborted, and from the liver and kidneys of piglets that died within 48 hours after 
birth (Kingscote, 1988). This information provides strong evidence for an association 
with clinical disease, yet serovars bralislava and muenchen have also been isolated from 
the genital tracts of sows at abattoirs with no known reproductive dysfunction (Ellis 
and Thiermann, 1986). As discussed previously, the serologic evidence is that infection 
by Australis serovars is extremely common. It is very possible that not all of the 
reported Australis isolations were causally related to clinical disease. 
Experimentally, attempts to reproduce reproductive disease with Australis 
serovars have been generally unsuccessful. Hathaway et al. (1983) failed to cause 
abortion with muenchen or bralislava but did with pomona. Weber and Fenske (1978) 
reported similar results with bralislava, although they did show transmission to sows 
placed in contact with the infected animals. Farina et al. (1977) found that bralislava 
infection had no influence on the duration of pregnancy, albeit it may have caused the 
death of some fetuses. Ellis (1988), on the other hand, reported success in reproducing 
abortion with bralislava, although he conceded that his results were "inconsistent." 
Studies examining the statistical association of Australis serovars and 
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reproductive inefficiency have also failed to clarify the issue of clinical significance of 
these organisms. The reports to date are nearly equally divided. Prescott and 
Nicholson (1987) found a significant association between the presence of animals with 
antibodies against bratislava or pomona and abortion. Hathaway and Little (1981b) 
showed statistical significance between Australis titers and infertility in sows. 
Pritchard et al. (1985) found no association between the Australis serogroup and 
abortion but did find a significant association between Australis and infertility. To the 
contrary. Miller et al. (1990) found no difference in the livebirth farrowing average 
between herds with high bratislava antibody titers and herds with low bratislava 
antibody titers. Weber and Fenske (1978) detected no evidence of impaired 
reproductive performance in eight herds with serological evidence of Australis 
serogroup infection. 
The effect of bratislava vaccine on herd reproductive performance has been 
used to provide indirect evidence that bratislava is, or is not, a significant pathogen. 
Franz et al. (1989) found a marked improvement in reproductive performance in herds 
infected with bratislava subsequent to use of a bacterin containing serovar bratislava, 
while Bolin and Cassells (1990) reported that reproductive signs persisted after vaccine 
was used in a herd from which bratislava was isolated. Anecdotal information 
supporting either perspective abounds. 
In conclusion, the clinical and experimental information must be allowed to 
define the role of serogroup Australis. It is apparent that there is insufficient evidence 
to do so at the present time. 
Toxoplasma eondii Toxoplasma gondii is a protozoan parasite belonging 
to phylum Apicomplexa, family Eimeriidae, class Sporozoasida (Levine, 1982). The 
geographic distribution of T. gondii is so broad, and infection so common, that one 
specialist succinctly declared that "prevention of infection is clearly impossible" 
(Beverley, 1976). Another proclaimed that " ... there is a sea of toxoplasma infection 
around us" (Jacobs, 1957). 
T. gondii has a complex life cycle with both sexual and asexual replication 
phases (Jacobs and Frenkel, 1981). The sexual reproductive cycle occurs in the 
intestinal epithelium of species of the family Felidae, especially the domestic cat {,Felis 
domesticus). Sexual reproduction results in the production of an oocyst with 2 
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sporocysts, each of which contains 4 sporozoites. The asexual replication cycle takes 
place in the tissues of susceptible species after ingestion of sporulated oocyts. Asexual 
stages appear to be capable of parasitizing essentially all warm-blooded animals, 
including mammals, marsupials, and birds. Even poikilothermic vertebrates can be 
infected, if their body temperatures are raised sufficiently high (Jacobs and Frenkel, 
1981). 
Transmission of Toxoplasma may be achieved by any one of several 
mechanisms involving exposure to oocysts, tachyzoites, or bradyzoites. Congenital 
transmission and cannibalism are also documented routes of transmission among swine 
(Dubey et al., 1986; Sanger and Cole, 1955; Work et al., 1970). Which of these is the 
primary route of transmission to swine in field situations is not known (Dubey, 1986). 
Oocysts, millions of which are present in the feces of shedding cats (Dubey and 
Beattie, 1988), are easily dispersed by wind, rain, arthropods, fomites, and earthworms 
(Chinchilla and Ruiz, 1976; Dubey et al., 1986; Frenkel et al., 1975; Smith and Frenkel, 
1978; Wallace, 1972). The infectious potential of a single Toxoplasma-lozé^A fecal 
deposit is colossal since as few as four oocysts is a dose sufficient to infect an adult 
swine, although probably, more than 1000 oocysts are required to cause clinical disease 
in adult animals, depending on the virulence of the strain (Durfee et al., 1974). 
Oocysts may be isolated directly from soil in which cats dung (Ruiz et al., 1973), and 
contaminated soil and/or feed has been directly linked with outbreaks of clinical 
toxoplasmosis in swine (Ito et al., 1975; Penkert, 1973) and humans (Teutsch et al., 
1979). Climatic factors interact to affect the length of survival of oocysts in the 
environment, but oocysts can remain infectious for a long period of time (Frenkel and 
Dubey, 1973). In one study, feces from cats placed in exposed soil in Kansas remained 
infectious for at least 18 months, including two winters (Frenkel et al., 1975). 
Mice and rats are commonly infected with Toxoplasma (Chinchilla, 1978; Eyles, 
1952; Rifaat, 1971), and consumption of dead rodents, the tissues of which contain 
infectious bradyzoites, may be an important route of transmission in the field. 
Congenital transmission in mice and rats also occurs, thereby potentiating and 
amplifying the infection within the rodent population. Indeed, congenital transmission 
by congenitally infected female mice may occur as far as the 10th generation 
(Beverley, 1959). Exclusion of rodents from swine feed and facilities is believed to be 
one means to markedly reduce the prevalence of toxoplasmosis in swine herds (Lubroth 
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et al., 1983). 
The role of arthropods in the transmission cycle has been examined closely 
because of the parasitemia accompanying the infection and the potential for 
transmission by hematophagous species. While it is possible to infect blood-sucking 
arthropods, it has not been shown to be consistently possible to transmit Toxoplasma 
by bite, nor has the epidemiological data supported the hypothesis of arthropod-borne 
transmission (Frenkel, 196S; Rifaat and Morsy, 1965; Soliman et al., 1964; Woke et al., 
1953). 
Raisanen and Saari (1978) have advanced the hypothesis that T. gondii 
tachyzoites play a role in the transmission of toxoplasmosis. Tachyzoites are a rapidly 
replicating cell-associated form. Thought to be extremely fragile, Raisanen and Saari 
(1976) were able to demonstrate that, depending on the suspending solution, tachyzoites 
could survive for a period of up to several days. Trophozoites remained infectious in 
excretions for several days; in tears for 4 days, in saliva for 5 days, in urine for 7 
days, and in milk for 6 days (Saari and Raisanen, 1974). They were also able to 
transmit toxoplasmosis to mice by intranasal exposure, instillation into the conjunctiva, 
and by mouth (Raisanen and Saari, 1978). The fact that tachyzoites have been 
recovered from essentially all body secretions in acutely infected swine, including 
urine, saliva, milk, nasal and eye discharges, and scrapings from the vaginal mucosa 
(Dienst and Verma, 1965; Dreesen and Lubroth, 1981; Koestner and Cole, I960; Sanger 
and Cole, 1955), would support the plausibility of transmission by tachyzoites. While 
some researchers dismiss the notion that tachyzoites might play a role in the 
transmission of toxoplasmosis (Frenkel and Wallace, 1979), it has been demonstrated 
under experimental conditions that swine could be infected by exposure to trachyzoites 
(Folkers, 1964b). Under "field" conditions, transmission of toxoplasmosis to humans 
via consumption of tachyzoites in raw goat's milk has been reported, as well (Riemann 
et al., 1975). 
Toxoplasmosis has been shown to be common in swine. On a world-wide basis, 
Dubey (1986) has estimated that approximately one-third of all swine are infected, 
although surveys show wide variation in prevalence among populations, even within the 
same region. In the United States, surveys have reported the prevalence of 
toxoplasmosis in swine as 108/413 (26.2 %) in Montana (Dubey, 1985), 337/891 
(37.8 %) in California (Garcia et al., 1979), 21.0 percent of 1,455 swine in Louisiana 
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(Hugh-Jones et al., 1986), 14/97 (14.4 %) in North Dakota (Mcllwain, 1969), and 
156/2,460 (6.1 %) in Iowa (Zimmerman et al., 1990). Survey results are not truly 
comparable because of differences in survey size, sample selection, population 
characteristics, and testing protocol. Nevertheless, it is clear that toxoplasmosis is 
common in the U. S. swine population. 
Toxoplasmosis in swine was first diagnosed in 1952 in Ohio, U.S.A. (Farrell et 
al., 1952). Clinical signs in this outbreak included a high mortality rate in pig under 3 
weeks of age and abortions and stillbirths in the breeding herd (Cole et al., 1954). 
About half of the swine on the premises died. Toxoplasma organisms were recovered 
from the spleen, heart, and milk of sows, as well as from stillborn pigs. Toxoplasms 
isolated from this first case were inoculated into swine, producing clinical signs and 
lesions identical to those in the naturally infected swine. Porcine toxoplasmosis, 
involving both clinical and subclinical infections, was reported in many parts of the 
world in the decade following the Ohio outbreak (Dubey, 1986). 
Whether or not infection results in clinical disease or reproductive losses in 
swine depends on the interaction of several factors, including age, route of exposure, 
dose of inoculum, virulence of the strain of Toxoplasma, and stage of gestation. In 
general, younger animals are more susceptible to clinical disease than adults, and the 
degree and extent of the lesions are more pronounced in younger animals (Beverley et 
al., 1978; Folkers, 1964a; Moller et al., 1970). 
Transmission may be accomplished by several routes, including intramuscular, 
intravenous, intranasal, intraperitoneal, conjunctival, oral, and intradermal routes, and 
by contact with infected pen mates (Folkers, 1964a; Folkers, 1964b; Pan and Lam, 
1963; Wilson et al., 1967). The route of infection exerts an influence on the course of 
the disease. Acute infection with pulmonary involvement occurs more frequently with 
the intranasal and intravenous routes, while infection through either the conjunctiva or 
scarified skin produces only a transient fever (Folkers, 1964b). 
Strains of Toxoplasma gondii vary in virulence. The oocysts of some strains 
are considered avirulent for swine (Work et al., 1970). Virulence is not static, 
however and may change (Beverley, 1976). It has been observed that virulence may 
increase following passage in an unusually susceptible individual host animal, or as a 
result of conversion into oocysts in cats, or in the laboratory by rapidly repeated 
intraperitoneal passages in mice (Beverley, 1976). 
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Although toxoplasmosis is common, as surveys of the parasite's prevalence have 
proven, there are only three reports documenting clinical toxoplasmosis in swine in the 
U.S. (Farrell et al., 1952; Dubey, 1979; Dubey et al., 1986). Thus, the majority of 
infections in swine are subclinical. Pertinent to this study, is the documented ability of 
toxoplasms to produce congenital infection of fetal swine and cause stillbirths and fetal 
death (Jones and Hunter, 1979; Koestner and Cole, 1960; Moller et al., 1970; Moriwaki 
et al., 1976; Pan et al., 1962; Sanger and Cole, 1955). 
Porcine parvovirus Porcine parvovirus (PPV) is a member of family 
Parvoviridae, genus Parvovirus (Matthews, 1982b). Parvoviruses as a group are unique 
in that they have a linear, single-stranded DNA genome. They have been isolated 
from both vertebrates and invertebrates and are the only group of DNA viruses known 
to be capable of replicating in the nucleus of both vertebrate and invertebrate cells 
(Tijssen, 1990). The cumulative evidence of comparisons of translational maps, 
antigenic cross-reactivity, and genome homology suggests that all members of the genus 
Parvovirus evolved from a common prototype (Ridpath and Mengeling, 1988a). 
Individual members of genus Parvovirus are thought of as being highly host-
specific, swine being the only reservoir of PPV (Ridpath and Mengeling, 1988b). 
Seemingly contradictory to this statement, antibody against PPV has been demonstrated 
in sera from cattle, sheep, cats, guinea pigs, mice, and rats (Joo et al., 1976). PPV is 
known to be infectious for rats (Johnson and Smith, 1990), but these infections are 
abortive and no significant transmission occurs among members of these species. Thus, 
the cumulative impact of non-porcine species on the natural history of PPV is minimal 
(Johnson and Smith, 1990). 
Numerous surveys have convincingly demonstrated that PPV is geographically 
widespread and prevails at high levels in swine populations throughout the world. In 
Australia, 33 percent of 430 sera tested positive for PPV antibodies (Cartwright and 
Huck, 1967). A seroprevalence of 70.3 percent was reported in 1,332 animals in Italy 
(Foni and Gualandi, 1989), and an early survey of 2,400 swine in Great Britain 
estimated a prevalence of 44.4 percent (Harkness et al., 1971). In Ontario, Canada, 
76.6 percent of the 1398 animals and 73.3 percent of the 462 herds tested were 
seropositive (Gagnon and Dulac, 1979). In the first report of PPV in the U.S., 40.7 
percent (172/423) of serum samples from swine in Arizona, Iowa, New Hampshire, 
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Vermont, Oregon, and Washington were reported to contain hemagglutination-
inhibition antibodies for PPV (Mengeling, 1972). A subsequent U.S. study showed that 
77 percent of 129 serum samples from 23 Ohio farms and 82 percent of 96 samples 
from slaughter plants in Ohio were seropositive for PPV (Redman et al., 1974). 
Parvoviruses are infectious by virtually any route. Oral exposure is probably 
the most common route of transmission under natural conditions, but inhalation of 
parvovirus in dust (intranasal exposure) is probably also important (Johnson and Smith, 
1990). Infection results in the contamination of the premises since the virus is shed 
into the environment. PPV is shed in feces and nasal secretions beginning from 3 to 
14 days post exposure and in urine beginning from 4 to 9 days post exposure (Sorensen 
and Nielsen, 1982). Frequently, susceptible individuals are infected as a result of 
exposure to food or water with PPV-contaminated feces and/or urine (Johnson and 
Smith, 1990). 
Once introduced into the environment, parvoviruses are extremely persistent. 
As reviewed by Johnson and Smith (1990), parvoviruses can withstand heating at 56 C 
for several hours and at 75 C for up to 10 minutes. They are able to remain infectious 
at pH range of 3 to 10, and are resistant to desiccation. Environments contaminated 
with PPV are able to serve as a source for susceptible individuals for an extended 
period of time. In one experiment, PPV-contaminated, uncleaned rooms previously 
occupied by experimentally infected pigs remained infectious for susceptible swine for 
at least 14 weeks (Mengeling and Paul, 1986). 
For individual animals, seropositivity is markedly age-dependent. Robinson et 
al. (1985) found that 82 percent (1917/2345) of sows, 56 percent (300/537) of gilts, and 
53 percent (10/19) of boars were PPV-positive. Foni and Gualandi (1989) 
demonstrated that sera from adult sows in Italy had a higher rate (73.1 %) of positive 
titers than those from 3- to 6-month-old pigs (40.7 %). 
A common misinterpretation of these data is that essentially 100 percent of 
adult swine over the age of one year possess antibodies against PPV due to natural 
exposure in endemically infected herds. This interpretation receives little support from 
field data. Cutler et al. (1983) reported that up to 50 percent of the females that 
experienced PPV-induced reproductive failure were mature sows. Johnson and 
Collings (1969), in an investigation of 17 swine herds, reported that as few as 50 
percent of breeding stock in a herd had antibody against PPV. Gillick (1977), 
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documenting an outbreak of PPV in two 750 sow units, reported that prior to the 
outbreak only 55 percent of adult swine were seropositive. Pointon et al. (1983) found 
the prevalence of PPV antibodies in sows more than 12 months of age ranged between 
44 and 100 percent in four endemically infected herds. 
In one study, PPV antibody titers in the sera of individual sows in one herd 
were monitored over the course of four years (Vannier et al., 1982). Some sows in this 
endemically infected herd remained free of PPV antibody for a year or more. Herd 
prevalence ranged from 20 percent to 97 percent. For nearly a two-year period, in-
herd prevalence was less than 40 percent. 
The mechanism by which PPV is maintained in endemically infected herds, 
particularly between clinical episodes, is not known (Mengeling and Paul, 1986). 
Hypotheses for maintaining endemicity have focused primarily on two mechanisms: 
persistence of PPV in the environment for periods of time sufficient to allow for 
eventual exposure of susceptible individuals, and shedding of virus by infected animals 
recently brought into the herd (Mengeling and Paul, 1986). There is one suggestion, as 
yet unproven, that survivors of in utero infection may become antibody-free, 
immunotolerant carriers and perpetual virus excretors (Johnson et al., 1976). 
Cartwright and Huck (1967) were the first to link PPV with naturally occurring 
reproductive disease in swine. In the course of their investigations, they repeatedly 
isolated PPV from cases of infertility, abortions, stillbirths, and neonatal losses in swine 
breeding herds. Johnson and Collings (1969) were also able to isolate PPV from 
aborted, stillborn, and normal pigs. Furthermore, they reported that the exposure of 
pigs or pregnant gilts by oral, intravenous, intramuscular, or intranasal routes produced 
no clinical signs. Pregnant gilts infected orally or intravenously during the last half of 
gestation farrowed normal pigs with antibody against PPV, thereby demonstrating 
transplacental infection of fetuses. In an astute assessment of the results, they stated 
that PPV would "probably be shown to be of significance only when infection of an 
antibody-free gilt or sow occurs at service, or during the early part of pregnancy." 
Reports of PPV (Johnson and Collings, 1969; Cartwright et al., 1971; Johnson, 1973; 
Mengeling et al., 1975; Redman et al., 1974) and demonstration of viral antigen in 
tissues from abnormal fetuses and stillborn pigs, as well as seroconversion of affected 
dams during gestation (Mengeling et al., 1975), followed these early reports. The 
cumulative evidence of these investigations indicates that the timing of infection 
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during gestation is important in producing reproductive disease. As summarized by 
Mengeling (1986), natural exposure of susceptible, pregnant females up to the 56th day 
of gestation results in the death of the conceptus and subsequent resorption or 
mummification, depending on the degree of fetal skeletal calcification. Exposure after 
the 56th day of gestation generally results in the production of antibodies against the 
virus by the fetus and survival of the fetus to term. 
Pseudorabies (Auieszkv's disease) virus The pseudorabies virus (PRV) is 
a member of family Herpesviridae, subfamily Alphaherpesvirinae (Matthews, 1982c). 
Suid herpesvirus type I is an enveloped DNA virus with a diameter of 150-186 
nanometers (Ben-Porat and Kaplan, 1985). 
PRV has a wide animal host range. Many species of mammals are naturally or 
experimentally susceptible to infection, including fur-bearing animals raised in 
production situations and all of the domesticated species (Gustafson, 1986; Konrad and 
Blazek, 1958; Lyubashenko et al., 1958; Trainer and Karstad, 1963; Ugorski, 1958). 
Reports of clinical pseudorabies in cattle (Bitsch, 1975; Hagemoser et ai., 1978; Kiorpes 
and Thompson, 1986), as well as in dogs and cats (Boucher and Beran, 1977; Dow and 
McFerran, 1963; Edison et al., 1953; Gore et al., 1977; Horvath and Papp, 1967) are 
not uncommon. Occasional reports of pseudorabies in wild animals are present in the 
literature, as well (Bitsch et al., 1969; Goyal et al., 1986; Pirtle et al., 1986; Schultze et 
al., 1986). A few species of birds have been infected under experimental conditions, 
but PRV-infected birds have not been reported under field conditions (Gustafson, 
1986). Some species of primates are susceptible to infection (Baskerville and Lloyd, 
1977), but humans, in spite of some slight evidence to the contrary, are considered 
non-susceptible (Baskerville and Lloyd, 1977; Hampl et al., 1984). 
Pseudorabies has been reported in domestic swine in countries throughout the 
world, with the exception of Canada, Australia, and certain countries in Africa and 
Latin America (Odend'hal, 1983). Feral swine are also commonly infected and may 
serve as a source of PRV for domestic swine and other animals (Clark et al., 1983; 
Corn et al., 1986; Nettles and Erickson, 1984; Pirtle et al., 1989). 
Currently, a number of countries are in the process of eradicating PRV from 
swine populations located within their borders. Among these countries are Belgium (de 
Smet et al., 1989), Denmark (Andersen et al., 1989), the Federal Republic of Germany 
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(Wittmann, 1989), the German Democratic Republic (Kretzschmar, 1989), Great Britain 
(Goodhand, 1983; Taylor, 1989), and the Netherlands (Nieuwenhuis, 1988). While a 
number of these national programs have come close to success, each has had occasional 
outbreaks or remains under threat of reinfection from infected neighboring countries. 
At the current time, the United States is in the process of implementing an eradication 
program, as well. 
Swine are most commonly exposed to PRV through the inhalation of virus in 
aerosol, or by nose-to-nose contact (Donaldson et al., 1984). Airborne virus particles 
have been isolated from the environment in which infected pigs were confined, and 
seronegative pigs in physically separate facilities were infected by exposure to the air 
piped in from infected animals (Donaldson et al., 1983). PRV has also been isolated 
from dust on surfaces inside a building occupied by infected finishing animals, 
indicating its dispersal in aerosol (Vannier et al., 1989). 
PRV can be isolated from oropharyngeal swabs of swine for up to 25 days after 
infection, in vaginal secretions and ejaculate for up to 12 days, and for 2 to 3 days in 
the milk (Wittmann and Rziha, 1989). The major factor contributing to the role of 
swine as the host and primary source of the virus is the capacity of the virus to 
become latent in swine that recover from infection. In recovered individuals, latent 
virus is present as DNA in association with cellular DNA, particularly in nerve tissues 
and tonsil (Beran et al., 1980; Gutekunst et al., 1980; McFarlane et al., 1986; Sabo, 
1985). The quiescent cell-associated viral DNA is capable of becoming activated and 
consequently expressing itself and forming new viral particles. Reactivation is 
generally associated with stress in the animal (Beran et al., 1980; Davies and Beran, 
1980). Thus, once infected, pigs remain potentially contagious throughout their 
lifetime. 
In most situations, movement of subclinically infected pigs is the method by 
which infection is spread between premises. However, it has also been observed that 
pseudorabies shows a distinct pattern of moving between farms in close proximity. 
Disease outbreaks often occur in one herd after another in a "domino effect." 
Frequently, transmission occurs without any apparent reason, i.e., without the 
introduction of new stock into the herd, without the movement of animals between 
premises, without the presence of vehicles and machinery on the farm, and without 
visitors in swine facilities. Alternate explanations for this "down-the-road" 
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transmission pattern have been offered. These include PRV-contaminated aerosols 
disseminated from infected herds to susceptible herds, and spread by PRV-
contaminated flies moving between herds. 
On the basis of empirical epidemiologic evidence, some workers have suggested 
that aerosolized PRV is capable of moving between herds and infecting swine over a 
distance of up to 9 kilometers or more (Andersen et al., 1989; Gloster et al., 1984). 
Others have found it more difficult to accurately evaluate the role of aerosol-borne 
virus in herd-to-herd transmission on the basis of epidemiological information (Taylor, 
1989). 
Experimentally, Schoenbaum et al. (1990) found that the recovery of infectious 
PRV in aerosols was dependent on environmental temperature and relative humidity. 
Under optimal conditions, the concentration of infectious PRV in aerosols decreased by 
SO percent in less than one hour. As discussed by Schoenbaum et al. (1990), the 
composition of the suspension medium markedly affected the stability of the virus in 
aerosol, with the addition of porcine mucin acting to markedly prolong the time in 
which infectious virus was recovered. The role of suspension medium was investigated 
at greater length by Naneva et al. (1983), who found that the stability of the virus in 
aerosol was enhanced by the addition of 10 percent peptone and 0.8 percent saccharose 
in a solution at pH 7. 
Medveczky et al. (1988) reported the transmission of pseudorabies under 
experimental conditions by laboratory-infected house flies to swine, rabbits, and a 
lamb. Transmission was achieved by oral, corneal, and abraded skin exposures. 
Subsequently, Zimmerman et ai. (1989) reported that PRV was readily recovered from 
within the bodies of house flies that had ingested the virus. The age of the fly and 
environmental temperature were shown to significantly affect the rate of virus 
inactivation. Maximum virus half-life was reported as slightly over 13 hours in 5-day-
old flies maintained at SO F. This research suggested that PRV could persist 
sufficiently long to allow dispersal of contaminated flies substantial distances in the 
field. However, it has not been proven that house flies actually serve as mechanical 
vectors of pseudorabies in the field. 
Clinical signs of pseudorabies infection are highly variable in swine, ranging 
from subclinical to acute death (Baskerville, 1972; Baskerville et al., 1973; Gustafson, 
1986; Kluge and Maré, 1974; McFerran and Dow, 1965; Nara, 1985). Factors that 
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interact in determining the course of the infection include: the age of the animal, the 
presence or absence of circulating antibody against PRY, the number of virus particles 
in the inoculum, the route of exposure, the strain of virus, and concomitant infections 
with other pathogens that may act synergistically to exacerbate the clinical course of 
the infection (Fuentes and Pijoan, 1984). 
Clinical signs in swine tend to be highly age-dependent. Infection in suckling 
pigs from unprotected sows may result in nearly 100 percent mortality. Fever, 
dyspnea, anorexia, excess salivation, and diarrhea, followed by ataxia, convulsions, 
coma, and death, are observed during the course of the disease. Older swine are more 
resistant to pseudorabies, and the clinical course of the disease tends to be less severe 
in growers and finishers and may even occur completely unobserved by the producer 
(Gustafson, 1986). 
The effect of PRY infection in gestating animals has been reported as leading 
to abortion, or the farrowing of macerated, mummified fetuses or stillborn pigs 
(Csontos et al., 1962; Gordon and Luke, 1955; Hoblet et al., 1987; Kluge and Maré, 
1974; Morrison and Joo, 1985). 
Akkermans (1975) regarded pseudorabies as a chronic cause of porcine abortion 
in swine herds in The Netherlands, and Baskerville et al. (1973) reported that abortion 
generally occurred 10 to 20 days after the onset of clinical illness in the dam. 
Importantly, more recent observations of abortions in swine breeding herds have 
suggested the possibility that PRY-induced abortions continue to occur despite 
vaccination with inactivated virus vaccines (de Muelenaere and Pensaert, 1989). 
As summarized by Kirkbride (1990), the effects of PRY on gestating animals 
are similar to those of the swine enteroviruses or porcine parvovirus. Infection in the 
first 30 days may cause embryonic death and resorption of embryonic tissues by the 
dam. Infection in midgestation may cause the death of the fetus and result in the dam 
farrowing a mixed litter of live, normal pigs and macerated, or mummified fetuses. 
Unlike the enteroviruses or parvovirus, however, infection in late gestation may still 
result in fatal infection in utero or in the birth of weak, live pigs at term (de 
Muelenaere and Pensaert, 1989). Thus, it may be concluded that infection at any time 
during gestation can result in PRY-induced reproductive losses (Maré et al., 1976). 
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Swine influenza virus The family Orthomyxoviridae consists of the genus 
Influenzavirus, which contains two species, influenza A and influenza B, and an 
unnamed genus which contains the influenza C viruses (Fenner et al., 1987). Influenza 
viruses are divided into types A, B, and C on the basis of the nucleoprotein and matrix 
protein antigens (Murphy and Webster, 1990). 
Relative to types B and C, influenza A viruses are the more important disease 
agents. In animals, they are the causative agents of equine influenza, swine influenza, 
and fowl plague (Buxton and Fraser, 1977). Type A viruses infect a wide range of 
hosts, including bears, cats, cattle, chickens, equines, gibbons, goats, humans, mink, 
seals, swine, water buffaloes, whales, yaks, and at least SO avian species (Easterday, 
1981; Lvov et al., 1978; Graves et al., 1974; Rott and Klenk, 1988; Stuart-Harris and 
Schild, 1976), 
The Orthomyxoviridae, but particularly the type A viruses, show a high degree 
of antigenic diversity. Current subtypes of influenza A viruses are constantly 
undergoing small antigenic modifications (antigenic drift) and subtypes showing major 
antigenic changes appear periodically (antigenic shift). This ongoing antigenic 
modification makes the nomenclature and identification of specific isolates challenging 
for this group. Schild et al. (1980), on the basis of the antigenic analysis of prototype 
strains of influenza A viruses of human, porcine, equine, and avian origin, identified 
12 hemagglutinin (H) antigens and 9 neuraminidase (N) antigens. This work formed 
the basis for a revision of the nomenclature for the influenza A viruses (WHO, 1980). 
The revised system of nomenclature contains 2 parts 1 ) type and strain 
designation, and 2) for influenza A viruses, a description of the antigenic specificity of 
the H and N antigens. The strain designation for influenza virus types A, B, and C 
contains information on the nucleoprotein antigenic type, the host of origin - if 
isolated from non-human species, geographical origin, strain number, and the year of 
isolation. For the influenza A viruses, the antigenic description indicating H and N 
antigen follows the strain designation in parentheses. Thus, the original agent of swine 
influenza is designated A/swine/Iowa/15/30 (HlNl). There is no provision for 
describing distinct subtypes of B and C viruses. 
Schild et al. (1980) grouped the H antigens into 12 subtypes (H1-H12) and the 
N antigens into 9 subtypes (N1-N9). Subsequently, Hinshaw et al. (1983) described a 
new hemagglutinin antigen (HI 3) isolated from gulls (Larus spp.) in the United States. 
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Thus, there are currently 13 H antigens (HI-HI3) and 9 N antigens (N1-N9). 
Extensive surveillance has not revealed further subtypes, suggesting that there may be a 
finite number of distinct influenza A viruses in nature (Murphy and Webster, 1990). 
The World Health Organization's international influenza A surveillance effort, 
begun in the late 1970's, accumulated information that has changed the concept of the 
epidemiology of the influenza viruses. The information that emerged regarding the 
influenza A viruses presented an extremely complex epidemiological picture 
characterized by varying degrees of antigenic relatedness among influenza subtypes 
infecting different species, a varying degree of infectivity among different species and 
evidence for cross-species transmission, and the documented observation that different 
subtypes of influenza infecting a single individual may recombine in vivo to form a 
"new virus." 
Demonstrating the close antigenic relationship sometimes seen among influenza 
subtypes infecting very different species, Lvov et al. (1978) reported the isolation of 
viruses that were antigenically related to known human influenza viruses from wild 
animals in the Pacific, including whales. The whale virus was similar to the human 
A/PR/8/34 (HlNl) virus except for one peptide. Other viruses isolated from animals 
have shown a high degree of association with strains isolated from humans. As 
reviewed by Lvov et al. (1978), a virus of the Hong Kong complex (H3N2) was 
isolated from a common murre (Uria aalge) and a virus of the Asian complex (H2N2) 
was isolated from pintail ducks {Anas acuta). 
The issue of cross-species transmission of influenza viruses achieved a high 
profile in the recent past. In 1976 an influenza virus derived from an enzootic swine 
virus was isolated from five military recruits with acute respiratory illness, in one case 
from the lung of a recruit who died, at Fort Dix, New Jersey (Beare et al,, 1980; Dacso 
et al., 1984; World Health Organization, 1976). Adding to the concern, the swine 
influenza subtype involved was closely related to "Spanish flu," the virus responsible 
for the 1918-1919 pandemic in which 21,000,000 people died (Shope, 1958). 
Serological evidence showed that about 500 recruits were infected with the virus in a 
4-week period. A retrospective evaluation showed that there was a total of 10 
isolations from humans from 1974 through 1977 (Dowdle and Hattwick, 1977), and that 
antigenically similar viruses had been circulating in the swine population for at least 3 
years prior to the Fort Dix incident (Easterday et al., 1977). The human epidemic that 
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was anticipated did not occur. 
The recovery of A/swine/Taiwan/7310/70 (H3N2), a subtype indistinguishable 
from human A/Hong Kong/68 (H3N2), from pigs in Taiwan in 1970 (Kundin and 
Easterday, 1970) provided the first direct evidence of the interspecific transfer of 
influenza viruses. Pigs exposed experimentally to either human-origin or porcine-
origin virus became infected and transmitted the virus to pen mates (Kundin, 1972). 
Beare et al. (1972) showed that A/swine/Taiwan/7310/70 (H3N2) readily infected 
human volunteers. The H3N2 swine virus was apparently derived from humans. The 
appearance of H3N2 in swine subsequent to H3N2 human epidemics has been 
documented extensively (Chang et al., 1977; Goto et al., 1988; Tumova et al., 1976; 
Tumova et al., 1980a; Wallace, 1979; Wibberley et al., 1988). Interestingly, even after 
the A/Hong Kong/1/68 (H3N2) influenza virus was no longer circulating in the human 
population, it has been maintained in the swine populations (Shortridge et al., 1977; 
Tumova et al., 1980b). 
Webster et al. (1971, 1973) proved that recombination of influenza A viruses 
from man and pigs and from chickens and turkeys could occur under conditions 
resembling natural transmission. In a series of experiments, influenza viruses were 
allowed to spread naturally from experimentally infected animals to contact animals. 
In all experiments, recombinant viruses were isolated from contact animals. In 
experiments with Hong Kong influenza (H3N2) and swine influenza virus (HlNl) in 
swine, both kinds of recombinants were isolated (H3N1, H1N2) and both of the 
recombinant viruses were genetically stable and caused mild infections in pigs. These 
studies provided evidence that recombination of influenza viruses could occur between 
different species and suggest a possible explanation for the origin of new strains of 
influenza viruses. 
The cumulative evidence indicates that birds may represent the reservoir species 
for the original prototype virus and are the primary reservoir for the creation of new 
influenza subtypes (Hinshaw et al., 1978; Rott and Klenk, 1988). Infection in birds 
represents a well adapted host-virus relationship in the sense that most influenza 
viruses are nonpathogenic for wild birds and tend to persist in avian populations. 
Influenza virus is stable for at least 4 weeks in water at 4 C and for 5 days in water at 
20 C, properties that facilitate transmission among water fowl and from birds to other 
species (Kaplan and Webster, 1977). All 13 H and all 9 N subtypes are found in birds. 
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so the opportunity for recombination is available. Furthermore, the genetic relatedness 
of avian virus strains to those appearing in other species also supports the possibility 
that the influenza viruses in birds are introduced into other population groups. The H3 
subtypes in man and the avian-like viruses in pigs, mink, seals, and whales may have 
emerged from birds (Hinshaw et al., 1978). Finally, migrating birds, especially feral 
ducks, have the potential for disseminating influenza virus over large areas and across 
great distances. 
Swine influenza viruses, or antibodies against swine influenza viruses, have 
been reported in Belgium, Brazil, Canada, the People's Republic of China, Colombia, 
Czechoslovakia, Denmark, France, Germany, Great Britain, Hong Kong, Iran, Italy, 
Japan, Kenya, The Netherlands, Poland, the Soviet Union, Sweden, Taiwan, and the 
United States (Easterday, 1986). 
Most influenza infections in swine have been associated with HlNl subtypes, 
although H1N2 (Sugimura et al., 1980) and H3N2 subtypes have been reported in 
swine, as well. There are infrequent reports of influenza type B and C infections in 
swine, as well. Lalitha Rao et al. (1983) reported 1 of 520 swine sera collected in India 
positive for B/Singapore/222/79. Undocumented serological studies in the People's 
Republic of China also suggested that influenza type B is infectious for swine, as well 
(Webster et al., 1984). These are relatively poorly documented infections, and the 
possibility of nonspecific serologic inhibition cannot be excluded in these cases. 
However, Takatsy et al. (1967), under experimental conditions, demonstrated the 
susceptibility of swine to influenza B virus and its transmissibility from infected 
animals to susceptible contact swine. In addition, specific antibodies against influenza 
B were found in swine from herds exhibiting an influenza-like disease during, or 
subsequent to, type B epidemics in the human population. 
Influenza type C has also been documented in swine. Guo et al. (1983) isolated 
15 strains of influenza C virus from abattoir swine in the People's Republic of China 
in 1981, and antibody against influenza C virus was found in swine sera. Experimental 
infection of pigs with influenza C virus demonstrated that swine could be infected 
with influenza C virus and that the virus could be transmitted from pig-to-pig for up 
to 25 days after experimental exposure. Porcine infection with types B and C is the 
rare exception. Most infections involve influenza type A subtypes. 
Historically, swine influenza is associated with HlNl subtypes, and until 
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recently, clinical outbreaks were considered to be restricted to North America. Since 
the mid-1970s, clinical outbreaks of swine influenza have been reported throughout the 
world (Aymard et al., 1985; Castro et al., 1988; Haesebrouck et al., 1985; Masurel et 
al., 1983; Nardelli et al., 1978; Pritchard et al., 1987; Roberts et al., 1987; Wibberley et 
al., 1988). These outbreaks generally involve influenza A "U.S." HlNl, "European" 
HlNl, or H3N2 subtypes. Although North American exported swine were originally 
thought to be the source of HlNl to the rest of the world, foci of infection in Hong 
Kong and the People's Republic of China would suggest otherwise (Shortridge and 
Webster, 1979). 
The classic perception of swine influenza was that of a highly seasonal disease, 
occurring primarily during fall and early winter (McBryde, 1927), the transmission of 
which involved a complex interaction among virus, earthworms, lungworms 
(Metastrongylus), and swine (Shope, 1958). The concept of seasonality began to 
undergo modification when Woods and Simpson (1964) showed that clinical outbreaks 
of influenza occurred in Illinois swine herds every month of the year, with a peak in 
the fall months. Furthermore, Nakamura et al. (1972) were able to isolate influenza 
from swine throughout the year. The transmission cycle postulated by Shope (1958) is 
overly complex and unnecessary. Wallace (1979) reported the presence of swine 
influenza in herds free of lungworms, and the contemporary evidence supports the 
view that convalescent carriers act as reservoirs of swine influenzavirus between 
epizootics (Nakamura et al., 1972). 
Field observations from veterinarians and swine producers have indicated that 
baby pigs from sows infected with influenza during pregnancy were often small and 
failed to live long (Easterday, 1986; Shope, 1958). Abortions in first and second 
trimester sows and early farrowings in third trimester sows have been reported in 
association with influenza epizootics in Belgium (Haesebrouck et al., 1985). Abortions 
concurrent with epizootics have been reported elsewhere in Europe, as well (Madec et 
al., 1989; Muller et al., 1981; Nardelli et al., 1978), occasionally with reports of virus 
isolation from aborted fetuses (Madec et al., 1989). In humans, infection with 
influenza virus has been associated with abortion or premature delivery, and influenza 
virus has been recovered from the placenta, amniotic fluid, and fetal heart (Harris, 
1984). Indirect field evidence in support of an association between influenza and 
reproductive inefficiency has also been reported. In a prospective study of 2709 sows. 
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a statistically significant association between seroconversion to swine influenza virus in 
early gestation and poor reproductive performance was found (Madec, 1988). 
The experimental evidence, however, is inconsistent. Mensik (1959, 1962) was 
able to recover swine influenza virus from stillborn pigs and from fetal membranes and 
fluids after experimentally exposing gestating sows to the virus. Woods and Mansfield 
(1974) reported that exposed gilts farrowed more stillborn and weak pigs. They were 
also able to isolate influenza from fetal lung tissue, indicating transplacental 
transmission. Other researchers have been unable to duplicate these effects (Tikkoo, 
1973). Brown et al. (1982) failed to show transplacental transmission of swine 
influenza; even in utero exposure of fetus failed to cause fetal death (Brown et ai., 
1980). 
Thus, the role of swine influenza virus in pregnancy wastage and infertility is 
not clear. The information relative to reproductive effects consists of field reports and 
experimental information. In the case of influenza, the field data are not well 
substantiated, and the experimental data are mixed. 
Statement of the Problem 
The question of the frequency with which pregnancy failure is associated with 
specific infectious agents in commercial swine herds was the crux of this work and the 
focus of Part 1. Further questions arose in the course of bringing the field work to 
completion. One of the critical questions was the interpretation and performance of 
the microtitration serum neutralization test in the diagnosis of encephalomyocarditis 
virus infection. Because of the central role in swine reproductive disease currently 
being hypothesized for encephalomyocarditis virus, it was believed that an evaluation 
of this test was mandatory. This work is described in Part 2. In Parts 3 and 4, the 
prevalence of encephalomyocarditis virus and Toxoplasma gondii estimated for the 
Iowa herd. These parts provide new information and another perspective from which 
to evaluate the potential role of specific infectious agents in reproductive diseases of 
swine. 
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PART I. ASSESSING THE ROLE OF INFECTIOUS AGENTS IN SWINE 
REPRODUCTIVE INEFFICIENCY: A FIELD STUDY 
Summary 
The role of 6 infectious agents known to be associated with reproductive failure 
in swine was studied in commercial swine herds. Blood samples were collected at 
breeding, mid-gestation, and farrowing from 210 first-litter gilts in IS swine herds. 
Serum samples were tested for antibody titers against encephalomyocarditis virus, swine 
influenza virus, pseudorabies virus, porcine parvovirus, Leptospira interrogans, and 
Toxoplasma gondii. The association between reproductive failure and infection, as 
determined by a ^4-fold increase in antibody titer, was determined. Farrowing ^3 
stillborn pigs, farrowing ^3 mummified fetuses, and farrowing ^6 live pigs were 
statistically associated with seroconversion to infectious agents. 
Introduction 
The reproductive efficiency of the breeding herd is one of the critical 
components in determining the profitability of a farrow-to-finish or feeder pig 
producing swine enterprise. An analysis of herds participating in the 1988 Iowa State 
University Swine Enterprise Records Program found the 99 highest profit herds to 
average 0.3 more live pigs per litter farrowed than the 99 lowest profit herds. Superior 
reproductive performance one of the important factors that was responsible for the 
difference in profitability between the 2 groups of herds (Stevermer, 1989). 
Reproductive inefficiency can result from any of a number of factors, acting 
alone or cumulatively. Madec (1988), in a study of 80 breeding herds and 2,709 sows 
followed through 2 parities, identified the IS most important components: 1. boar's 
previous mating results, 2. semen characteristics, 3. breed of sow, 4. rectal 
temperature around service, 5. urinary tract infection, 6. previous litter size, 7. 
farrowing-mating interval, 8. body condition, 9. motor activity, 10. seroconversion to 
porcine parvovirus or swine influenza virus near service, 11. method of service 
(artifical insemination or natural), 12. duration of copulation, 13. mating behavior, 
14. feed protein level, and IS. ambient temperature during the first month. The fact 
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that some of these are factors may act cumulatively to reduce the probability of 
successful reproduction explains why correcting only one deficit will not necessarily 
produce an improvement in reproductive performance. 
Infectious agents account for 30 to 40 percent of reproductive failures (Penny, 
1982; Straw, 1986). Madec (1988) found seroconversion to porcine parvovirus or swine 
influenza virus to be associated with poor reproductive performance in the field. The 
area of interest of this work was the role of infectious agents in reproductive failure. 
The specific focus of this study was the evaluation of the incidence of reproductive 
inefficiency in gilts in conjunction with seroconversion to any of several infectious 
agents commonly reported to be involved in reproductive losses in commercial swine 
breeding herds; encephalomyocarditis virus, porcine parvovirus, Leptospira 
interrogans, swine influenza virus, pseudorabies virus, and Toxoplasma gondii. 
Materials and Methods 
Description of herds Fifteen commercial swine herds participated in the 
study. Herds were geographically located within a radius of approximately ISO miles 
of Ames, Iowa and shared certain specific attributes. All herds were able to locate and 
identify individual gilts, sows, and boars in the breeding herd, and maintained records 
of the origin, breeding histories, and reproductive performance of each sow, gilt, and 
boar. All herds hand-mated sows and gilts, as opposed to pen-mated, making exact 
breeding dates available. Most herds purchased replacement gilts, rather than raising 
in-herd replacement animals. In all herds, commercial computer software was utilized 
to facilitate the collection, management, and analysis of herd performance data at all 
stages of production. 
Information relative to herd baseline production parameters is given in Table 1. 
Nine herds were identified as exclusively farrow-to-finish enterprises. One herd was 
primarily a farrow-to-finish operation, with occasional feeder pig sales. Three herds 
were identified as feeder pig producing herds, with occasional or secondary sales of 
finished animals to market. Two herds were identified as exclusively feeder pig 
producing herds. 
Herd reproduction data (Table 1) were based on the 12-month average prior to 
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the commencement of the study. Herd population statistics were based on the actual 
in-herd inventory during the study. No herds had expanded or contracted significantly 
within the previous 12-month period. Average sow inventory ranged from 85 to 1006, 
with an average among all herds of 358.5. Average boar inventory ranged from 7 to 
44, with an average of 10.2. The mean number of litters farrowed per sow per year 
ranged from 1.9 to 2.4, with an average of 2.2 among all herds. Average live born per 
litter ranged from 8.6 to 11.2 among the IS herds, with an overall average of 10.2. 
Most herds maintained records of stillborns and mummified fetuses observed at 
farrowing. Two herds, rather than recording each category separately, maintained a 
record of the sum total of stillborns and mummies per litter. 
These figures may be compared with information collected on swine herds 
participating in the National Animal Health Monitoring System (NAHMS) in Iowa (W. 
J. Owen, Iowa State University, Ames, Iowa, personal communication, 1990). In the 
NAHMS program, participants were selected according to a statistically valid, 
randomized protocol. The results, therefore, are considered representative of the Iowa 
herd. Herd production and economic data were collected by monthly interviews of 
NAHMS producers over the 12- to 18-month courses of their participation. Between 
1984 and 1989, 70 herds in the program reported farrowing sows. In these herds the 
average number of sows ranged from 11 to 507, with an average among all herds of 
109 sows. They reported farrowing an average of 1.9 litters per sow per year, with an 
average of 9.6 pigs born live per farrowing. 
By comparison, the herds participating in the current study averaged more than 
3 times the sow inventory of the average NAHMS participant herd, farrowed more 
litters per sow per year (1.9 versus 2.2), and produced more live pigs per litter 
farrowed (9.6 versus 10.2). These data would imply that the herds participating in the 
current study do not necessarily represent the norm in the state of Iowa. 
Producers were requested to provide information regarding the use in the 
breeding herd of vaccines against the 6 infectious agents of interest in this study. This 
information is given in Table 1 for each herd. Vaccination against PPV infection was 
carried out in 8/15 (53.3 %) of the herds, and against PRV in 9/15 (60.0 %). Vaccine 
against Leptospira serovars canicola, grippotyphosa, hard jo, icterohaemorrhagiae, and 
pomona was used in 9 (60.0 %) herds, and a single producer vaccinated against serovar 
Table 1. Baseline production parameters in IS survey herds (12 month average) 
Herd type —Inventory— Herd average per litter Litters/ -Vaccination in breeders-
Herd FF® FPP° Sows Boars Livebom Stillborn Mummified sow/year PPV L-5® L-b** PRV 
1 yes 1S6 10 10.8 0.8 0.2 2.2 yes yes yes 
2 yes® yes 1006 44 9.6 •— 0.85 ——— 2.3 yes yes yes 
3 yes — —  730 30 8.6 0.5 0.2 2.1 yes yes yes 
4 yes 218 11 10.1 0.8 0.3 2.1 yes yes yes 
5 yes 171 7 10.3 0.7 0.2 2.3 
6 yes — —  190 9 10.9 0.7 0.2 2.3 
7 yes® yes 134 6 10.7 0.8 0.3 2.0 yes yes yes yes 
8 yes yes* 322 17 9.8 0.6 0.1 1.9 yes yes yes 
9 yes 396 18 9.6 0.7 0.3 2.4 — — — yes 
10 yes 8S 6 9.7 1.3 0.7 1.9 
11 yes 103 10 10.8 0.7 0.5 2.1 — yes — 
12 yes 29S 14 10.0 0.7 0.3 2.2 
13 yes — —  2S3 11 11.2 0.5 0.2 2.3 
14 — —  yes 734 32 10.4 0.3 0.4 2.3 yes yes yes 
IS yes® yes S8S 20 10.0 —  — -•— 0.70 ———— 2.1 yes yes yes 
x= 358.5 16.3 10.2 0.97 ———— 2.2 
®Farrow-to-finish enterprise. 
^Feeder pig producing enterprise. 
^Vaccine against Leptospira interrogans serovars canicola, grippotyphosa, hard jo, icterohaemorrhagiae, and pomona. 
^Vaccine against Leptospira interrogans serovar bratislava. 
^Finishing swine to market is secondary to production of feeder pigs. 
Production of feeder pigs is secondary to finishing swine to market. 
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bratislava. At the time this study was done, no vaccine was available against EMCV, 
Toxoplasma or SIV infections. In the case of the gilts being monitored in the study, 
vaccinations were made 2 weeks prior to breeding to avoid confounding rising antibody 
titers due to infection with rising antibody titers resulting from vaccination. 
Experimental design In-herd prevalence of each of the 6 agents was 
estimated by serologic testing of 15 sows and 15 finishing animals in each herd, with 
the exception that finishing animals were not bled in feeder pig producing herds or in 
farrow-to-finish herds in which finishers were fed to market on premises removed 
from those in which the breeding herd was maintained. 
Animals to be bled were selected from all buildings on the premises and, within 
buildings, from assorted pens or crates. All sows had farrowed at least one litter, and 
finishing animals were greater that 150 pounds in weight. In sows, blood was colleted 
from the anterior vena cava using 4-inch 17-gauge needles. Finishing animals were 
bled using 1.5 inch 20-gauge single-use needles into an evacuated blood collection 
tube. Serum samples were stored at -70 C in 1 milliliter aliquots until serologic testing 
was performed. 
Antibody titers were monitored in gilts through the gestation period. Gilts 
were bled between 1 and 7 days prior to breeding and at midgestation. At farrowing, 
a count of live pigs, stillborn pigs and mummified fetuses was done, and a third blood 
collection was made. In the event that gilts farrowed more than 2 stillborn pigs or 
more than 2 mummified fetuses, samples were submitted to the Iowa State University, 
Veterinary Diagnositic Laboratory or to the United States Department of Agriculture, 
National Veterinary Services Laboratories for diagnosis. 
Stipulations were also made for non-productive reproductive events. Gilts that 
failed to settle after the inital breeding were re-bred and an additional blood collection 
was made. Gilts that failed to conceive after being bred through two consecutive 
periods of estrus were bled a third time and terminated from the study. Gilts that 
were discovered "open" (not pregnant) after more than 42 days of gestation were bled 
and terminated from the study. If abortion was observed in participating gilts, 
producers were requested to collect and refrigerate tissues for diagnostic evaluation. 
A gilt was defined as having completed the study when one of the following 
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Table 2. Number of gilts monitored from each herd 
Herd Gilts Herd Gilts 
1 8 9 13 
2 IS 10 13 
3 17 11 12 
4 11 12 17 
5 6 13 12 
6 10 14 23 
7 14 IS 20 
8 19 
conditions was met, and the final blood sample was collected; 1. bred three 
consecutive estrous cycles without becoming pregnant, 2. discovered "open" more than 
42 days after commencing gestation, 3. farrowed and information on litter was 
obtained. 
As given in Table 2, a total of 210 gilts from IS commercial swine herds were 
monitored in the study. The number of gilts per herd ranged from 6 to 23, with a 
mean of 14. 
In addition, producers were encouraged to collect and submit samples associated 
with reproductive failure. Such events were defined as circumstances where there were 
2 or more stillbirths or mummified fetuses in a litter at farrowing, or where tissues 
were available from aborted litters. Investigators personally collected the tissues from 
the farm and submitted the samples to the diagnositic facilities in order to avoid time 
delays and maximize the possibility of arriving at a diagnosis. In most cases, samples 
were at the diagnostic laboratory within 24 hours of the event. 
Analysis of data In this study, the Fisher exact test and the chi-square 
test were used to determine the probability of an association between the 
seroconversion and reproductive losses. Statistical measures of association are meant to 
assess the significance of the relationship between a hypothesized causal factor and a 
disease event. In the epidemiologic sense, demonstration of significance is necessary, 
but not sufficient. The reason this is so stems from the fact that, almost always, 
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exposure to causal factors will produce disease in only part of the population. Thus, a 
measure of the degree of association between the factor and the disease it causes is 
required. From another point of view, this may be considered to constitute an estimate 
of the extent to which the disease is caused by the hypothesized causal factor. Several 
measures are commonly in use in epidemiological research, including relative risk, odds 
ratio, attributable risk, and etiological fraction. For the purposes of this study, relative 
risk was used to describe the measure of association. 
Relative risk is calculated as the ratio between the rate of disease in the 
population exposed to the hypothesized causal factor, and the rate of disease in the 
unexposed group. If no association exists between the factor and the disease, the 
relative risk will be 1. The farther the relative risk estimate deviates from either side 
of 1, the stronger the association between the factor and the disease. Values less than 
1 imply that the factor provides a protective effect; values greater than 1 indicate a 
causal effect. 
Chi-squares, relative risk, and 95 percent confidence intervals for relative risk 
were calcuated using Epi Info, Version 5 (Dean et al., 1990). In addition, 95 percent 
confidence intervals for prevalence estimates were calculated using the method 
described by Galen and Gambino (1975), and statistical comparisons between 
population prevalence estimates were done as described by Snedecor and Cochran 
(1980). 
Results 
In-herd prevalence of the agents of interest was determined by serologic testing 
of sows, gilts and finishers for the presence of antibody. The results of these 
determinations, as well as associated analyses, are given in Tables 3 through 39. 
In gilts, the results reported here were obtained from the inital blood sample 
collected prior to breeding. As such, these data represent the serum antibody baseline 
in the monitored gilts. Most herds purchased gilts from seedstock multiplier herds 
rather than raise in-herd replacement gilts. In performing the analysis, it was not 
possible to identify whether gilts were purchased, or how long they had been in the 
herd before commencement of the study. The fact that most gilts have a background 
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in more than one herd may account for some differences in prevalence observed in the 
group. 
Finishers were not tested in feeder pig producing herds, or in herds that 
finished market animals on premises separate and apart from the breeding herd 
facilities. This accounts for the absence of these data in some herds identified as 
farrow-to-finish. 
Prevalence of enceohalomvocarditis virus Serum samples were tested for 
the antibodies against EMCV by the serum neutralization test at the Veterinary 
Diagnostic Laboratory, Iowa State University. Antibody titers of 1:8 were considered 
indicative of infection, with an estimated 97.8 percent sensitivity and 95.7 percent 
specificity at this dilution (Zimmerman et ai., 1990). The cumulative results of the 
EMCV serology are given by animal type in Table 3. Table 4 presents the analysis of 
the serology by animal type, including prevalence, relative risk, and a comparison of 
the prevalences for significant differences. Cumulative results of the EMCV serology 
by animal type and herd are given in Table 5. 
As given in Table 4, gilts (22.86 %) demonstrated a higher prevalence rate than 
either finishers (8.57 %) or sows (15.11 %). A comparison of proportions showed that 
these differences were significant. As estimated by relative risk, the rate of infection 
in sows was 1.77 times greater than in finishers, and the rate of infection in gilts was 
2.68 times greater than finishers. An explanation for the observed pattern is difficult 
to construe. It could be hypothesized that, since most gilts were purchased rather than 
home-raised, antibody titers may represent background exposures in their herds of 
origins. While it would not be expected that all gilts would originate from a single 
seedstock supplier, it is not impossible that few enough suppliers were involved to 
exert an significant impact on the overall prevalence in the group. 
As shown in Table 5, all herds had 1 or more animals with antibody titers >1:8, 
and fourteen herds had 1 or more animals with antibody titers >1:16. It may be 
concluded that EMCV was probably present in all 15 study herds. 
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Prevalence of swine influenza virus Serum samples were analyzed for the 
presence of antibodies against SIV (HlNl) by the hemagglutination-inhibition test (HI) 
at the Veterinary Diagnostic Laboratory, Iowa State University. Antibody titers of 
<1:10 were considered negative for swine influenza infection. The cumulative results 
of the SIV serology are given by animal type in Table 6. The analysis of the serology 
by animal type is given in Table 7. The cumulative results of the SIV serology by 
animal type and herd are given in Table 8. 
As Table 6 shows, infection was common in the subpopulations studied. The 
prevalence in finshers was estimated at 57.93 percent, in sows at 74.67 percent, and in 
gilts at 50.95 percent. The analysis supports the supposition that the prevalence is 
essentially the same in finishing animals and gilts; the 95 percent confidence interval 
in each category includes the prevalence estimate of the other group, and the direct 
comparison of proportions showed no differences between the level of infection in the 
two groups. In contrast, the sow population showed a significantly higher prevalence 
of infection. The rate of SIV infection in sows was 1.28 times the rate in finishers. 
As given in Table 8, antibodies against SIV at a dilution of >1:10 were 
demonstrated in multiple animals in all herds. These results suggest the presence of the 
virus throughout the 15 herds. 
Prevalence of porcine parvovirus Serum samples were analyzed for the 
presence of antibodies against PPV by the hemagglutination-inhibition test (HI) at the 
National Animal Disease Centers, Ames, Iowa. As shown in Table 1, 8 of the 15 herds 
were vaccinating against PPV infection. Thus, interpretation of HI test results was 
complicated by the presence of PPV vaccinal titers. Straw (1986) interpreted antibody 
titers of ^1:320 as characteristic of antibody levels in previously exposed sows in 
endemically infected herds. 
Colostral antibodies against PPV are also known to persist for an extended 
period of time and may confound serologic data (Paul et al., 1982). Johnson et al 
(1976) reported HI passively-acquired HI antibody titers of 1:10,000 to 1:40,000 in pigs 
suckling immune sows. Wrathall et al (1987) reported that passively-acquired HI 
antibody titers of up to 1:160 may persist at 6 months of age. 
To account for vaccinal and colostral antibodies, >1:320 was used as a 
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reasonable threshold value for infection. As given in Table 10, prevalence rates 
showed a strong age-related trend. The rate of PPV infection in gilts was 1.37 times 
that in finishers, and the rate in sows was 1.75 times the rate in finishers. Prevalence 
in finishing animals was estimated at 48.17 percent, in sows at 84.44 percent, and in 
gilts at 66.19 percent. Comparisons of prevalences showed that the estimated value in 
each animal type classification was significantly different from the other two. 
All herds appeared to have PPV-infected animals, as every herd had animals in 
which HI antibody titers were 3:1280. Interestingly, some herds had one or more 
animal type groups in which no detectable antibodies were present. In herds 1, 4, and 
7, all finishers tested had antibody titers of ^10, as did all gilts in herds 1, 3, and 7. 
Prevalence of oseudorabies virus As in the case of parvovirus, the 
interpretation of PRV serologic results is confounded with vaccine-derived antibodies. 
As shown in Table 1, 9 herds were using vaccines against PRV. To differentiate 
between vaccine-induced antibodies and field infection, a series of 3 tests was run. 
Serum samples from finishers and sows were analyzed for the presence of antibodies 
against PRV by the serum neutralization test at the Veterinary Diagnostic Laboratory, 
Iowa State University (Tables 12 and 13). Samples from finishers, sows, and gilts were 
also assayed by the latex agglutination test* (Table 14). Latex agglutination-positive 
samples were further tested by the Suvaxyn® gl ELISA test^ (Tables 14 and 18). 
By the serum neutralization test, 6.70 percent of finishing animals and 47.11 
percent of sows were positive at an antibody titer of 1:4 or greater. Gilt samples were 
not tested by serum neutralization. By the Suvaxyn® glycoprotein (gl) differential 
enzyme-linked immunosorbent assay (ELISA), run on latex agglutination-positive 
samples only, 10.37 percent of finishers, 36.44 percent of sows, and 22.86 percent of 
gilts were PRV-positive. 
The results from the latex agglutination test indicated that 62.19 percent of 
finishers, 80.44 percent of sows, and 60.48 percent of gilts were positive for antibodies 
* Viral Antigens Inc., Memphis, TN. 
^Eurodiagnostics, Apeldorn, The Netherlands. 
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against PRV. It is believed that the lack of agreement between the latex agglutination 
test and the two other tests arose from misinterpretation of the latex agglutination 
results or misreading of results. Controlled studies have shown the latex agglutination 
test to have specificity and sensitivity equal or superior to other tests (Schoenbaum et 
al., 1990). 
The gl ELISA, by the use of monoclonal antibody technology, is able to 
differentiate between infected pigs and vaccinated pigs, provided the animals are 
immunized with vaccines based on viruses that do not contain the gl antigen. Under 
such circumstances, researchers have reported a high degree of reliability for 
differentiation of vaccinates from infected animals by the gl ELISA (Eloit et al., 1989; 
Mellencamp et al., 1989; van Oirschot et al., 1988). Since the true PRV status of the 
animals in this study was not known, a scientific comparison of performance could not 
be made between tests. Seemingly, the gl ELISA and the SN test (Table 16) showed 
reasonable agreement in finishing animals, and less so in breeding animals. Since the 
exact vaccine history of each individual animal could not be ascertained with certainty, 
it is possible that some gl positives were the result of vaccination with a non-gl deleted 
vaccine, as for example in herd 8 in which all animals tested gl-positive. 
On the basis of the gl ELISA results, the rate of infection in sows was 
estimated to be 3.52 times greater than in finishers, and the rate in gilts was 2.21 times 
greater compared with finishers. Using gl ELISA in conjunction with herd history, 7 
herds were classified as PRV-positive. This consists of herds 1, 3, 4, 8, 9, 12, and 14. 
Herd 8 was considered PRV-infected on the basis of a prior diagnosis of clinical 
disease in the herd. 
Prevalence of Toxoplasma eondii Serum samples were tested for the 
presence of antibodies against Toxoplasma gondii by enzyme-linked immunosorbent 
assay at the University of Georgia, Athens, Georgia. ELISA results were reported as 
negative, positive, or suspect, as shown in Tables 19 and 20. Suspect responses were 
re-interpreted on the basis of serology in the herd of origin. Suspect samples from a 
herd containing other ELISA-positive samples were considered positive. Suspect 
samples originating from a herd with no ELISA-positive samples were considered 
negative. Using this "adjustment," all suspects were positive. The results of this 
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convention are used as the basis of analysis and discussion. The cumulative results of 
the adjusted Toxoplasma serologic results are given by animal type in Table 21. Table 
22 presents the analysis of the serologic results by animal type, including prevalence, 
relative risk, and a comparison of the prevalences for significant differences. 
Cumulative results of the adjusted Toxoplasma serologic tests by animal type and herd 
are given in Table 23. 
Over all, 12 of IS herds had 1 or more Toxoplasma-positive animals (Table 23). 
As given in Table 21, prevalence in finishing animals (6.10 %) was lower than in gilts 
(9.52 %), which was in turn lower than the prevalence in sows (11.56 %). The rate of 
infection in sows was 1.90 time that in finishers, and the rate in gilts was 1.56 times 
that in finishers. However, a comparison of proportions showed no significant 
difference in prevalence among the three groups. Furthermore, the 95 percent 
confidence intervals for prevalence overlapped, and the 95 percent confidence intervals 
for relative risk included 1 in all 3 cases. We would conclude that prevalence rates 
showed a tendency to increase by age, but this tendency was not statistically 
significant. 
Prevalence of Leptospira interroeans Serum samples were tested for 
agglutinating antibodies against 12 serovars of Leptospira interrogans at the National 
Veterinary Services Laboratories, Ames, Iowa. The cumulative results are given by 
animal type in Table 24. Results for each herd by animal type are listed in Tables 25 
to 39. 
Interpretation of Leptospira interrogans serology on the basis of a single serum 
sample is difficult. The agglutination test measures primarily IgM (Hanson et al., 
1972). Since IgM declines rapidly, serum from vaccinated swine are generally negative. 
Even so, vaccination can stimulate aggutination antibody titers as high as 1:400, and 
occasionally 1:800, which may persist at this level for 2 or 3 months (Hill, 1988). As 
given in Table 1, 9 herds were vaccinating against Leptospira. 
In one study, antibody titers to homologous antigens in experimentally infected 
animals showed considerable variability, ranging from 1:400 to 1:25,600 in gilts 
(Hathaway et al., 1983). Peak titers were maintained for a 27 to 33 days before 
declining to lower levels. Low antibody titers may persist for several years, sometimes 
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at levels not generally considered indicative of infection. Ellis and Thiermann (1986) 
reported bratislava antibody titers of 1:25 and ^1:100 in 2 sows from which bratislava 
was isolated. 
Cross reactions between serovars is also known to occur. Serovar cmicola is 
reported to cross react with icterohemorrhagiae, pontona with grippotyphosa, and 
bratislava with autumnalis, muenchen, and copenhageni (Hanson et al., 1972; Hathaway 
et al., 1983; Miller et al., 1990). 
Swine experimentally infected with one serovar may produce a higher 
agglutination titer to a serovar other than that with which they were infected. This is 
termed a "paradoxical reaction." Hathaway et al. (1983) described paradoxical reactions 
to bratislava in pigs infected with muenchen and copenhageni (Hathaway et al., 1983). 
Hathaway et al. (1983) concluded that, without additional information, leptospiral 
antibody titers found in serological could only be regarded as "potentially serotype 
indicative." 
There has been no consensus as to what constitutes a diagnostic antibody titer 
on the basis of a single serum sample. As reviewed by McErlean (1972), antibody 
titers ranging from 1:10 to 1:300 have been considered indicative of infection by 
different investigators. 
In this study, the algorithm used to determine herd infection status was based 
on 3 considerations. Herds were considered to be infected if 1. antibody titers >1:200 
were present in finishing animals or unvaccinated breeding animals, or 2. antibody 
titers ^1:800 were observed in sows and gilts, or 3. a 4-fold rise in titer was seen 
between 2 consecutive serum samples from monitored gilts. One or more gilts in 12 
herds showed a 4-fold rise in antibody titer. Serology in finishers and sows IS herds 
met the criteria established for positivity. On this basis, all herds were considered 
positive. 
Apportionment of gilts The outcome of monitoring 210 gilts is given in 
Table 40. This information is given by herd in Table 41. 
Six (2.86 %) animals were removed from the study when their ear tags were lost 
and they could no longer be reliably identified. An additional 7 (3.33 %) animals died 
during the study period. In most cases the cause of death was not determined and was 
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simply reported by the producer after the fact. One animal is known to have broken a 
leg and was shot. Eighteen (8.57 %) gilts failed to cycle and were never bred. 
Twenty-three (10.95 %) animals were bred one or more times but failed to conceive 
and were removed from the breeding herd by the producers. Twenty-five (11.90 %) 
animals were bred and became pregnant, but were identified as "open" during the 
course of the gestation period. Two (0.95 %) animals are known to have aborted 
because of the physical presence of fetal membranes and tissues. It is possible that 
some of the open gilts may have aborted, but the absence of any physical evidence of 
abortion precluded the possibility of reliably identifying any such animals. One 
hundred twenty-nine animals were bred and farrowed at term. 
Nearly 20 percent either did not cycle normally and become receptive for 
breeding, or were bred one or more times and did not become pregnant. High ambient 
temperatures are known to impact adversely on breeding (Hurtgen, 1980), and the 
reproductive failure of some of these gilts was probably linked to the extremely high 
ambient temperatures that occurred during the summer and fall they entered the 
breeding herd. 
Table 43 provides a summary of the gilt reproductivity by herd. From this 
table, it can be seen that the farrowing rate ranged from 20.0 to 100 percent. The 
average number of pigs born live ranged from 5.0 to 12.75. The average number of 
stillborn pigs ranged from 0.00 to 2.00, and the average number of mummified fetuses 
ranged from 0.00 to 2.00. 
The reproductive information in Table 43 is juxtaposed with the raw data on 
the number of significant seroconversions, defined as four-fold increases in antibody 
titer, against any of the 6 agents of interest during gestation by any gilt in the herd. 
Table 43 does not account for multiple infections in a single animal, but it does 
provide an indication of the transmission activity within each herd during the period 
of monitoring. In this analysis, a 4-fold rise in antibody titer against any Leptospira 
interrogans serovar was considered indicative of infection. Also, leptospiral infections 
were considered a single classification, rather than analyzing each serovar 
independently. 
Significant rises in antibody titer were seen against all infectious agents except 
for pseudorabies virus. A high level of transmission activity was not necessarily 
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associated with poor reproductive performance. The gilts in herd 6, for example, 
showed evidence of infection by Leptospira, parvovirus, encephalomyocarditis virus, 
and swine influenza virus, but 10 of 10 gilts farrowed an average of 11.5 live pigs. 
Conversely, a lack of infectious activity was seen to occur in a herd with a poor 
reproductive performance; in herd 15 only 4 of 20 gilts farrowed. 
Porcine parvovirus-induced reproductive losses were diagnosed in 5 herds 
during the course of the study on the basis of submissions of fetal tissues to the Iowa 
State University, Veterinary Diagnostic Laboratory. Four of these herds included PPV 
vaccine in the prophylactic regime. Two study gilts in herd 3 produced litters of 
stillborn and macerated pigs which were diagnosed as PPV-positive. 
Analvsis of losses The analysis of reproductive losses associated with 
infectious agents was performed using the 2-by-2 classification illustrated in Figure 1. 
Each "reproductive event," i.e., failure to settle, failure to farrow, etc., was cross-
classified by the presence or absence of a 4-fold seroconversion to an infectious agent 
or combination of infectious agents. The "disease positive" classification was balanced 
by "a disease negative" classification also cross-classified by the presence or absence of 
seroconversion to disease agent(s). The significance of infection in conjunction with 
reproductive loss was assessed using the Fischer exact test or the chi-square test, 
depending on the size of the value in each cell. If the value of any cell was less than 
5, the Fisher exact probability test was used. In statistically significant situations 
(P:^O.OS), the measure of association was assessed by relative risk. 
Relative risk is the ratio between the rate of reproductive loss in the population 
infected during pregnancy and the rate of reproductive loss in the group in which no 
evidence of infection exists. Using the notation given in Figure 1, relative risk was 
calculated as (A/ng)/(C/n^). If no association exists between the factor and the 
disease, the relative risk is 1. The farther the relative risk estimate deviates from 
either side of 1, the stronger the association between the factor and the disease. Values 
less than 1 imply that the factor provides a protective effect, whereas values greater 
than 1 indicate a causal effect. 
The analysis of reproductive losses is given in Tables 44 through 48. The 
analysis was performed on five defined reproductive loss categories; 1. failure to 
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conceive, 2. failure to farrow, 3. farrowing 2:3 stillborn pigs in a litter, 4. farrowing 
^3 mummified fetuses in a litter, and S. farrowing £6 live pigs in a litter. The 
category of failure to farrow included both animals that failed to maintain pregnancy 
and were found open, and animals that were known to have aborted. 
Each possible combination of infections was analyzed separately. This was 
required to account for possible synergistic or sparing interactions between agents and 
to avoid "double counting." Thus, an infection with parvovirus alone is considered to 
be different from a dual infection with parvovirus and encephalomyocariditis virus. 
However, because of the ambiguity of antibody titers against Leptospira, including 
paradoxical reactions and rising antibodies against heterologous serovars, any 4-fold 
increase in any serovar was analyzed as Leptospira-ipositwQ. Calculations were not 
done for specific serovars. 
From the results of the analyses given in Tables 44 through 48, it can be seen 
that infection, as indicated by 4-fold rising antibody titers, was statistically associated 
with specific types of reproductive losses. These include farrowing >3 stillborn pigs, 
farrowing ^3 mummified fetuses, and farrowing ^6 live pigs. No such association was 
seen in animals failing to conceive or failing to farrow. Gilts showed significant 
increases in antibody titers in 66.7 percent (6/9) of cases in which 3 or more stillborn 
pigs were observed at farrowing, although no single infectious agent, or combination of 
infectious agents, was more commonly seen in conjunction with stillbirths. Infection 
was seen in 57.1 percent (4/7) of the cases of farrowing 3 or more mummified fetuses. 
Three of the cases involved parvovirus infection and 1 swine influenza virus. Infection 
was detected in 67.9 percent (19/28) of the cases in which 6 or fewer live pigs were 
farrowed. No single infectious agent, or combination of agents, predominated in this 
category. 
Ancillarv diagnostic studies Participating producers were encouraged to 
submit tissue and serum samples involving reproductive failure in breeding stock other 
than gilts involved in the project. This would include abortions and instances where 
there were 2 or more stillbirths, mummified, or macerated fetuses in a litter at 
farrowing. Investigators collected the tissues and blood samples from the farm and 
submitted the samples to the diagnositic facilities. In most cases, samples were at the 
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diagnostic laboratory within 24 hours of the event. The diagnostic results on the 
submissions are given in Table 49. 
Samples were submitted from 9 of the 15 herds. Submissions from 5 of these 
herds had 1 or more porcine parvovirus positive diagnoses. In all, 17.6 percent <9/51) 
of the litters were diagnosed with parvovirus. One isolation of swine influenza virus 
was made. 
Discussion 
In this study, the role of 6 infectious agents known to be associated with 
reproductive failure in swine was studied in commercial swine herds. On the basis of 
in-herd serologic testing of finishers, gilts, and sows, it was concluded that all herds 
were infected with encephalomyocarditis virus, swine influenza virus, Leptospira 
interrogans, and porcine parvovirus. Seven herds were considered infected with 
pseudorabies virus, and 12 herds showed evidence of infection with Toxoplasma 
gondii. 
Blood samples were collected at breeding, mid-gestation, and farrowing from 
210 first-litter gilts in 15 swine herds. Serum samples were tested for antibody titers, 
and the association between reproductive failure and infection, as indicated by a >4-
fold increase in antibody titer, was determined. 
Significant rises in antibody titer were seen against all infectious agents except 
for pseudorabies virus. The failure to detect seroconversion to pseudorabies virus 
implied that pseudorabies was not circulating among breeding animals in the 7 infected 
herds. This, despite the fact that a clinical outbreak of PRY was diagnosed in the 
finishing animals in one herd during the study. 
No significant association was observed between seroconversion and animals 
that failed to conceive, or animals that were open in presumed mid-gestation. 
Farrowing ^3 stillborn pigs, farrowing >3 mummified fetuses, and farrowing <6 live 
pigs was associated with infectious agents. No single infectious agent was determined 
to be associated most frequently with 3 or more stillborns at farrowing, although 
seroconverstion, per se, significantly associated with this event. However, 
seroconversion to porcine parvovirus was associated with 3 or more mummified fetuses 
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at farrowing. Seroconversion to parvovirus increased the risk of this event by 6.18 for 
gilts in this study. The birth of 6 or fewer live pigs at farrowing was linked with 
infection. Cumulatively, gilts that seroconverted were 2.78 times more likely to 
produce a litter of 6 or less. 
The ability of this study to fully evaluate the effects of the infectious agents of 
interest on porcine reproduction was compromised by the relatively small number of 
animals showing seroconversions. As a result, cell sizes were small in the statistical 
analysis. For the same reason, it was not possible to adequately assess the role of 
multiple infections or determine whether specific combinations of infections were 
additive, synergistic, or protective. These problems result directly from the fact that 
this research was field-based rather than artificially manipulated in the laboratory. On 
the other hand, these data are more representative of the true circumstances under 
which infections occur. 
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Additional Tables 
Table 3. Serum antibody titers against encephalomyocarditis virus by animal type 
Reciprocal of antibody titer 
Animal type Number 0 2 4 8 16 32 64 128 ^256 
Finishers 
(Percent) 
162 109 25 14 8 
(67.3) (15.4) (8.6) (4,9) 
4 2 0 
(2.5) (1.2) 
0 0 
Sows 
(Percent) 
225 124 45 22 19 
(55.1) (20.0) (9.8) (8.4) 
4 8 12 0 
(1.8) (3.6) (0.4) (0.9) 
Gilts 
(Percent) 
210 93 48 21 23 
(44.3) (22.9) (10.0) (11.0) 
8 8 5 3 1 
(3.8) (3.8) (2.4) (1.4) (0.5) 
Table 4. Assessment of association between EMCV antibody titers and animal type 
Animal 
type Pos^ Neg" 
—Prevalence--- --Relative risk--
/ (95 % CI)° RR (95 % CI)° 
Prevalence 
comparisons® 
Finishers (/) 14 ISO 8.S4 (4.17, 12.90) 1.0 — 1. Pf - P* 
Sows ( s )  34 191 15.11 (10.34, 19.89) 1.77 (0.98, 3.69) 2. P/ - Y 
Gilts { g )  48 162 22.86(17.06, 28.65) 2.68 (1.53, 4.68) 3. Pg - P* 
^Antibody titers >1:8 classified positive. 
^Antibody titers <1:8 classified negative. 
^Prevalence (p) calculated as [(positive/(positive + negative)) x 100]. 
^95 percent confidence interval. 
®HQ: p\ = p2 vs Hg: p\ # p2. 
*Significant at 0.05 level. 
tSignificant at 0.0002 level 
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Table S. Serum antibody titers against encephalomyocarditis virus by herd 
Herd Animal Reciprocal of antibody titer 
number type (N) 0 2 4 8 16 32 64 128 ^256 
1 Finishers (15) 12 1 2 
Sows (15) 8 2 1 1 3 
Gilts (8) 2 4 2 
2 Finishers (15) 7 4 1 2 1 
Sows (15) 11 2 1 1 
Gilts (15) 4 6 2 3 
3 Finishers (15) 8 2 2 1 1 1 
Sows (15) 8 2 1 2 1 
Gilts (17) 4 10 1 1 
4 Finishers (15) 12 1 1 1 
Sows (15) 9 2 2 2 
Gilts (11) 5 3 1 1 1 
5 Finishers (15) 10 3 1 1 
Sows (15) 9 2 2 2 
Gilts (6) 2 1 1 1 1 
6 Finishers (13) 8 1 2 1 1 
Sows (15) 8 3 2 1 
Gilts (10) 5 2 1 1 
7 Finishers (15) 11 4 
Sows (15) 7 7 1 
Gilts (14) 10 1 1 2 
8 Finishers (15) 11 1 3 
Sows (15) 8 4 2 1 
Gilts (19) 12 2 2 1 
9 Sows (15) 9 1 4 
Gilts (13) 7 2 1 3 
10 Sows (15) 7 3 1 2 1 1 
Gilts (13) 4 2 4 2 1 
11 Sows (15) 5 4 2 3 1 
Gilts (12) 8 1 2 
12 Finishers (14) 10 3 1 
Sows (15) 11 3 1 
Gilts (17) 10 4 2 
13 Finishers (15) 13 1 1 
Sows (15) 6 4 3 2 
Gilts (12) 7 2 1 2 
14 Sows (15) 10 3 1 1 
Gilts (23) 9 2 2 5 2 
IS Finishers (15) 7 5 1 1 1 
Sows (15) 8 3 2 1 1 
Gilts (20) 4 7 3 5 1 
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Table 6. Serum antibody titers against swine influenza virus (HlNl) by animal type 
Reciprocal of antibody titer 
Animal type Number 0 10 20 40 80 160 320 ^640 
Finishers 164 69 30 24 13 14 4 4 6 
(Percent) (42.1) (18.3) (14.6) (7.9) (8.5) (2.4) (2.4) (3.7) 
Sows 225 57 45 49 24 25 13 4 8 
(Percent) (25.3) (20.0) (21.8) (10.7) (11.1) (5.8) (1.8) (3.6) 
Gilts 210 103 40 29 25 7 2 2 2 
(Percent) (49.0) (19.0) (13.8) (11.9) (3.3) (1.0) (1.0) (1.0) 
Table 7. Assessment of association between SIV antibody titers and animal type 
Animal 
type Pos® Neg^ 
—Prevalence—-
( 9 5  %  C l f  
—Relative risk--
RR (95 % CI)^ 
Prevalence 
comparisons® 
Finishers (/) 95 69 57.93 (50.22, 65.64) 1.0 1. Pf - Ps\ 
Sows ( s )  168 57 74.67 (68.87, 80.47) 1.28 (1.11, 1.50) 2. Pf - Pg* 
Gilts ( g )  107 103 50.95 (44.05, 57.85) 0.88 (0.73, 1.06) 3. Pg - Pst 
^Antibody titers >1:10 classified positive. 
^Antibody titers <1:10 classified negative. 
^Prevalence (p) calculated as [(positive/(positive + negative)) x 100]. 
^95 percent confidence interval. 
®HQ: pi = p2 vs Hg: pi # p2. 
*No significant difference at 0.05 level. 
fSignificant at 0.001 level. 
ISignificant at 0.0001 level 
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Table 8. Serum antibody titers against swine influenza virus (HlNl) by herd 
Herd Animal Reciprocal of antibody titer 
number type (N) 0 10 20 40 80 160 320 >640 
1 Finishers (15) 1 3 5 3 1 1 1 
Sows (15) 3 2 2 4 3 1 
Gilts (8) 4 3 1 
2 Finishers (15) 6 2 3 2 1 1 
Sows (15) 2 6 4 1 1 1 
Gilts (15) 2 3 4 1 1 1 1 2 
3 Finishers (15) 2 3 5 2 3 
Sows (15) 4 1 6 1 3 
Gilts (17) 5 8 3 1 
4 Finishers (15) 13 1 1 
Sows (15) 3 5 6 1 
Gilts (11) 1 3 4 2 1 
5 Finishers (15) 13 1 1 
Sows (15) 10 2 1 1 1 
Gilts (6) 3 2 1 
6 Finishers (15) 1 3 4 2 1 2 2 
Sows (15) 1 10 2 1 1 
Gilts (10) 8 2 
7 Finishers (15) 13 2 
Sows (15) 1 2 4 5 1 2 
Gilts (14) 9 2 3 
8 Finishers (15) 9 1 2 3 
Sows (15) 3 6 2 3 1 
Gilts (19) 17 1 1 
9 Sows (15) 3 4 3 2 2 1 
Gilts (13) 13 
10 Sows (15) 1 1 2 2 4 4 1 
Gilts (13) 9 3 1 
11 Sows (15) 2 5 3 1 3 1 
Gilts (12) 6 5 1 
12 Finishers (14) 7 5 2 
Sows (15) 6 4 2 1 1 1 
Gilts (17) 7 4 4 2 
13 Finishers (15) 7 6 1 1 
Sows (15) 6 3 2 3 1 
Gilts (12) 7 4 1 
14 Sows (15) 10 3 1 1 
Gilts (23) 7 7 3 6 
15 Finishers (15) 1 8 6 
Sows (15) 7 4 1 1 1 1 
Gilts (20) 10 7 2 1 
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Table 9. Serum antibody titers against porcine parvovirus by animal type 
Reciprocal of antibody titer 
Animal type Number ^10 40 80 160 320 640 2:1280 
Finishers 
(Percent) 
164 82 
(50.0) 
0 1 
(0.6) 
2 
(1.2) 
12 
(7.3) 
14 53 
(8.5) (32.3) 
Sows 
(Percent) 
225 15 
(6.7) (0.4) 
6 
(2.7) 
13 
(5.8) 
36 
(16.0) 
41 113 
(18.2) (50.2) 
Gilts 
(Percent) 
210 61 
(29.0) 
2 
(1.0) 
1 
(0.5) 
7 
(3.3) 
18 
(8.6) 
43 78 
(20.5) (37.1) 
Table 10. Assessment of association between PPV antibody titers and animal type 
Animal 
type Pos® Neg'^ 
—Prevalence—-
/ (95 % CI)° 
—Relative risk--
RR (95 % CI)° 
Prevalence 
comparisons® 
Finishers (/) 79 85 48.17(40.37, 55.97) 1.0 1. Pf - Pgf 
Sows (s) 190 35 84.44(79.61, 89.28) 1.75 (1.48, 2.07) 2. Pf - Pg* 
Gilts ( g )  139 71 66.19(59.66, 72.72) 1.37 (1.14, 1.65) 3. Pg - Psi 
®Antibody titers ^1:320 classified positive. 
'^Antibody titers <1:320 classified negative. 
^Prevalence ( p )  calculated as [(positive/(positive + negative)) x 100]. 
^95 percent confidence interval. 
®HQ: p\ = p2 vs H^: pi # p2. 
''Significant at 0.001 level. 
fSignificant at 0.0001 level 
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Table 11. Serum antibody titers against porcine parvovirus by herd 
Herd Animal Reciprocal of antibody titer 
number type (N) £10 40 80 160 320 640 ^1280 
1 Finishers (15) 15 
Sows (15) 1 2 2 4 6 
Gilts (8) 8 
2 Finishers (15) 7 3 2 3 
Sows (15) 1 2 1 1 10 
Gilts (15) 5 10 
3 Finishers (15) 13 2 
Sows (15) 1 4 5 5 
Gilts (17) 17 
4 Finishers (15) 15 
Sows (15) 1 3 1 10 
Gilts (11) 11 
5 Finishers (15) 1 1 1 7 2 3 
Sows (15) 2 2 6 3 2 
Gilts (6) 1 1 1 1 2 
6 Finishers (15) 5 1 3 6 
Sows (15) 2 1 2 3 7 
Gilts (10) 1 1 6 1 1 
7 Finishers (15) 15 
Sows (15) 5 2 2 6 
Gilts (14) 14 
8 Finishers (15) 7 4 4 
Sows (15) 1 4 6 4 
Gilts (19) 1 18 
9 Sows (15) 1 2 2 3 7 
Gilts (13) 1 2 5 5 
10 Sows (15) 2 1 2 2 8 
Gilts (13) 1 1 2 4 5 
11 Sows (15) 1 1 1 12 
Gilts (12) 2 1 2 7 
12 Finishers (14) 1 1 2 10 
Sows (15) 2 3 2 8 
Gilts (17) 1 2 5 9 
13 Finishers (15) 15 
Sows (15) 1 1 3 8 
Gilts (12) 3 2 1 1 4 1 
14 Sows (15) 1 4 10 
Gilts (23) 3 1 1 3 8 7 
15 Finishers (15) 4 1 10 
Sows (15) 1 1 2 1 10 
Gilts (20) 7 13 
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Table 12. Serum antibody titers against pseudorabies virus by animal type 
Animal type Number 
Reciprocal of antibody titer 
0 2 4 8 16 32 64 ^128 
Finishers 
(Percent) 
164 141 10 2 6 2 2 0 1 
(86.0) (6.1) (1.2) (3.7) (1.2) (1.2) (0.6) 
Sows 
(Percent) 
225 83 36 30 20 28 17 6 5 
(36.9) (16.0) (13.3) (8.9) (12.4) (7.6) (2.7) (2.2) 
Gilts 210 (Serum neutralization test not performed) 
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Table 13. Serum antibody titers against pseudorabies virus by herd 
Herd Animal Reciprocal of antibody titer 
number type (N) 0 2 4 8 16 32 64 >128 
1 Finishers (15) 
Sows (15) 
13 2 
1 1 4 2 3 
2 Finishers (15) 
Sows (15) 
15 
1 2 5 3 3 1 
3 Finishers (15) 
Sows (15) 
15 
2 2 2 3 3 
4 Finishers (15) 
Sows (15) 
14 
4 
1 
10 1 
5 Finishers (15) 
Sows (15) 
15 
15 
6 Finishers (15) 
Sows (15) 
15 
15 
7 Finishers (15) 
Sows (15) 
15 
3 6 3 1 1 1 
8 Finishers (15) 
Sows (15) 
2 2 6 
1 
2 
8 
2 
3 
9 Sows (15) 2 3 1 4 4 
10 Sows (15) 15 
11 Sows (15) 15 
12 Finishers (14) 
Sows (15) 
11 3 
4 5 2 3 1 
13 Finishers (15) 
Sows (15) 
13 
15 
2 
14 Sows (15) 4 5 2 3 1 
15 Finishers (15) 
Sows (15) 
15 
5 5 4 1 
59 
Table 14. Pseudorabies infection status by animal type as determined by 
the latex agglutination test^ 
Latex agglutination test 
Animal type Number Positive Negative 
Finishers 164 102 62 
(Percent) (62.19) (37.80) 
Sows 225 181 44 
(Percent) (80.44) (19.56) 
Gilts 210 127 83 
(Percent) (60.48) (39.52) 
®Viral Antigens, Inc., Memphis, Tennessee. 
Table 15. Pseudorabies infection status by animal type as determined by 
the Suvaxyn® gl ELISA test^ 
gl ELISA 
Animal type Number^ Positive Negative Not done 
Finishers 164 17 85 62 
(Percent) (10.37) (51.83) 
Sows 225 82 99 44 
(Percent) (36.44) (44.00) 
Gilts 210 48 79 83 
(Percent) (22.86) (37.62) 
^Eurodiagnostics, Apeldorn, The Netherlands. 
^Test run on latex agglutination-positive samples only. 
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Table 16. Comparison of the Suvaxyn® gl ELISA test and serum neutralizing 
antibody titers by animal type 
Animal Reciprocal of serum neutralizing antibody titer 
type (N) gl ELISA 0 2 4 8 16 32 64 ^128 
Finishers Positive 0 4 2 6 2 2 0 1 
Negative 81 4 0 0 0 0 0 0 
Sows Positive 2 15 8 8 23 15 6 5 
Negative 37 21 22 12 5 2 0 0 
Table 17. Assessment of association between Suvaxyn® gl ELISA results 
and animal type 
Animal 
type Pos Neg 
—Prevalence---
/ (95 % CI)" 
--Relative risk--
RR (95 % CI)° 
Prevalence 
comparisons^ 
Finishers (/) 17 147 10.37 (5.61, 15.13) 1.0 t P f - P s ^  
Sows (s) 82 143 36.44 (30.03, 42.86) 3.52 (2.17, 5.69) 2. Pf - P/ 
Gilts ( g )  48 162 22.86(17.06, 28.65) 2.21 (1.32, 3.69) 3. Pg - p/ 
^Prevalence ( p )  calculated as [(positive/(positive + negative)) x 100]. 
^95 percent confidence interval. 
pi = p2 vs Hg: pi # p2. 
""Significant at 0.002 level. 
tSignificant at 0.0001 level 
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Table 18. PRY status by herd as determined by the gl ELISA 
Herd Animal gl ELISA 
number type (N) Positive Negative 
1 Finishers 0 9 
Sows 11 4 
Gilts 8 0 
2 Finishers 0 12 
Sows 0 15 
Gilts 0 15 
3 Finishers 0 12 
Sows 13 2 
Gilts 0 17 
4 Finishers 0 15 
Sows 12 3 
Gilts 7 4 
5 Finishers 0 13 
Sows 0 8 
Gilts 0 1 
6 Finishers 0 12 
Sows 0 15 
Gilts 0 0 
7 Finishers 0 7 
Sows 0 15 
Gilts 0 12 
8 Finishers 15 0 
Sows 15 0 
Gilts 19 0 
9 Sows 11 4 
Gilts 0 2 
10 Sows 0 2 
Gilts 0 0 
11 Sows 0 4 
Gilts 0 0 
12 Finishers 2 5 
Sows 11 4 
Gilts 14 3 
13 Finishers 0 0 
Sows 0 2 
Gilts 0 0 
14 Sows 9 6 
Gilts 0 6 
15 Finishers 0 0 
Sows 0 15 
Gilts 0 19 
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Table 19. Toxoplasma gondii infection status by animal type as determined by ELISA 
Animal type Number Positive 
-ELISA results-
Negative Suspect 
Finishers 164 3 154 7 
(Percent) (1.8) (93.9) (4.3) 
Sows 225 9 197 19 
(Percent) (4.0) (87.6) (8.4) 
Gilts 210 6 190 14 
(Percent) (2.9) (90.5) (6.7) 
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Table 20. Toxoplasma gondii infection status by herd as determined by ELISA 
Herd Animal ELISA results 
Number type (N) Positive Negative Suspect 
1 Finishers (15) 1 14 
Sows (15) 14 1 
Gilts (8) 1 7 
2 Finishers (15) 45 
Sows (15) 11 4 
Gilts (15) 1 13 1 
3 Finishers (15) 15 
Sows (15) 1 11 3 
Gilts (17) 17 
4 Finishers (15) 15 
Sows (15) 15 
Gilts (11) 11 
5 Finishers (15) 15 
Sows (15) 15 
Gilts (6) 6 
6 Finishers (13) 1 11 3 
Sows (15) I 14 
Gilts (10) 10 
7 Finishers (15) 15 
Sows (15) 13 2 
Gilts (14) 1 11 2 
8 Finishers (15) 1 13 I 
Sows (15) 14 1 
Gilts (19) 16 3 
9 Sows (15) 13 2 
Gilts (13) 13 
10 Sows (15) 1 14 
Gilts (13) 12 1 
11 Sows (15) 3 11 1 
Gilts (12) 12 
12 Finishers (14) 13 1 
Sows (15) 14 1 
Gilts (17) 3 10 
13 Finishers (15) 14 1 
Sows (15) 1 13 1 
Gilts (12) 11 1 
14 Sows (15) 14 1 
Gilts (23) 21 2 
15 Finishers (15) 14 1 
Sows (15) 2 11 2 
Gilts (20) 20 
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Table 21. "Adjusted" Toxoplasma gondii infection status by animal type* 
Animal type Number Positive Negative 
Finishers 164 10 154 
(Percent) (6.1) (93.9) 
Sows 225 26 199 
(Percent) (11.6) (88.4) 
Gilts 210 20 190 
(Percent) (9.5) (90.5) 
®ELISA "suspect" 
negative. 
animals recoded as "positive" if other positives in herd; else 
Table 22. Assessment of association between "adjusted" Toxoplasma gondii results 
and infection status by animal type 
Animal 
type Pos® Neg^ 
—Prevalence—-
p^ (95 % CI)d 
--Relative risk--
RR (95 % CI)d 
Prevalence 
comparisons® 
Finishers (/) 10 154 6.10 (2.36, 9.83) 1.0 
Sows (s) 26 199 11.56 (7.29, 15.81) 1.90 (0.94, 3.82) 2. Pf - Pg* 
Gilts (f) 20 190 9.52 (5.47, 13.58) 1.56 (0.75, 3.84) 3. Pg - P' 
^Antibody titers >1:8 classified positive. 
^Antibody titers <1:8 classified negative. 
^Prevalence ( p )  calculated as [(positive/(positive + negative)) x 100]. 
^95 percent confidence interval. 
®HQ: pi = p2 vs Hg: pi + pi. 
*No significant difference at 0.05 level. 
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Table 23. "Adjusted" Toxoplasma gondii infection status by herd 
Herd Animal 
Number type (N) Positive Negative 
1 Finishers (15) 1 14 
Sows (15) 1 14 
Gilts (8) 1 7 
2 Finishers (15) 15 
Sows (15) 4 11 
Gilts (15) 1 14 
3 Finishers (15) 15 
Sows (15) 4 11 
Gilts (17) 17 
4 Finishers (15) 15 
Sows (15) 15 
Gilts (11) 11 
5 Finishers (15) 15 
Sows (15) 15 
Gilts (6) 6 
6 Finishers (15) 4 11 
Sows (15) 1 14 
Gilts (10) 10 
7 Finishers (15) 15 
Sows (15) 2 13 
Gilts (14) 1 13 
8 Finishers (15) 2 13 
Sows (15) 1 14 
Gilts (19) 1 18 
9 Sows (15) 15 
Gilts (13) 13 
10 Sows (15) I 14 
Gilts (13) 13 
11 Sows (15) 4 11 
Gilts (12) 12 
12 Finishers (14) 1 13 
Sows (15) 1 14 
Gilts (17) 4 13 
13 Finishers (15) 1 14 
Sows (15) 2 13 
Gilts (12) 1 11 
14 Sows (15) 1 14 
Gilts (23) 1 22 
15 Finishers (15) 1 14 
Sows (15) 4 11 
Gilts (20) 20 
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Table 24. Serum antibody titers against Leptospira interrogans serovars by animal type 
Reciprocal of antibody titer 
Animal type Serovar^ 0 100 200 400 800 1600 3200 
Finishers australis 164 
(n = 164) autumnalis 154 7 3 
ballum 
bataviae 
163 
161 
1 
1 2 
bratislava 139 8 13 3 1 
canicola 164 
grippotyphosa 163 1 
hardjo 163 1 
icierohaemorrhagiae 163 
pomona 164 
pyrogenes 164 
tarassovi 164 
Sows australis 222 1 1 1 
(n = 225) autumnalis 193 11 19 2 
ballum 224 1 
bataviae 215 3 5 2 
bratislava 175 18 24 4 4 
canicola 212 6 6 1 
grippotyphosa 217 2 5 1 
hardjo 212 5 5 2 1 
icterohaemorrhagiae 154 22 29 15 3 1 1 
pomona 211 6 5 3 
pyrogenes 223 2 
tarassovi 225 
Gilts australis 207 2 1 
(n = 210) autumnalis 143 23 31 8 4 1 
ballum 
bataviae 
204 
209 
3 
1 
3 
bratislava 115 26 48 17 2 1 1 
canicola 184 8 12 2 3 1 
grippotyphosa 197 8 3 2 
hardjo 198 8 3 1 
icterohaemorrhagiae 96 31 44 19 9 11 
pomona 196 6 6 1 1 
pyrogenes 205 2 2 1 
tarassovi 210 
^Vaccine against serovars canicola, grippotyphosa, hardjo, icierohaemorrhagiae, 
and pomona used in 9 herds; 1 of the 9 also vaccinated against serovar bratislava. 
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Table 25. Herd 1; serum antibody titers against Leptospira interrogans serovars 
Reciprocal of antibody titer 
Animal type Serovar^ 0 100 200 400 800 1600 3200 
Finishers australis 15 
(n = 15) autumnaiis 15 
ballum 15 
bataviae 15 
Bratislava 14 1 
canicola 15 
grippotyphosa 15 
hardjo 15 
icterohaemorrhagiae 15 
pomona 15 
pyrogenes 15 
tarassovi 15 
Sows australis 15 
(n = 15) autumnaiis 11 3 1 
ballum 15 
bataviae 15 
bratislava 12 2 1 
canicola 13 2 
grippotyphosa 14 1 
hardjo 14 1 
icterohaemorrhagiae 7 I 4 2 1 
pomona 12 1 1 1 
pyrogenes 15 
tarassovi 15 
Gilts australis 8 OO II 3
 autumnaiis 1 3 3 1 ballum 8 
bataviae 8 
bratislava 1 1 6 
canicola 4 4 
grippotyphosa 7 1 
hardjo 5 3 
icterohaemorrhagiae 1 3 2 2 
pomona 5 2 1 
pyrogenes 7 1 
tarassovi 8 
^Vaccine against serovars canicola, grippotyphosa, hardjo, icterohaemorrhagiae, 
and pomona used in this herd. 
68 
Table 26. Herd 2: serum antibody titers against Leptospira interrogans serovars 
Animal type Serovar® 
"Reciprocal of antibody titer 
100 200 400 800 1600 3200 
Finishers 
(n = 15) 
Sows 
(n = 15) 
Gilts 
(n = 15) 
australis 15 
autumnalis 15 
ballum 15 
bataviae 15 
bratislava 12 1 2 
canicola 12 
grippotyphosa 15 
hardjo 15 
icterohaemorrhagiae 14 1 
pomona 15 
pyrogenes 15 
tarassovi 15 
australis 15 
autumnalis 11 3 1 
ballum 15 
bataviae 15 
bratislava 12 3 
canicola 8 4 2 1 
grippotyphosa 11 3 1 
hardjo 12 1 1 1 
icterohaemorrhagiae 2 5 2 3 1 1 1 
pomona 9 3 2 1 
pyrogenes 14 1 
tarassovi 15 
australis 15 
autumnalis 8 3 3 1 
ballum 15 
bataviae 15 
bratislava 4 3 7 1 
canicola 7 3 1 3 1 
grippotyphosa 12 2 1 
hardjo 15 
icterohaemorrhagiae 1 2 5 4 3 
pomona 13 1 J 
pyrogenes 15 
tarassovi 15 
^Vaccine against serovars canicola^ grippotyphosa, hard jo, icterohaemorrhagiae, 
and pomona used in this herd. 
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Table 27. Herd 3: serum antibody titers against Leptospira interrogans serovars 
Animal type Serovar® 
--Reciprocal of antibody titer 
100 200 400 800 1600 3200 
Finishers 
(n = 15) 
Sows 
(n = 15) 
Gilts 
(n = 17) 
australis 15 
autumnalis 15 
ballum 15 
bataviae 15 
bratislava 13 2 
canicola 15 
grippotyphosa 15 
hardjo 15 
icterohaemorrhagiae 15 
pomona 15 
pyrogenes 15 
tarassovi 15 
australis 15 
autumnalis 11 1 3 
ballum 15 
bataviae 15 
bratislava 12 3 
canicola 13 2 
grippotyphosa 15 
hardjo 14 1 
icterohaemorrhagiae 7 5 2 1 
pomona 12 1 1 1 
pyrogenes 15 
tarassovi 15 
australis 17 
autumnalis 12 4 1 
ballum 17 
bataviae 17 
bratislava 9 2 3 2 1 
canicola 17 
grippotyphosa 17 
hardjo 16 1 
icterohaemorrhagiae 12 2 2 1 
pomona 17 
pyrogenes 17 
tarassovi 17 
^Vaccine against serovars canicola, grippotyphosa, hard jo, icterohaemorrhagiae, 
and pomona used in this herd. 
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Table 28. Herd 4: serum antibody titers against Leptospira interrogans serovars 
Serovar® 
--Reciprocal of antibody titer 
Animal type 0 100 200 400 800 1600 3200 
Finishers australis 15 
(n = 15) autumnalis 15 
ballum 15 
bataviae 15 
Bratislava 15 
canicola 15 
grippotyphosa 15 
hardjo 15 
icterohaemorrhagiae 15 
pomona 15 
pyrogenes 15 
tarassovi 15 
Sows australis 15 
(n = 15) autumnalis 12 1 2 
ballum 15 
bataviae 15 
bratislava 14 1 
canicola 15 
grippotyphosa 15 
hardjo 15 
icterohaemorrhagiae 15 
pomona 15 
pyrogenes 15 
tarassovi 15 
Gilts australis 11 
(n = 11) autumnalis 7 1 2 1 
ballum 10 1 
bataviae 11 
bratislava 6 4 1 
canicola 11 
grippotyphosa 11 
hardjo 9 1 1 
icterohaemorrhagiae 8 2 1 
pomona 11 
pyrogenes 10 1 
tarassovi 11 
^Vaccine against serovars canicola, grippotyphosa, hardjo, icterohaemorrhagiae, 
and pomona used in this herd. 
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Table 29. Herd S: serum antibody titers against Leptospira interrogans serovars 
Serovar® 
—Reciprocal of antibody titer 
Animal type 0 100 200 400 800 1600 3200 
Finishers austraiis 15 
(n = 15) autumnalis 15 
baiium 15 
bataviae 15 
bratislava 14 1 
canicola 15 
grippotyphosa 15 
hardjo 14 1 
icterohaemorrhagiae 15 
pomona 15 
pyrogenes 15 
tarassovi 15 
Sows austraiis 15 
II autumnalis 13 1 1 
ballum 15 
bataviae 15 
bratislava 11 4 
canicola 15 
grippotyphosa 15 
hardjo 15 
icterohaemorrhagiae 15 
pomona 15 
pyrogenes 15 
tarassovi 15 
Gilts austraiis 6 
(n = 6) autumnalis 5 1 
ballum 6 
bataviae 6 
bratislava 4 1 1 
canicola 5 1 
grippotyphosa 6 
hardjo 6 
icterohaemorrhagiae 3 3 
pomona 6 
pyrogenes 6 
tarassovi 6 
®No vaccine against Leptospira used in this herd. 
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Table 30. Herd 6: serum antibody titers against Leptospira interrogans serovars 
Animal type Serovar® 
—Reciprocal of antibody titer 
100 200 400 800 1600 3200 
Finishers 
(n = 15) 
Sows 
(n = 15) 
Gilts 
(n = 10) 
austral is 15 
autumnalis 12 1 2 
ballum 15 
bataviae 15 
bratislava 10 2 2 1 
canicola 15 
grippotyphosa 15 
hardjo 15 
icterohaemorrhagiae 15 
pomona 15 
pyrogenes 15 
tarassovi 15 
australis 15 
autumnalis 11 1 3 
ballum 15 
bataviae 15 
bratislava 13 1 1 
canicola 15 
grippotyphosa 15 
hardjo 15 
icterohaemorrhagiae 14 1 
pomona 15 
pyrogenes 15 
tarassovi 15 
australis 10 
autumnalis 6 4 
ballum 10 
bataviae 10 
bratislava 7 1 1 1 
canicola 9 1 
grippotyphosa 10 
hardjo 9 1 
icterohaemorrhagiae 2 3 2 3 
pomona 10 
pyrogenes 10 
tarassovi 10 
®No vaccine against Leptospira used in this herd. 
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Table 31. Herd 7: serum antibody titers against Leptospira interrogans serovars 
Reciprocal of antibody titer 
Animal type Serovar^ 0 100 200 400 800 1600 3200 
Finishers australis 15 
(n = 15) autumnalis 15 
ballum 15 
bataviae 15 
bratislava 13 2 
canicola 15 
grippotyphosa 15 
hardjo 15 
icterohaemorrhagiae 15 
pomona 15 
pyrogenes 15 
tarassovi 15 
Sows australis 14 1 II 5
 autumnalis 11 1 2 1 
ballum 15 
bataviae 15 
bratislava 3 1 7 1 3 
canicola 15 
grippotyphosa 14 1 
hardjo 15 
icterohaemorrhagiae 8 1 5 1 
pomona 15 
pyrogenes 15 
tarassovi 15 
Gilts australis 14 
II S
 autumnalis 14 
ballum 14 
bataviae 14 
bratislava 4 5 2 2 1 
canicola 12 1 1 
grippotyphosa 13 1 
hardjo 13 1 
icterohaemorrhagiae 10 1 1 2 
pomona 14 
pyrogenes 14 
tarassovi 14 
^Vaccine against serovars bratislava, canicola, grippotyphosa, hard jo, 
icterohaemorrhagiae, and pomona used in this herd. 
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Table 32. Herd 8: serum antibody titers against Leptospira interrogans serovars 
Animal type Serovar® 
—Reciprocal of antibody titer 
100 200 400 800 1600 3200 
Finishers 
(n = 15) 
Sows 
(n = 15) 
Gilts 
(n = 19) 
australis 15 
autumnalis 11 3 1 
ballum 15 
bataviae 15 
bratislava 10 3 2 
canicola 15 
grippotyphosa 15 
hardjo 15 
icterohaemorrhagiae 15 
pomona 15 
pyrogenes 15 
tarassovi 15 
australis 15 
autumnalis 14 1 
ballum 15 
bataviae 15 
bratislava 12 1 2 
canicola 14 1 
grippotyphosa 15 
hardjo 13 1 1 
icterohaemorrhagiae 10 1 2 2 
pomona 15 
pyrogenes 15 
tarassovi 15 
australis 17 2 
autumnalis 6 3 5 2 2 1 
ballum 18 1 
bataviae 18 1 
bratislava 4 2 6 5 1 1 
canicola 18 1 
grippotyphosa 18 1 
hardjo 18 1 
icterohaemorrhagiae 1 12 2 3 1 
pomona 18 1 
pyrogenes 17 2 
tarassovi 15 
^Vaccine against serovars canicola, grippotyphosa, hard jo, icterohaemorrhagiae, 
and pomona used in this herd. 
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Table 33. Herd 9: serum antibody titers against Leptospira interrogans serovars 
Serovar® 
—Reciprocal of antibody titer 
Animal type 0 100 200 400 800 1600 3200 
Sows australis 15 
(n . 15) autumnalis 14 1 
ballum 15 
bataviae 15 
bratislava 12 2 1 
canicola 15 
grippotyphosa 15 
hardjo 15 
icterohaemorrhagiae 2 6 4 3 
pomona 14 1 
pyrogenes 15 
tarassovi 15 
Gilts australis 13 
(n = 13) autumnalis 8 2 3 
ballum 13 
bataviae 13 
bratislava 6 2 2 3 
canicola 12 1 
grippotyphosa 12 1 
hardjo 13 
icterohaemorrhagiae 4 5 3 1 
pomona 13 
pyrogenes 13 
tarassovi 13 
^No vaccine against Leptospira used in this herd. 
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Table 34. Herd 10: serum antibody titers against Leptospira interrogans serovars 
Reciprocal of antibody titer 
Animal type Serovar^ 0 100 200 400 800 1600 3200 
Sows 
(n = 15) 
Gilts 
(n = 13) 
australis 14 1 
autumnalis 13 1 1 
ballum 15 
bataviae 15 
bratislava 10 1 3 
canicola 15 
grippotyphosa 15 
hardjo 15 
icterohaemorrhagiae 14 
pomona 15 
pyrogenes 15 
tarassovi 15 
australis 13 
autumnalis 11 1 
ballum 12 1 
bataviae 13 
bratislava 8 3 2 
canicola 13 
grippotyphosa 13 
hardjo 13 
icterohaemorrhagiae 12 1 
pomona 13 
pyrogenes 13 
tarassovi 13 
®No vaccine against Leptospira used in this herd. 
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Table 35. Herd 11: serum antibody titers against Leptospira interrogans serovars 
Serovar® 
—Reciprocal of antibody titer 
Animal type 0 100 200 400 800 1600 3200 
Sows austraiis 15 
(n = 15) autumnalis 14 1 
ballum 15 
bataviae 15 
bratislava 9 2 4 
canicola 15 
grippotyphosa 14 1 
hardjo 11 2 1 1 
icterohaemorrhagiae 15 
pomona 15 
pyrogenes 15 
tarassovi 15 
Gilts austraiis 12 
(n = 12) autumnalis 8 2 2 
ballum 12 
bataviae 12 
bratislava 9 2 1 
canicola 12 
grippotyphosa 9 3 
hardjo 11 I 
icterohaemorrhagiae 6 1 3 1 1 
pomona 7 3 2 
pyrogenes 12 
tarassovi 12 
^Vaccine against serovars canicola, grippotyphosa, hardjo, icterohaemorrhagiae, 
and pomona used in this herd. 
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Table 36. Herd 12: serum antibody titers against Leptospira interrogans serovars 
Serovar® 
—Reciprocal of antibody titer 
Animal type 0 100 200 400 800 1600 3200 
Finishers australis 14 
(n = 14) autumnaiis 12 2 
ballum 14 
bataviae 14 
bratislava 11 2 1 
canicola 14 
grippotyphosa 13 1 
hardjo 14 
icterohaemorrhagiae 14 
pomona 14 
pyrogenes 14 
tarassovi 14 
Sows australis 15 
(n = 15) autumnaiis 15 
ballum 15 
bataviae 15 
bratislava 10 2 3 
canicola 15 
grippotyphosa 15 
hardjo 15 
icterohaemorrhagiae 15 
pomona 15 
pyrogenes 15 
tarassovi 15 
Gilts australis 17 
(n = 17) autumnaiis 14 1 1 1 
ballum 17 
bataviae 17 
bratislava 14 2 1 
canicola 17 
grippotyphosa 17 
hardjo 16 1 
icterohaemorrhagiae 17 
pomona 17 
pyrogenes 16 1 
tarassovi 17 
^No vaccine against Leptospira used in this herd. 
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Table 37. Herd 13: serum antibody titers against Leptospira interrogans serovars 
Reciprocal of antibody titer 
Animal type Serovar^ 0 100 200 400 800 1600 3200 
Finishers australis IS 
(n = 15) autumnalis 14 1 
balium IS 
bataviae 12 1 2 
bratisiava 1S 
canicola 15 
grippotyphosa 15 
hardjo 15 
icterohaemorrhagiae 15 
pomona 15 
pyrogenes 15 
tarassovi 15 
Sows australis 15 
(n = 15) autumnalis 15 
ballum 14 1 
bataviae 14 1 
bratisiava 15 
canicola 15 
grippotyphosa 15 
hardjo 14 1 
icterohaemorrhagiae 14 1 
pomona 15 
pyrogenes 15 
tarassovi IJ 
Gilts australis 12 
(n = 12) autumnalis 12 
ballum 12 
bataviae 12 
bratisiava 8 3 1 
canicola 11 1 
grippotyphosa 12 
hardjo 12 
icterohaemorrhagiae 5 5 2 
pomona 12 
pyrogenes 12 
tarassovi 12 
®No vaccine against Leptospira used in this herd. 
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Table 38. Herd 14: serum antibody titers against Leptospira interrogans serovars 
Serovar® 
—Reciprocal of antibody titer 
Animal type 0 100 200 400 800 1600 3200 
Sows australis 14 1 
(n - 15) autumnalis 14 1 
ballum IS 
bataviae 10 2 2 1 
bratislava IS 
canicola 14 1 
grippotyphosa 15 
hardjo 15 
icterohaemorrhagiae 5 6 3 1 
pomona 14 1 
pyrogenes 14 1 
tarassovi 15 
Gilts australis 22 1 
(n = 23) autumnalis 22 1 
ballum 23 
bataviae 23 
bratislava 20 1 2 
canicola 20 1 1 1 
grippotyphosa 21 1 1 
hardjo 22 1 
icterohaemorrhagiae 12 7 2 2 
pomona 21 1 1 
pyrogenes 23 
tarassovi 23 
^Vaccine against serovars canicola, grippotyphosa, hardjo, icterohaemorrhagiae, 
and pomona used in this herd. 
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Table 39. Herd IS: serum antibody titers against Leptospira interrogans serovars 
Animal type Serovar® 
—Reciprocal of antibody titer 
100 200 400 800 1600 3200 
Finishers 
(n - 15) 
Sows 
(n = 15) 
Gilts 
(n = 20) 
australis 15 
autumnaiis 15 
ballum 14 1 
bataviae 15 
Bratislava 12 1 2 
canicola 15 
grippotyphosa 15 
hardjo 15 
icterohaemorrhagiae 15 
pomona 15 
pyrogenes 15 
tarassovi 15 
australis 15 
autumnaiis 14 1 
ballum 15 
bataviae 11 1 2 1 
Bratislava 15 
canicola 15 
grippotyphosa 14 1 
hardjo 14 1 
icterohaemorrhagiae 11 1 3 
pomona 15 
pyrogenes 15 
tarassovi 15 
australis 20 
autumnaiis 9 3 5 3 
ballum 17 2 1 
bataviae 20 
bratislava 9 3 8 
canicola 20 
grippotyphosa 19 1 
hardjo 20 
icterohaemorrhagiae 4 3 10 2 1 
pomona 19 1 
pyrogenes 20 
tarassovi 20 
^Vaccine against serovars canicola, grippotyphosa, hardjo, icterohaemorrhagiae, 
and pomona used in this herd. 
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Table 40. Apportionment of 210 gilts monitored in IS breeding herds 
Outcome Frequency (Percent) 
Lost identification 6 (2.86) 
Dead 7 (3.33) 
Failure to cycle (not bred) 18 (8.57) 
Failure to conceive (not "settled") 23 (10.95) 
Failure to maintain pregnancy ("open") 25 (11.90) 
Abortion 2 (0.95) 
Farrowed at term 129 (61.43) 
Table 41. Apportionment of 210 monitored gilts by herd 
OUTCOME 
Herd Number Not Not 
Number of gilts Lost Dead bred settled Open Aborted Farrowed 
1 8 - - - - 1 1 6 
2 15 1 - 2 - 4 - 8 
3 17 2 - - - 2 - 13 
4 11 - - - 1 3 - 7 
5 6 - - - - - - 6 
6 10 - - - - - - 10 
7 14 - 2 1 - 3 - 8 
8 19 - - 4 - 1 - 14 
9 13 - 1 1 2 - - 9 
10 13 1 - 5 - 2 - 5 
11 12 - 1 1 2 1 - 7 
12 17 1 - 3 3 2 1 7 
13 12 1 1 - 2 - - 8 
14 23 - 2 - 4 - - 17 
15 20 - - 1 9 6 - 4 
Sum 210 6 7 18 23 25 2 129 
Table 42. Cumulative reproductive performance of 129 gilts farrowing at term 
No. of No. of Percent 
livebom litters w/ of litters 
No. of No. of Percent 
stillborn litters w/ of litters 
No. of 
mummies 
No. of Percent 
litters /w of litters 
0 1 0.8 0 76 62.3 0 95 77.9 
1 - - 1 27 22.1 1 17 13.9 
2 4 3.1 2 10 8.2 2 3 2.5 
3 2 1.6 3 4 3.3 3 5 4.1 
4 11 8.5 4 3 2.5 4 - -
5 5 3.9 5 - - 5 1 0.8 
6 5 3.9 6 1 0.8 6 - -
7 13 10.1 7 - - 7 - -
8 9 7.0 8 - - 8 - -
9 17 13.2 9 - - 9 1 0.8 
10 19 14.7 10 - - 10 - -
11 14 10.9 11 1 - 11 - -
12 10 7.8 12 - - 12 - -
13 14 10.9 13 - - 13 - -
14 2 1.6 14 - - 14 - -
15 3 2.3 15 - - 15 - -
Total liveborn 1144 
Litter average 8.87 
Standard deviation 3.32 
Total stillborn 88 
Litter average 0.72 
Standard deviation 1.42 
Total mummies 52 
Litter average 0.43 
Standard deviation 1.14 
Table 43. Reproductive performance and seroconversions in gilts by herd 
Herd Number —Litter average among gilts— -No. 
Ll° 
gilts w/ 4X rise in titer during gestation-
number farrowed FR^ Livebom Stillborn Mummies PPV TG EMCV SIV PRV 
1 6 75.0 12.17 0.67 0.00 0 0 2 0 0 0 
2 8 57.1 9.75 0.50 0.13 3 0 1 1 1 0 
3C 13 86.7 7.62 0.69 0.46 8 9 3 4 1 0 
4C 7 63.6 6.43 1.14 2.00 0 11 0 1 2 0 
5 6 100.0 10.67 0.33 0.00 1 0 0 0 0 0 
6 10 100.0 11.50 0.70 0.10 2 1 0 2 3 0 
8 66.7 11.13 0.00 1.00 1 0 0 3 0 0 
8 14 73.7 6.57 0.79 0.36 1 0 0 3 0 0 
9 9 75.0 6.56 0.67 1.00 1 0 0 1 3 0 
10^ 5 41.7 9.20 1.40 1.20 2 0 1 2 0 0 
11 7 63.6 8.57 2.00 0.29 4 1 2 1 2 0 
12 7 43.8 9.29 0.43 0.00 3 0 0 2 1 0 
13 8 72.7 6.00 1.00 0.00 0 5 0 2 3 0 
14C 17 81.0 9.41 0.29 0.24 7 1 0 2 0 0 
15 4 20.0 12.75 0.00 0.75 1 0 0 1 0 0 
^Farrowing rate calculated as (number farrowed/(total gilts in study - gilts lost or dead)) x 100. 
^Serovars are considered cumulatively; includes a 4-fold rise in antibody titer against any Leptospira serovar. 
^PPV-induced reproductive losses diagnosed in herd during course of study. 
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Reproductive loss 
Yes No 
Four-fold t 
in antibody 
titer 
Yes 
No 
A B 
C D 
A + B = n-
C + D = n. 
A + C = ni — B + D 
Figure 1. Notation for analysis of reproductive losses 
Table 44. Analysis of reproductive losses: failure to conceive 
Infectious agent(s)^ Ab B C D N P value RR° (95 % CI) 
PPV 1 13 20 83 117 0.4597 NA 
PPV/TG 1 1 20 83 105 0.3615 NA 
SIV/TG/LI 1 1 20 83 105 0.3615 NA 
Cumulative 3 15 20 83 121 1.0000 NA 
®EMC = encephalomyocarditis virus, LI = Leptospira interrogans, PPV = 
porcine parvovirus, SIV = swine influenza virus, and TG = Toxoplasma gondii, 
^Column denotations correspond to Figure 1. 
"^Relative risk. 
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Table 45. Analysis of reproductive losses: failure to farrow ("open" or abortion) 
Infectious agent(s)® Ab B C D N P value RR® (95 % CI) 
EMC 2 11 15 68 96 1.000 NA 
EMC/LI 1 3 15 68 87 0.5635 NA 
EMC/SIV/TG/LI 1 0 15 68 84 0.1905 NA 
LI 2 14 15 68 99 0.7317 NA 
PPV 2 11 15 68 96 1.0000 NA 
PPV/LI 1 2 15 68 86 0.4651 NA 
PPV/SIV 1 4 15 68 88 1.0000 NA 
SIV/LI 1 1 15 68 85 0.3429 NA 
TG 1 2 15 68 86 0.4651 NA 
Cumulative 12 48 15 68 143 0.9409 NA 
^EMC = encephalomyocarditis virus, LI = Leptospira interrogans, PPV = 
porcine parvovirus, SIV = swine influenza virus, and TG = Toxoplasma gondii, 
^Column denotations correspond to Figure 1. 
^Relative risk. 
Table 46. Analysis of reproductive losses: farrow >3 stillborn pigs in a litter 
Infectious agent(s)^ Ab B C D N P value RR(: (95 % CI) 
LI 2 12 3 65 82 0.2001 NA 
PPV+EMC 1 1 3 65 70 0.1118 NA 
PPV+SIV 1 3 3 65 72 0.2084 NA 
SIV 1 3 3 65 72 0.2084 NA 
TG 1 1 3 65 70 0.1118 NA 
Cumulative 6 20 3 65 94 0.0124 5.23 (1.41,19.39) 
®EMC = encephalomyocarditis virus, LI = Leptospira interrogans, PPV = 
porcine parvovirus, SIV = swine influenza virus, and TG = Toxoplasma gondii, 
^Column denotations correspond to Figure 1. 
^Relative risk. 
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Table 47. Analysis of reproductive losses: farrow ^3 mummified fetuses in a litter 
Infectious agent(s)® Ab B C D N P value RR'^ (95 % CI) 
PPV 3 8 3 65 79 0.3260 6.18 (1.42,26.84) 
SIV 1 3 3 65 72 0.2084 NA 
Cumulative 4 11 3 65 83 0.0182 6.04 (1.51,24.23) 
®EMC = encephalomyocarditis virus, LI = Leptospira interrogans, PPV = 
porcine parvovirus, SIV = swine influenza virus, and TG = Toxoplasma gondii, 
^Column denotations correspond to Figure 1. 
^Relative risk. 
Table 48. Analysis of reproductive losses; farrow ^6 live pigs in a litter 
Infectious agent(s)® Ab B C D N P value RR(^ (95 % CI) 
LI 4 10 9 59 82 0.2215 NA 
EMC 2 9 9 59 79 0.6461 NA 
EMC+SIV 1 1 9 59 70 0.2671 NA 
PPV 4 7 9 59 79 0.0764 NA 
PPV+EMC 2 0 9 59 70 0.0228 7.56 (4.11, 13.89) 
PPV+EMC+ICT 1 0 9 59 69 0.1449 NA 
PPV+SIV 2 2 9 59 72 0.1079 NA 
SIV 1 3 9 59 72 0.4578 NA 
TG 1 1 9 59 70 0.2671 NA 
Cumulative 19 33 9 59 120 0.0028 2.78 (1.36, 5.59) 
®EMC = encephalomyocarditis virus, LI = Leptospira interrogans, PPV = 
porcine parvovirus, SIV = swine influenza virus, and TG = Toxoplasma gondii, 
^Column denotations correspond to Figure 1. 
^Relative risk. 
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Table 49. Ancillary diagnostic studies on reproductive losses 
Herd number 
Number of 
litters sampled Result 
5 1 
3 
PPV positive 
No diagnosis 
6 3 
2 
PPV positive 
No diagnosis 
9 2 
2 
PPV positive 
No diagnosis 
10 2 No diagnosis 
11 1 No diagnosis 
12 2 
4 
PPV positive 
No diagnosis 
15 2 No diagnosis 
16 1 
1 
23 
PPV positive 
SIV isolated 
No diagnosis 
17 2 No diagnosis 
89 
SEROLOGIC DIAGNOSIS OF ENCEPHALOMYOCARDITIS VIRUS INFECTION 
IN SWINE BY THE MICROTITRATION SERUM NEUTRALIZATION TEST: 
ESTIMATION OF SENSITIVITY, SPECIFICITY, AND A DIAGNOSTIC TITER 
Jeffrey J. Zimmerman, DVM, MS 
Howard T. Hill, DVM, PhD 
George W. Beran, DVM, PhD 
Michael C. Meetz, BS 
From the Department of Veterinary Microbiology and Preventive Medicine, 
College of Veterinary Medicine (Zimmerman, Beran), and the Veterinary Diagnostic 
Laboratory (Hill, Meetz), Iowa State University, Ames, Iowa 50011. 
90 
PART II. SEROLOGIC DIAGNOSIS OF ENCEPHALOMYOCARDITIS VIRUS 
INFECTION IN SWINE BY THE MICROTITRATION SERUM 
NEUTRALIZATION TEST: ESTIMATION OF SENSITIVITY, 
SPECIFICITY, AND A DIAGNOSTIC TITER 
Summary 
Fourteen 2-month-old swine were used to determine the sensitivity, specificity, 
and diagnostic titer of the microtitration serum neutralization test (SN). Eleven animals 
were exposed intramuscularly to 1.78 x 10^ TCIDgQ of NVSL strain (also known as 
Florida strain) encephalomyocarditis virus (EMCV). Three sentinel swine were 
commingled with the experimental group. Animals were bled at approximately 7-day 
intervals beginning 36 days prior to exposure and continuing through post-inoculation 
day (PID) 126. One sentinel animal seroconverted to EMCV during the course of the 
experiment. The mean antibody titer was 1:1.4 in uninfected animals and 1:79 in 
infected animals. Antibody titers up to 1:8 were observed in uninfected animals and 
ranged from 1:5.7 to 1:1024 in infected animals. SN antibody titers of 1:8 were highly 
suggestive of infection, with an estimated 97.8 percent sensitivity and 95.7 percent 
specificity at this dilution. Antibody titers of 1:16 or greater were conclusive for 
EMCV infection, based on a test specificity of 100 percent at these dilutions. 
Introduction 
Encephalomyocarditis virus (EMCV) is a member of family Picornaviridae, 
genus Cardiovirus. Picornaviruses are small (22 - 30 nm), naked viruses that tend to 
resist inactivation in the environment (Matthews, 1982). Most viruses in this group 
infect a relatively narrow range of species (Matthews, 1982). EMCV conforms to this 
general description, but unlike most picornaviruses EMCV is infectious for many 
species of animals. Infection in domestic animals, as determined by virus isolation, the 
presence of serum antibodies, or clinical disease, has been reported in cattle (Adamcova 
and Bardos, 1959; Alcolado and Gomez, 1982; Causey et al., 1962; Gainer, 1961; Ramos 
et al., 1983; Spradbrow and Chung, 1970; Tesh and Wallace, 1978; Tiggleman-Van 
Krugten and Collier, 1955), horses (Adamcova and Bardos, 1959; Bardos, 1957; Bardos, 
1958; Causey et al., 1962; Gainer et al., 1968; Pope and Scott, 1960), dogs (Tiggleman-
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Van Krugten and Collier, 1955), cats (Tesh and Wallace, 1978), and swine (Acland et 
al., 1970; Acland and Littlejohns, 1975; Adamcova and Bardos, 1959; Gainer and 
Murchison, 1961; Gainer et al., 1968; Gomez et al, 1982; Gualandi et al., 1989; Hill et 
al., 1985; Joo et al., 1988; Kim et al., 1989; Kovatch et al., 1969; Links et al., 1986; 
Littlejohns, 1984; Mercy et al., 1988; Murnane et al., 1960; Ramos et al., 1982; Ramos 
et al., 1983; Roehe et al., 1985; Sanford et al., 1985; Sanford et al., 1989; Sangar et al., 
1977; Seaman et al., 1986; Spradbrow, 1968; Sutherland, 1977; Tesh and Wallace, 1978; 
Tiggleman-Van Krugten and Collier, 1955; Williams, 1981). 
Infection resulting in clinical disease has rarely been reported in domestic 
animals other than swine. In swine, clinical signs reported in acute outbreaks include 
depression, inappetance, trembling, staggering, paralysis, vomiting, and dyspnea 
(Acland and Littlejohns, 1975; Hill et al., 1985; Kovatch et al., 1969; Murnane et al., 
1960; Ramos et al., 1982; Ramos and Luya, 1983). Sudden death, often in the absence 
of clinical signs, is also described (Acland et al., 1970; Acland and Littlejohns, 1975; 
Craighead et al., 1963; Gainer and Murchison, 1961; Gainer et al., 1968; Hill et al., 
1985; Horner and Hunter, 1979; Kovatch et al., 1969; Mercy et al., 1988; Ramos et al., 
1982; Roehe et al., 1985; Seaman et al., 1986; Sutherland, 1977; Williams, 1981). 
Reproductive losses due to EMCV infection, including embryonic and fetal deaths 
(mummies and stillbirths), acute death in neonates and a decrease in conception rate, 
have been documented in the last decade (Gomez et al., 1982; Joo et al., 1988; Kim et 
al., 1989; Links et al., 1986; Littlejohns, 1984; Love and Grewal, 1986; Mercy et al., 
1988). EMCV is currently of particular interest because of its hypothesized role in the 
so-called "mystery swine disease" (Pilchard, 1989; Reotutar, 1989). 
Serum neutralization (SN) or hemagglutination-inhibition (HI) tests are used to 
diagnose EMCV infection serologically, although the experimental use of latex 
agglutination and enzyme immunoassay techniques have been reported (Teschner et al., 
1978; Vlaspolder et al., 1988; Vlaspolder et al., 1989). Interpretation of serologic tests 
in the diagnostic setting has been compromised by the fact that an antibody titer 
diagnostic for EMCV infection has not been established under controlled conditions 
(Boulton, 1987). Therefore, the objective of this study was to measure antibody titers 
in experimentally infected swine in order to establish an appropriate diagnostic ("cut 
off") titer for the SN test as well as an estimate of sensitivity and specificity values. 
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Materials and Methods 
Virus cultivation EMCV-NVSL strain (also known as Florida strain), 
obtained from USDA, APHIS National Veterinary Services Laboratories, Ames, Iowa 
was used to infect the animals in this experiment and as the challenge virus in the SN 
test. This isolate was originally recovered from a pig during an outbreak of EMCV in 
a swine herd in Florida and subsequently passaged in mice and tissue culture (J. H. 
Gainer, Food and Drug Administration, Beltsville, MD, personal communication, 1990). 
The virus was grown using standard methods on a baby hamster kidney (BHK-21) cell 
line in ISO cm^ single-use cell culture flasks.^ Minimum essential medium (MEM)^ 
with 10 percent fetal bovine serum (FBS), to which tryptose phosphate broth (4 
ml/liter), sodium bicarbonate (2.2 g/liter) and gentamicin sulfate (0.5 mg/100 ml) were 
added, was used for cell growth. Virus was harvested at 48 hours. Flasks were freeze-
thawed once, decanted into SO ml centrifuge tubes^ and centrifuged at 3000 g for 20 
minutes. The supernate was decanted and stored in 1 ml aliquots at -70 C. Virus 
concentration (TCID^g) was determined by the Kârber method using a series of 10-
fold dilutions (Schmidt and Emmons, 1989). The virus suspension was diluted to the 
desired virus concentration for the SN assay or animal exposure with MEM without 
additives. 
Virus exposure Fourteen 2-month-old swine were used in the 
experiment. Eleven animals were exposed to 1.78 x 10^ TCID^q of EMC-NVSL strain 
virus in a single 1 ml intramuscular (IM) injection. Three sentinel swine were 
commingled with the experimental group. 
Animal monitoring All 14 animals were bled at approximately 7-day 
intervals beginning 36 days prior to exposure and continuing through post-inoculation 
day (PID) 126. Blood samples were collected from the anterior vena cava in serum 
separation tubes.'^ Serum samples were stored in 1 ml aliquots at -70 C until assayed 
by the SN test. 
'Tissue culture flask No. 3150, Costar Corporation, Cambridge, MA. 
^MEM 410-2100 powder, GIBCO Laboratories, Grand Island, NY. 
^50 ml conical centrifuge tube No. 60.547, Sarstedt, Inc., Arlington, TX. 
^Vacutainer brand SST® tubes, Becton Dickinson and Co., Rutherford, NJ. 
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No animals died over the course of the experiment, nor were there overt signs 
of clinical disease during this period, with the exception of a single episode of 
vomiting observed in 3 swine after they were restrained and bled on PID 63. The 
absence of clinical signs in swine after experimental exposure to EMCV has been 
reported previously (Craighead et al., 1963; Horner and Hunter, 1979; Love and 
Grewal, 1986). 
At slaughter on PID 154, the white-to-yellow focal or streaked myocardial 
plaques often reported in association with EMCV infection were absent. Histologically, 
the myocardium appeared normal. However, fibrous adhesion of the epicardium to the 
pericardium was present in six animals. The accumulation of serous to serofibrinous 
exudate in the pericardial sac has been reported (Murnane et al., 1960; Ramos et al., 
1982; Sanford et al., 1989; Sutherland, 1977; Tsangaris et al., 1989; Watt and 
Spradbrow, 1974). The observed lesions have not been documented as sequellae to 
EMCV exposure and may or may not have resulted from the experimental infection. 
Microtitration serum neutralization test Serum samples were assayed by 
the microtitration SN test. The test protocol is described in detail in Supplement I. 
Before submission for testing, animal number and collection date information were 
removed and vials randomly renumbered. All serum samples were assayed 
concurrently. The assay was repeated one week later. The challenge virus 
concentration for the SN test was determined to be 750 TCID^q. In no case did the 
two test results on any one sample vary by more than one dilution. 
Analysis of data The analysis was done using the mean of the two SN 
test results for each sample. Antibody concentration was converted to the reciprocal of 
the SN titer to the logarithm base 2 for performing the analysis. Thus, antibody titers 
of 1:2, 1:4, 1:8, etc., were transformed to I, 2, 3, etc. This convention is also used in 
reporting the results of this study. The geometric mean titer (GMT) for any set of 
observations was calculated as the arithmetic mean of the logarithms base 2 of the 
individual observations (Chan et al., 1983). Conversion of the transformed antibody 
titers to conventional serum antibody titers is readily performed with a hand calculator 
by taking the reciprocal of 2\ where "t" equals the transformed antibody titer. For 
example, a transformed titer of 6.0 is equivalent to a serum dilution of 1:2^'^ or 1:64. 
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Results 
The cumulative results of the SN tests are given in Table 1 for each animal by 
EMCV infection status. The collection of 4 samples per animal prior to experimental 
exposure established the EMCV-free status of each animal with a high degree of 
confidence. The cumulative GMT was 0.49 in uninfected animals and 6.30 in infected 
animals. EMCV antibody titers ranged from 0.0 to 3.0 in uninfected animals and 2.5 
to 10.0 in infected animals. 
Table 1. EMCV-neutralizing antibody titers by animal^ 
EMCV-uninfected interval^ EMCV -infected interval® 
Pifi No. OMT" Median Range GMT° Median Ranee 
01 0.00 0.0 0.0 6.63 7.0 5.0 - 7.0 
02 0.00 0.0 0.0 6.63 7.0 5.0 - 8.0 
03 0.75 0.0 0.0 - 3.0 7.00 7.0 5.0 - 10.0 
04® 0.41 0.0 0.0 - 3.0 Uninfected animal 
05® 0.00 0.0 0.0 4.11 4.0 2.5 - 5.0 
06 1.75 2.0 1.0 - 2.0 5.16 5.0 4.0 - 6.0 
07 0.50 0.5 0.0 - 1.0 6.63 7.0 5.0 - 9.0 
08 0.25 0.0 0.0 - 1.0 6.79 7.0 5.0 - 8.0 
09 1.00 1.0 0.0 - 2.0 6.68 7.0 6.0 - 7.0 
10 1.13 1.0 0.0 - 2.5 6.13 6.0 5.0 - 7.0 
11 0.63 0.8 0.0 - 1.0 6.87 7.0 6.0 - 9.0 
12 0.00 0.0 0.0 6.37 6.0 5.0 - 7.0 
13 0.25 0.0 0.0 - 1.0 6.58 7.0 5.0 - 10.0 
14® 0.52 0.0 0.0 - 3.0 Uninfected animal 
Cumulative 0.49 0.0 0.0 - 3.0 6.30 7.0 2.5 - 10.0 
^Titers expressed as reciprocal of serum dilution (log2). 
^For infected animals, the interval contains days -36 through 0; for uninfected 
animals, i.e., pigs 04 and 14, the interval contains days -36 through 126. 
^The interval consists of days 7 through 126. 
^Geometric mean titer. 
^Commingled sentinel animals. 
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Bars show range of data 
Reciprocal 
of titer 
log base 2 
-4 -2 0 2 4 6 8 10 12 14 16 18 
TIME (weeks) 
EMCV (-) pigs (n=2) EMCV (+) pigs (n=12) 
Figure 1. Geometric mean titer and range of data in EMCV-infected (n = 12) and 
EMCV-uninfected (n = 2) groups of swine over time. 
Antibody titers by time are given in Figure 1 and Table 2. In the uninfected 
group, the GMT ranged from 0.0 to 2.0 over the course of the experiment. In the 
infected animals, antibody response was rapid and persisted at approximately the same 
serum concentration throughout the 126 day monitoring period. The GMT on day 7 
for the infected group was 6.13, with the GMT ranging from 5.75 to 6.75 over the 
course of the experiment. 
One of three commingled sentinel pigs became infected with EMCV, as 
indicated by a significant rise in SN antibody titers. As shown in Figure 2, no 
antibodies against EMCV were detected in this animal in any of the four serum 
samples collected prior to day 7. Presumably, transmission of EMCV to this sentinel 
animal occurred either by exposure to virus shed into the environment by the IM 
infected pigs or contamination of the environment with EMCV during exposure of the 
experimental animals. 
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Table 2. EMCV-neutralizing antibody titers by time® 
EMCV-uninfected animals'' El^V-infected animals^ 
Day GMT^ Median Range GMT^ Median Ranee 
- n • 14 n = 0 
-36 0.29 0.0 0.0 - 1.0 — — — 
-29 0.52 0.0 0.0 - 2.0 — — — 
-14 0.32 0.0 0.0 - 2.0 — — — 
0 0.81 0.0 0.0 - 3.0 — — — 
7 0.00 NA 0.0 6.13 6.0 4.0 - 7.0 
10 0.00 NA 0.0 6.58 7.0 5.0 - 7.0 
14 1.00 NA 0.0 - 2.0 6.67 7.0 5.0 - 10.0 
21 0.00 NA 0.0 5.92 6.5 3.0 - 7.0 
28 0.00 NA 0.0 5.75 6.0 2.5 - 7.0 
35 0.00 NA 0.0 6.17 6.5 3.0 - 7.0 
43 1.50 NA 1.0 - 2.0 6.08 6.5 3.0 - 8.0 
47 2.00 NA 1.0 - 3.0 6.38 7.0 4.0 - 7.0 
56 1.00 NA 0.5 - 1.5 6.29 6.5 4.5 - 7.0 
63 2.00 NA 1.0 - 3.0 6.17 6.0 4.0 - 9.0 
70 0.50 NA 0.0 - 1.0 6.17 6.0 5.0 - 7.0 
77 0.00 NA 0.0 6.42 7.0 4.0 - 7,0 
84 0.00 NA 0.0 6.25 6.5 4.0 - 7.0 
91 1.00 NA 0.0 6.33 7.0 3.0 - 7,0 
98 0.00 NA 0.0 6.25 6.5 5.0 - 7.0 
105 0.00 NA 0.0 6.50 7.0 4.0 - 8.0 
112 1.25 NA 1.0 - 1.5 6.75 7.0 5.0 - 9.0 
118 0.00 NA 0.0 6.67 7.0 5.0 - 10.0 
126 0.00 NA 0.0 6.21 6.5 5.0 - 7.0 
^Titers expressed as reciprocal of serum dilution (Iog2). 
^All animals classified as EMCV-uninfected until day 7; thereafter, n = 2. 
^No animals classified as EMCV-infected until day 7; thereafter, n = 12. 
^Geometric mean titer. 
Reciprocal 
of titer 
log base Z 
(-) Sentinels (n=2) Exptl pigs (n=H) 
(+) Sentinel (n=l) 
Range (excluding + sentinel) 
TIME (weeks) 
Figure 2. Antibody titers in a seroconverted sentinel animal compared to IM exposed 
(n = 11) and seronegative sentinel (n = 2) swine. 
The EMCV-positive sentinel animal showed a marked difference in antibody 
response compared to the IM infected animals. For PID 7 through 126, antibody titers 
ranged from 2.5 - 5.0 in the commingled animal, compared to 4.0 - 10.0 in the 
experimentally exposed animals. The mean GMT of 4.11 in the sentinel animal was 
substantially lower than the mean GMT of 6.50 in the IM infected swine, as indicated 
in Table 1. As shown in Figures 1 and 2, the antibody titers from this pig formed the 
lower bound of the range in the infected animals at every serum sampling period. 
However, antibody titers in 14 of the 19 samples collected from this animal over the 
course of the experiment were equal to or greater than the lower bound of the range of 
antibody titers in the IM infected animals. 
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Figure 3. Cumulative distribution of antibody titers by infection status. 
Table 3. Sensitivity and specificity of serum neutralization test by serum dilution 
Serum dilution® Sensitivitv Soecificitv 
1 100.0 66.0 
2 100.0 86.2 
3 97.8 95.7 
4 93.9 100.0 
5 80.3 100.0 
6 53.1 100.0 
7 3.1 100.0 
^Expressed as reciprocal of serum dilution (log2). 
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Sensitivity and specificity are specific quantitative measures of the performance 
of a serologic test. Sensitivity is an estimate of the capacity of a test to correctly 
identify infected individuals, and specificity is a measure of its ability to correctly 
identify uninfected individuals. These were calculated as: 
Test positive Test negative 
• EMCV infcled • EMCV uninfeced 
The distribution of antibody titers for all serum samples is given in Figure 3 by 
infection status. Since a titer diagnostic for infection was assumed to be unknown, 
sensitivity and specificity were calculated at each serum dilution. The outcome of these 
calculations are given in Table 3. Based on these results, it was concluded that a SN 
antibody titer of 1:8 or greater was indicative of infection with EMCV. The 
microtitration SN test sensitivity was estimated as 97.8 percent and specificity as 95.7 
percent at this dilution. 
Discussion 
In this study, the EMCV status of each animal was known through extensive 
serologic monitoring and exposure to the virus under relatively controlled conditions. 
Sensitivity, specificity, and a diagnostic antibody titer were calculated from the serologic 
results of animals of known EMCV status, as opposed to retrospectively interpreting the 
significance of antibody titers on the basis of their association with clinical signs of 
infection. Interestingly, the cumulative GMT of 6.3 in EMCV-infected swine reported 
in this paper was in close agreement with an analysis of antibody titers observed in 
association with clinical cases (Boulton, 1987). 
A significant occurrence was the seroconversion of a commingled sentinel animal. 
The finding that the antibody titers in this individual were considerably lower than the 
antibody titers in animals exposed intramuscularly may be important because of its 
implications for naturally acquired infections. The reasons for the difference between 
this animal and the experimentally inoculated animals could not be determined from this 
experiment, but factors that may be hypothesized to play a part in the lower antibody 
response seen in this animal include 1) normal biological variation, 2) response to the 
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size of the inoculum, 3) response to the route of exposure, 4) idiosyncratic variation, 
or 5) some combination of 1 - 4. Infection in this animal may more closely represent 
field exposure in terms of the dose of inoculum, route of transmission, and magnitude 
of response. If this were the case, the sensitivity of the microtitration SN test may be 
somewhat less than the estimate reported. 
One concern in the evaluation of the SN results is the possible neutralization of 
virus by serum fractions not associated with antibodies. Previous work has 
demonstrated, however, that SN activity is associated with immunoglobulins and not 
associated with nonspecific neutralizing substances (Sangar et ai., 1977; Tesh, 1978). 
Possible neutralization activity by antibodies against infectious agents other than 
EMCV is also a consideration. Cross reactions by SN have been reported between 
antibodies against EMCV and cricket paralysis virus (CPV) (Tinsley et al., 1984). In a 2 
X 2 experiment, exposure of either CPV or EMCV was shown to sensitize guinea pigs to 
subsequent inoculations of CPV or EMCV. However, CPV antiserum did not neutralize 
the infectivity of EMCV for BHK-21 cells or mice. Furthermore, natural infections of 
swine or other domestic animals with CPV are not reported. 
Neutralization studies between EMCV and 62 human enterovirus serotypes 
showed no cross reactions (Tesh, 1978). Nor did cross neutralization studies between 
EMCV and 11 porcine enterovirus serotypes (PEVS) (D. Jutting, National Veterinary 
Services Laboratories, Ames, lA, personal communication, 1989). In this unpublished 
study, EMCV antiserum produced in gnotobiotic pigs failed to react with any of the 11 
PEVS by the microtitration SN test at an initial serum dilution of 1:32. These EMCV 
antisera also failed to react with PEVS at a 1:10 dilution by the indirect 
immunofluorescence assay. A microtitration SN test against EMCV using the 11 
serotypes of PEVS antiserum also showed no neutralizing activity at an initial serum 
dilution of 1:32. In addition, an alpha (constant serum, varying virus) SN study was 
done and no neutralization by any of the 11 serotypes of PEVS antisera occurred using 
dilutions capable of neutralizing 100,000 TCID^q of their homologous PEVS against 
EMCV dilutions of 100, 500, and 1000 TCIDgg. It was concluded that there was no 
cross reaction of PEVS and EMCV antibodies in either direction. 
Cross reaction studies have also been done against a variety of other viruses, 
including poliomyelitis, Bwamba fever. West Nile fever, Semliki Forest, Bunyamwera 
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fever, Ntaya, Zika fever, Uganda S, Kumba, Anopheles A, Anopheles B, Wyeomyia, 
Ilheus, Leucocelaenus, Haemagogus A, Haemagogus B, Sabethes, St. Louis encephalitis, 
Japanese B encephalitis, Russian spring-summer encephalitis, louping ill, western equine 
encephalitis, eastern equine encephalitis, Venezuelan equine encephalitis, dengue, French 
neurotropic yellow fever, and the GDVII and FA strains of mouse encephalomyelitis 
viruses (Dick, 1949; Smithburn, 1952). No evidence of cross neutralization was detected 
between these viruses and EMCV. 
Thus, false-positive reactions due to cross reactions with antibodies produced 
against agents infectious for mammals have not been demonstrated. From the bulk of 
the evidence, it would seem that antibody titers previously considered nonspecific, i.e., 
in the range of 1:8 - 1:32, represent infection with EMCV. 
The possibility of antigenic differences between the SN challenge strain and a 
field strain of EMCV resulting in false-negative test reactions is also a consideration. 
However, complete cross neutralization between strains or isolates of EMCV has been 
reported by several workers (Dick et al., 1948; Dick, 1949; Joo et al., 1988; Jungeblut, 
1952; Luya et al., 1979; Warren et al., 1949). The absence of cross neutralization 
between strains or isolates has not been reported. 
In conclusion, the microtitration SN test appears to be a relatively specific and 
sensitive test for the diagnosis of infection by EMCV. Antibody titers of 1:8 were 
highly suggestive of infection using the protocol described here. Antibody titers of 1:16 
or greater were definitive for EMCV infection, based on a test specificity of 100 
percent at these dilutions. Particularly since the data indicate that SN titers persist for 
months, it is mandatory to test paired serum samples from individual animals for the 
diagnosis of a clinical outbreak. Paired samples tested concurrently with a four-fold rise 
in titer are diagnostic for recent infection. 
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Supplement I - EMCV microtitration serum neutralization test 
Specific products are given for completeness and are not intended as 
endorsements. EMCV is considered a human pathogen. Procedures using EMCV should 
be performed under conditions appropriate for biological containment and protection to 
personnel. 
1. Inactivate undiluted serum at 60 C for 20 minutes or 56 C for 30 minutes. 
2. The test is done using a 96-well flat-bottomed tissue culture plate^ (8 rows by 12 
columns). In this protocol, the 12 columns of wells are identified as A through L, 
and the 8 rows as I through 8. Serum samples are placed across columns A through 
L and dilutions made down rows 1 through 8. 
3. Dispense 0.050 ml of heat inactivated serum into row 1. Use two columns for each 
sample; a sample control column (SCC) and a sample test column (STC). 
4. Dispense 0.025 ml of diluent in rows 2 through 8. Diluent is minimum essential 
medium (MEM) with gentamicin sulfate (0.5 mg/100 ml). 
5. Make 1:2 serial dilutions of the serum down rows 1 through 8. For each column, 
enter row I and draw 0.025 ml into the pipetter. Transfer this volume to row 2, mix 
well and transfer 0.025 ml into row 3. Proceed in this fashion through row 8. 
6. Add 0.025 ml of diluent to rows 1 through 8 of the SCC of each specimen to make a 
final volume of 0.050 ml in each well. 
7. Add 0.025 ml of antigen to rows 1 through 8 of the STC of each specimen. The 
EMCV should be pre-titered and diluted with MEM with gentamicin sulfate 
(0.5mg/100 ml) in order to deliver between 500 - 1000 TCID^q per well. 
8. Negative and positive control serums should be included on each plate. These 
controls are assayed the same as the test samples. In addition, a cell control well 
must be included on each plate. 
^Tissue culture 96-well plate No. 3596, Costar Corporation, Cambridge, MA. 
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9. Virus controls are mandatory for each test. Virus controls start with the dilution 
used in the test and include 10~^ through lO"'* dilutions of the test dose using 8 
wells for each dilution. These wells should contain 0.025 ml of diluent and 0.025 ml 
of the appropriate virus dilution. The TCIDgg is calculated using the Kârber 
method (Schmidt and Emmons, 1989). 
10. Allow the virus-serum solution to interact at room temperature for 60 minutes. 
Plates may occasionally be agitated slightly to expedite mixing of the solution. Plates 
should remain covered at all times to minimize exposure to contaminants, reduce 
evaporation, and avoid inducing pH variations, 
11. A cell culture suspension is prepared during the last portion of the incubation 
period. The cell suspension should contain 3 - 5 X 10^ baby hamster kidney (BHK-
21) cells per ml in a solution of MEM with 10 percent fetal bovine serum (FBS), 
tryptose phosphate broth (4 ml/liter), sodium bicarbonate (2.2 g/liter) and gentamicin 
sulfate (0.5 mg/100 ml). Cell concentration may be determined using a 
hemocytometer counting chamber. 
12. At the end of the incubation period, add 0.15 ml of cell suspension to all wells. A 
cell control must be run for each test. Cell controls may be included on the sample 
plate or on a separate plate. Cell control wells contain 0.05 ml of diluent plus 0.15 
ml cell suspension. 
13. Cover plates and place them in a 37 C incubator containing S percent CO2. 
14. The microtitration plates are examined for cytopathic effects at 48 hours using an 
inverted light microscope. For a valid test, virus control wells must indicate a test 
challenge virus concentration between 500 - 1000 TCID^Q. Also, known positive 
serum controls must not vary by more than a 2-fold dilution and negative serum 
controls must shown no neutralizing activity. Antibody titers are read beginning at a 
1:2 dilution (row 1). The titer is the highest serum dilution showing complete virus 
neutralization, as indicated by an absence of cytopathic effects. 
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PART m. SEROPREVALENCE OF ANTIBODIES AGAINST 
ENCEPHALOMYOCARDITIS VIRUS IN IOWA SWINE 
Summary 
A total of 2,614 animals from 104 herds located throughout the state of Iowa 
was tested for antibodies against encephalomyocarditis virus (EMCV) by the microtiter 
serum neutralization (SN) test. The sample was composed of 587 sows and gilts and 
2027 finishing animals. A significant difference (P<0.002) was observed between the 
prevalence in sows and gilts (17.2 %) vs. finishing animals (12.2 %). Breeding swine 
maintained in total confinement (20.5 %) showed a higher prevalence (P = 0.04) than 
breeders maintained in other types of housing (12.1 %), while the prevalence in 
finishing animals raised in total confinement (6.4 %) was lower (P = 0.02) than 
finishers not raised in total confinement (13.6 %). No association was detected between 
prevalence and herd size or prevalence and season. Adjusting for test specificity and 
sensitivity, the true prevalence of EMCV in Iowa swine was estimated to be 13.8 
percent in breeding stock and 8.5 percent in finishing animals. On a herd basis, 89.4 
percent (93/104) of the herds had one or more EMCV-positive animals. 
Introduction 
The first documented outbreak of EMCV in swine occurred in 1958 in Panama. 
(Murnane et al., 1960) Since that time, numerous clinical outbreaks of EMCV in swine 
herds have been described (Acland et al., 1970; Acland and Littlejohns, 1975; Gainer 
and Murchison, 1961; Hill et al., 1985; Kovatch et al., 1969; Mercy et al., 1988; Ramos 
et al., 1982; Roehe et al., 1985). Clinical signs in swine include depression, 
inappetence, trembling, staggering, paralysis, vomiting, and dyspnea (Acland and 
Littlejohns, 1975; Hill et al., 1985; Kovatch et al., 1969; Murnane et al., I960; Ramos 
et al., 1982; Ramos and Luya, 1983). Frequently, infected pigs die acutely without 
prior observable signs of infection or are simply found dead (Acland et al., 1970; 
Acland and Littlejohns, 1975; Craighead et al., 1963; Gainer and Murchison, 1961; 
Gainer et al., 1968; Hill et al., 1985; Horner and Hunter, 1979; Kovatch et al., 1969; 
Mercy et al., 1988; Ramos et al., 1982; Roehe et al., 1985; Seaman et al., 1986; 
Sutherland, 1977; Williams, 1981). EMCV-induced reproductive disease in pigs was 
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first indicated by the isolation of the virus from a fetus (Gomez et al., 1982). 
Subsequently, EMCV was associated with poor conception rates, embryonic resorption, 
increased mummification, stillbirths, abortions, and neonatal deaths (Joo et al., 1988; 
Kim et al., 1989; Links et al., 1986; Littlejohns, 1984). 
EMCV infections in swine have been reported throughout the world, including 
Australia (Acland et al., 1970; Acland and Littlejohns, 1975; Glastonbury, 1977; Hill et 
al., 1985; Links et al., 1986; Littlejohns, 1984; Mercy et al., 1988), Brazil (Roehe et al,, 
1985), Britain (Sangar et al., 1977), Canada (Sanford et al., 1985; Sanford et al., 1989), 
Cuba (Gomez et al., 1982; Ramos et al., 1982), Czechoslovakia (Adamcova and Bardos, 
1959), Greece (Tsangaris et al., 1989), Guatemala (Kovatch et al., 1969), Italy 
(Gualandi, 1989), New Zealand (Sutherland, 1977), Panama (Murnane et al., 1960), 
Puerto Rico (D. R. Jutting, National Veterinary Services Laboratories, Ames, lA, 
personal communication, 1989), and South Africa (Williams, 1981). In the United 
States, EMCV has been isolated from swine in the states of Florida (Gainer and 
Murchison, 1961), Georgia (R. F. Solorzano, Diagnostic Laboratory, College of 
Veterinary Medicine, University of Missouri, Columbia, MO, personal communication, 
1990), Hawaii (D. R. Jutting, National Veterinary Services Laboratories, Ames, lA, 
personal communication, 1989), Maryland (J. C. M. Huang, Animal Health Laboratory, 
Maryland Department of Agriculture, College Park, MD, personal communication, 
1989), and Minnesota (Joo et al., 1988; J. I. Kresse (retired), National Veterinary 
Services Laboratories, Ames, lA, personal communication, 1989). 
The objective of this study was to estimate the prevalence of EMCV in Iowa 
swine using the microtiter serum neutralization test to detect infection. The 
availability of herd data in association with individual serum samples made it possible 
to assess the association of EMCV seropositivity with animal type, herd size, herd 
facilities, and season. 
Materials and Methods 
Selection of herds Serum samples were collected from 2,015 animals in 
89 Iowa swine herds participating in the National Animal Health Monitoring System 
(NAHMS) between 1984 and 1989. Samples from an additional 599 animals from 15 
self-selected herds were included in the survey. 
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NAHMS participants provided pertinent herd data during monthly on-the-farm 
interviews during the 12- to 18-month period of collaboration. Non-NAHMS 
producers maintained production records comparable to the data available from the 
NAHMS herds. Survey herds were geographically distributed throughout the state. 
Iowa has 99 counties of approximately equal size, and 60 counties were represented in 
the sample. 
Serum samples A total of 587 female breeders from 25 herds and 2,027 
finishing animals from 91 herds were sampled. Finishing animals weighed a minimum 
of 68 kg and most weighed in excess of 81 kg. In the IS non-NAHMS herds, data 
were of sufficient quality to identify breeding stock as either gilts or sows. Boars were 
not included in the survey. 
Blood was collected from animals either on the premises or at slaughter. All 
samples were hand delivered to reduce transport time and expedite processing and 
storage. Serum samples were prepared and frozen to -70 C in 1 ml aliquots for storage 
within 24 hours of blood collection. 
Microtiter serum neutralization test Serum samples were assayed for the 
presence of antibodies against EMCV by the microtiter serum neutralization (SN) test. 
EMCV-NVSL strain (a.k.a. Florida strain) obtained from the United States Department 
of Agriculture, National Veterinary Services Laboratories, Ames, Iowa was used as the 
challenge virus in the SN test. The virus was grown using standard virus cultivation 
methods in a baby hamster kidney (BHK-21) cell line in ISO cm^ single-use cell 
culture flasks.' Minimum essential medium (MEM)^ with 10 percent fetal bovine 
serum (FBS), tryptose phosphate broth (4 ml/liter), sodium bicarbonate (2.2 g/liter) and 
gentamicin sulfate (0.5 mg/100 ml) was used for cell growth. Virus was harvested at 
48 hours. Flasks were freeze-thawed once, decanted into SO ml centrifuge tubes^ and 
centrifuged at 3000 g for 20 minutes. The supernate was decanted and stored in 1 ml 
aliquots at -70 C. Virus concentration (TCID^Q) was determined by the Kârber 
method using a series of 10-fold dilutions (Schmidt and Emmons, 1989). 
^Tissue culture flask No. 3150, Costar Corporation, Cambridge, MA. 
^MEM 410-2100 powder, GIBCO Laboratories, Grand Island, NY. 
^50 ml conical centrifuge tube No. 60.547, Sarstedt, Inc., Arlington, TX. 
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The SN test was run using 1:2 serial dilutions of heat-inactivated serum in 96-
well flat-bottomed tissue culture plates.^ The EMCV challenge virus was pre-titered 
and diluted with MEM plus gentamicin sulfate (O.Smg/100 ml) to deliver between 500 
and 1000 TCID^g per well, as recommended at the time by the National Veterinary 
Services Laboratories (K. A. Eernisse, United States Department of Agriculture, 
National Veterinary Services Laboratories, Ames, lA, personal communication, 1990). 
The virus-serum solution was incubated at room temperature for 60 minutes after 
which 0.15 ml of a cell suspension containing 3 - 5 X 10^ BHK-2I cells per ml in a 
solution of MEM with 10 percent FBS, tryptose phosphate broth (4 ml/liter), sodium 
bicarbonate (2.2 g/liter) and gentamicin sulfate (0.5 mg/100 ml) was added to each 
well. The plates were then incubated in a 37 C incubator containing 5 percent CO2 
and examined for cytopathic effects at 48 hours using an inverted light microscope. 
The antibody titer was read as the highest serum dilution showing complete virus 
neutralization, as indicated by an absence of cytopathic effects. SN antibody titers 
^1:8 were considered positive, with an estimated specificity of 95.7 percent and 
sensitivity of 97.8 percent at this dilution (Zimmerman et al., 1990). 
Results 
Swine type Cumulative results, prevalence by animal type, and frequency 
of infection on a herd basis is given in Table 1. In the aggregate, 13.4 percent 
(349/2,614) of all swine tested were positive for antibodies against EMCV. By animal 
type, 17.2 percent (101/587) of sows and gilts and 12.2 percent (248/2,027) of finishers 
were positive. A chi-square test of the distribution of seropositivity showed a 
difference in the prevalence of EMCV in breeders compared to finishers (P<0.002). 
Herd infectivitv rate As shown in Table 1, 88.0 percent (22/25) of the 
herds in which sows and gilts were tested and 86.8 percent (79/91) of the herds in 
which finishing animals were tested contained EMCV-infected swine. In 12 herds, 
both finishers and breeders were sampled. Three of these herds had seropositive 
^Tissue culture 96-well plate No. 3596, Costar Corporation, Cambridge, MA. 
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Table 1. Prevalence of EMCV: Summary data 
Animals Herds 
Animal type Test® Frequency Percent (95% CI") Frequency Percent 
Sows and gilts + 101 17.21 (14.16, 20.26) 22 88.00 
- 486 82.79 (79.74, 85.84) 03 12.00 
Finishers + 248 12.23 (10.80, 13.66) 79 86.81 
- 1779 87.77 (86.34, 89.20) 12 13.19 
Cumulative + 349 13.35 (12.05, 14.65) 93 89.42 
— 2265 86.65 (85.35, 87.95) 11 10.58 
^Seropositive = +; seronegative = 
^Confidence interval. 
breeding stock and seronegative finishers. In 8 herds, seropositive animals were detected 
in both breeding and finishing groups, and in one herd finishers tested EMCV-positive 
while breeding stock were negative. 
The detection of seropositive animals in a herd was related to the herd sample 
size. As given in Table 2, the mean number of swine tested in EMCV-negative herds 
was 15.8, compared to 26.2 animals in EMCV-positive herds. The probability of 
detecting at least one positive individual in a herd is a function of sample size, as well 
as disease prevalence (Thrushfield, 1986). It follows that the likelihood of detecting one 
or more infected animals in a herd increases as more animals are tested. In this study, 
the uniformly smaller number of animals tested in negative herds implies that some 
herds identified as negative were probably infected. 
Since nearly all herds contained positive swine, the average prevalence in 
infected herds was nearly the same as the prevalence estimated among all animals. 
Among all animal types, prevalence averaged 14.5 percent (SD, 8.2) in positive herds. 
By animal type, 18.1 percent (SD, 7.9) of sows and gilts and 13.7 percent (SD, 7.9) of 
finishing animals in EMCV-positive herds were infected. Prevalence in EMCV-positive 
herds ranged from 3.3 percent to 48.0 percent. 
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Table 2. Herd sampling statistics by herd EMCV status and animal type 
PMCV 
Sows & 
Hsids 
gilts sampled: 
Samples fSP)® 
Finishers sampled; 
Herds Samoles ^SD)® 
Among all herds: 
Herds Samoles fSD)® 
Negative 
Positive 
3 
22 
11.33 (3.51) 
25.14 (8.22) 
12 16.67 (6.20) 
79 23.00 (6.59) 
11 15.82(7.17) 
93 26.24 (9.02) 
Total 25 23.48 (9.00) 91 22.27 (6.82) 104 25.13 (9.39) 
^Mean samples per herd (standard deviation). 
Table 3. Prevalence of EMCV in sows and gilts by breeding herd size 
Animals Herds 
Breeding herd size Test® Frequency Percent (95% CI ) Frequency Percent 
1 - 99 + 15 17.24 (9.30, 25.18) 3 60.00 
- 72 82.76 (74.82, 90.70) 2 40.00 
100 - 199 + 28 14.51 (9.54, 19.48) 9 90.00 
- 165 85.49 (80.52, 90.46) 1 10.00 
200 - 399 + 21 14.29 (8.63, 19.94) 5 100.00 
- 126 85.71 (80.06, 91.37) 0 0.00 
>399 + 37 23.13 (16.59, 29.66) 5 100.00 
123 76.88 (76.88, 83.41) 0 0.00 
^Seropositive = +; seronegative = 
^Confidence interval. 
Herd size The effect of herd size on prevalence was examined for 
breeding and finishing animals separately. The 25 herds in which sows and gilts were 
tested were divided into 4 size categories on the basis of the number of animals in the 
breeding herd. Size categories were 1 - 99, 100 - 199, 200 - 399, and >399 breeders in 
116 
Table 4. Prevalence of EMCV in finishing animals by average total inventory 
Animals Herds 
Average inventory Test® Frequency Percent (95% Cl") Frequency Percent 
1 - 299 + 51 11.43 (8.48. 14.39) 17 80.95 
- 395 88.57 (85.61, 91.52) 4 19.05 
300 - 599 + 45 9.57 (6.91, 12.23) 17 85.00 
- 425 90.43 (87.77, 93.09) 3 15.00 
600 - 999 + 65 14.32 (11.10, 17.54) 17 89.47 
- 389 85.68 (82.46, 88.90) 2 10.53 
1000 - 1999 + 39 11.11 (7.82, 14.40) 14 87.50 
- 312 88.89 (85.60, 92.18) 2 12.50 
&1999 + 48 15.69 (11.62, 19.76) 14 93.33 
- 258 84.31 (80.24, 88.39) 1 66.67 
^Seropositive = +; seronegative = 
^Confidence interval. 
the herd. The results of this analysis are given in Table 3. 
Because finishing swine did not necessarily originate from a herd with breeding 
animals, e.g., feeder pig finishing herds, the 91 herds from which finishers were sampled 
were divided into five size categories based on average total inventory. Inventory 
categories were 1 - 299, 300 - 599, 600 - 999, 1000 - 1999, and >1999 animals in the 
herd. The outcome of this classification is listed in Table 4. 
In both analyses prevalence was relatively uniformly distributed across the range 
of herd sizes. In neither case was there a statistically significant difference in the 
proportion of infected animals on the basis of herd size. Furthermore, the 95 percent 
confidence intervals calculated for the proportions at each size category overlapped in 
every case. Thus, herd size was not associated with prevalence. 
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Table 5. Prevalence of EMCV by animal type and facility type 
Facility type Animals Herds 
(Animal type) Test® Frequency Percent (95% CI") Frequency Percent 
Confined + 53 20.46 (15.55, 25.37) 9 100.00 
(Sows & gilts) - 206 79.54 (74.63, 84.45) 0 0.00 
Not confined + 16 12.12 ( 6.55, 17.69) 6 85.71 
(Sows & gilts) - 116 87.88 (82.31, 93.45) 1 14.29 
Confined + 8 6.40 ( 2.11, 10.69) 4 66.67 
(Finishers) - 117 93.60 (89.31, 97.89) 2 33.33 
Not confined + 124 13.57 (11.35, 15.79) 36 90.00 
(Finishers) - 790 86.43 (84.21, 88.65) 4 10.00 
^Seropositive = +; seronegative = 
^Confidence interval. 
Facilities In order to evaluate the effect of facilities on prevalence, herd 
facilities were classified as either confined or unconfined. Confined facilities were 
defined as completely enclosed buildings equipped with power ventilation and slotted 
floors. Herds providing both confined and unconfined environments were excluded 
from the analysis, since they constituted a cross-classified group. This method of 
classification is less than ideal in the sense that it does not include all types of 
confinement facilities. Also, it does not make efficient use of the data available. 
However, alternative means of evaluating the association of facilites and prevalence were 
not available using the data at hand. 
Among the 25 herds in which breeding swine were tested, the facilities in 9 
herds were classified as confined, in 7 as unconfined, and 9 herds employed both types 
of facilities. As shown in Table 5, 20.5 percent (53/206) of the breeding stock housed 
in confinement were EMCV-positive, as opposed to 12.1 percent (16/116) maintained in 
unconfined facilities. This is a statistically significant difference (P=0.041) in prevalence 
on the basis of the chi-square test of the distribution. In terms of relative risk, breeders 
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in confinement were 1.69 (1.01, 2.83)^ times more likely to be EMCV-positive than sows 
and gilts in unconfined situations. 
Among the 91 herds in which finishing swine were sampled, 6 herds were 
classified as confined and 40 as unconfined. Among finishers in the confined category, 
6.4 percent were seropositive for EMCV, as opposed to 13.6 percent of the finishing 
animals raised in unconfined facilities. The risk of infection was 2.12 (1.06, 4.23)^ 
times greater in unconfined finishers. As in the case of breeding animals, the chi-
square test indicated a significant difference in prevalence (P-0.024) between the 2 
groups. 
Seasonal effects Clinical outbreaks of EMCV occur throughout the year, 
but the incidence is reportedly somewhat lower in the summer (Boulton, 1984; Links et 
al., 1986; Littlejohns and Acland, 1975) Seasonal effects on incidence were tested 
indirectly by comparing the prevalence of EMCV by the season in which the sample was 
collected. Only samples from finishing swine were used to reduced the observed effect 
of age on seropositivity. By season, the prevalence was 12.0 percent (34/284) in the 
winter, 12.9 percent (51/395) in the spring, 12.1 percent (76/628) in the summer, and 
12.1 percent (87/720) in the fall. These data provided no support to a hypothesis for a 
seasonal distribution of infection. 
True prevalence A more accurate estimate of the level of infection in a 
population, the true prevalence, can be made using the performance limitations 
(sensitivity and specificity) of a test. A method for calculating true prevalence has been 
described elsewhere (Thrushfield, 1986). The true prevalence of EMCV infection in the 
survey population was calculated using the sensitivity of 97.8 percent and specificity of 
95.7 percent reported for the microtiter SN test (Zimmerman et al., 1990). Disregarding 
animal type, the true prevalence was 9.7 percent among all samples. The true prevalence 
among finishing animals was 8.5 percent and among breeding stock was 13.8 percent. 
^95 % confidence interval. 
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Discussion 
The results of this survey indicate that EMCV infection is widespread in swine 
in Iowa. The data infer that in excess of 90 percent of Iowa swine herds are infected. 
Within herds, the prevalence tends to increase with age. Sows and gilts have a 
significantly higher prevalence (17.2 %) than finishing swine (12.2 %). This differs from 
a survey which found no difference in prevalence in swine on the basis of age (Gualandi 
et al., 1989). No seasonal variations in prevalence were detected. 
The effect of facilities on prevalence was statistically significant but difficult to 
interpret. The level of infection was essentially identical between finishers (13.5 %) and 
breeders (12.1 %) in unconfined facilities, but different between finishers (6.4 %) and 
breeders (20.5 %) in confinement. Confinement facilities appeared to reduce the 
transmission of EMCV between finishing swine, but exacerbate transmission within 
breeding herds. Reasons for this seemingly contradictory information were not 
forthcoming from the data. In terms of the dynamics of disease transmission vis-à-vis 
swine production, it would be reasonable to assume that producers finishing swine to 
market under total confinement also tend to employ all-in, all-out management and 
thereby reduce the transmission of EMCV between groups of swine. The same rationale 
cannot explain the differences seen in breeding animals housed in confinement vs. other 
types of facilities. Although an explanation for this observation is not yet evident, the 
implication is readily apparent that gilts and sows in totally confined facilities represent 
a group at a significantly higher risk of contracting EMCV. By inference, economically 
significant losses from EMCV in the form of embryonic resorption, mummies, stillbirths, 
and lower conception rates are more likely to be observed under confinement conditions. 
Other surveys provide a context for the interpretation of this study. In Italy, all 
herds (42) and 69.13 percent (439/635) of swine were seropositive for EMCV (Gualandi 
et ai., 1989) and in Britain, at least 28 percent of 127 abattoir samples were positive 
(Sangar et al., 1977). An Australian abattoir survey reported a prevalence of 1.0 percent 
(1/100) (Spradbrow, 1968), whereas 22.5 percent (9/40) of swine tested in Hawaii (Tesh 
and Wallace, 1978), and 9.8 percent (10/102) in Surinam (Tiggleman-Van Krugten and 
Collier, 1955) were infected. In North America, serologic testing in human populations 
(Gajdusek and Rogers, 1955; Jonkers, 1961; Jungeblut and Bautista, 1954; Tesh, 1978) 
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has shown a prevalence rate of between 3.5 percent (33/947) and 19.8 percent (26/131). 
Comparisons between surveys should be made with circumspection. Critical differences 
in sample size, sample selection, and serologic methods between surveys make such 
comparisons prone to error. On the whole, however, it can be seen that this study does 
not present unprecedented information. Rather, it expands on current knowledge. 
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PART IV. PREVALENCE OF TOXOPLASMOSIS IN IOWA SWINE 
Summary 
A total of 2,616 animals from 104 herds were tested for the presence of 
antibodies against Toxoplasma gondii by enzyme-linked immunosorbent assay. Data 
were analyzed by animal type, herd size, facility type, and season. The true prevalence 
of toxoplasmosis was estimated as 5.4 percent among finishing swine and 11.4 percent 
among sows and gilts. Herds with fewer than 100 breeders were significantly more 
likely to be infected than herds with 100 or more breeders (P<0.05). Seropositivity in 
breeding stock was approximately the same in Infected herds, regardless of herd size. 
Herds with finishers in total confinement were as likely to become infected as herds 
with other types of facilities, but infected herds with finishers in confinement 
appeared to have a lower in-herd prevalence than herds with other types of facilities 
(P=0.09). No seasonal effects were observed, and prevalence remained relatively 
constant throughout the year. The prevalence of porcine toxoplasmosis in Iowa was 
markedly lower than other areas of the United States surveyed within the past decade. 
Introduction 
Infection with Toxoplasma gondii was first diagnosed in swine in 1952 in Ohio, 
U.S.A. in association with an outbreak of disease characterized by high mortality in 
pigs under 3 weeks of age and abortions and stillbirths in the breeding herd (Farrell et 
al., 1952). Toxoplasmosis in swine, both clinical and subclinical infections, was 
reported in many parts of the world in the decade following the Ohio outbreak (Dubey, 
1986). 
The majority of infections in swine are subclinical. There are only three 
reports documenting clinical toxoplasmosis in swine in the U.S.A. (Dubey, 1979; Dubey 
et al., 1986; Farrell et al., 1952) Synergism of Toxoplasma with other swine pathogens 
has been hypothesized, but not proven (Dubey, 1986). Toxoplasmosis in food animals 
is primarily of concern because of the potential for transmission of Toxoplasma to 
humans by the consumption of inadequately cooked meats and the subsequent risk of 
prenatal infections, or clinical toxoplasmosis in immunocompromised or 
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immunosuppressed persons (Frenkel et al., 1975; Gleason and Hamlin, 1974; Navia et 
al., 1986; Whiteside and Begent, 1975). 
The purpose of the study reported here was to investigate the prevalence of 
toxoplasmosis in swine in Iowa. The availability of descriptive data on participating 
herds made it possible to examine the relationship of animal type, herd size, facility 
type, and season relative to prevalence. 
Materials and Methods 
Selection of herds Serological samples from 89 Iowa swine herds 
participating in the National Animal Health Monitoring System (NAHMS), comprising 
a total of 2,017 animals, were available for the survey. Herd data were collected by 
monthly interviews of producers over the course of their participation in NAHMS (12 
to 18 months). 
In addition to serological samples from herds enrolled in the NAHMS program, 
serum samples were available from 15 self-selected herds. These herds had production 
records approximately equivalent in scope and quality to the NAHMS herds. Inclusion 
of these herds brought the total to 2,616 serum samples from 104 herds. 
Geographically, the survey herds were distributed throughout the state. Iowa 
has 99 counties of nearly equal size. Survey herds were from 60 of these 99 counties. 
Serological sampling of herds All blood samples were identified as 
originating either from finishers or from female breeders. Blood samples were taken 
from animals on the premises or, in some cases, from market animals followed to 
slaughter. In all cases, finishers were greater than 150 pounds in weight and the 
majority exceeded 180 pounds. Breeding stock were either sows or gilts; no boars were 
included in the sample. In the case of the 15 non-NAHMS herds, records were of 
sufficient quality to identify breeders as either gilts or sows. The reproductive or 
medical history of individual animals was not known or taken into consideration in 
selecting animals to be sampled. Following collection, serological samples were 
processed, numbered, and frozen to -70 C within 24 hours in 1 milliliter aliquots for 
storage. 
In total, 2,029 finisher samples were taken from 91 herds and 587 breeder 
samples from 25 herds. Both animal types were sampled in 12 herds. Cumulatively, 
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an average of 25.2 (SD 9.4) samples were collected from each herd. In those herds in 
which finishers were sampled, the average was 22.3 (SD 6.8) finishers sampled per 
herd. In those herds in which sows and gilts were sampled, the average was 23.5 (SD 
9.0) breeders. 
Enzvme-linked immunosorbent assay (ELISA) All samples were assayed 
for the presence of antibodies against Toxoplasma by ELIS A. The RH strain of 
Toxoplasma was used as the antigen. The tachyzoite stage was maintained as frozen 
stock and stored at -70 C. Tachyzoites were revived by intraperitoneal (IP) injection 
in 22-25 g female CFl mice. After 6 to 9 days, the tachyzoites were harvested from 
the peritoneal cavity in phosphate-buffered solution (PBS) at pH 7.4; 2-5 x 10^ 
tachyzoites were then passaged by IP inoculation into another mouse. Three days post 
inoculation, the peritoneal exudate was collected, pooled, washed with PBS, and 
centrifuged at 3000 x g for 30 minutes at 4 C. The precipitate was resuspended in 
NH^Cl-Tris at pH 7.2 and incubated for approximately 1 minute at room temperature 
to lyse the erythrocytes. The suspension was centrifuged immediately using a 
microcentrifuge at 13,000 rpm for 45 seconds, resuspended in PBS, and passed through 
a 3 /^m polycarbonate membrane' to remove host cells and cell debris, then washed 
twice in PBS. The purified tachyzoites were resuspended in sterile distilled water, then 
y 
sonicated until no intact organisms were detected microscopically. Cellular debris 
was removed by centrifugation at 9,000 x g for 1 hour. The supernatant was collected 
and stored at -20 C until used. Protein concentration was determined using Pierce 
protein assay reagent.^ 
The standardization and basic assay procedures have been previously described 
(Waltman et al., 1984). All sera were assayed using an alkaline-phosphatase labeled 
rabbit anti-IgG (H and L chains) conjugate. This assay differed from that described 
by Waltman et al. only in that 0,05 percent Tween 20 in Tris-NaCl, pH 7.5 buffer was 
used instead of 0.05 percent Tween 20 in PBS, pH 7.2. 
^Nucleopore, Pleasanton, CA 
^Model W-22, Heat Systems-Ultrasonics, Inc., Farmingdale, NY 
^Pierce Chemical Company, Rockford, IL 
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ELISA results were reported as negative, positive, or suspect. Among all 
samples, 58 samples were reported as suspect, 108 as positive, and 2,450 as negative. 
Insufficient serum was available to run suspect samples in an alternate assay to resolve 
their status. Therefore, suspect responses were interpreted on the basis of serology in 
the herd of origin. Suspect samples originating from a herd containing other ELISA 
positive samples were considered positive. Suspect samples originating from a herd 
with no ELISA positive samples were considered negative. Using this classification, 48 
of the 58 suspects were positive, 10 were negative. The results of this convention are 
used as the basis of analysis and discussion. 
Results 
Results by animal type, herd size, and facility type are presented in Tables I 
through 4. As shown in Table 1, the cumulative prevalence was 6.0 percent 
(156/2626). By herd, 51.0 percent (53/104) were positive, and within positive herds, 
an average of 12.7 percent (SD 9.9) of the animals tested were positive for 
Toxoplasma. 
Animal tvoe Among sows and gilts, 10.0 percent were positive for 
toxoplasmosis, as compared to 4.8 percent of finishers. A Yates corrected chi-square 
test of the distribution showed the difference in prevalence between the finishers and 
breeders to be significant (P<0.001). In herds with seropositive sows and gilts, 16.4 
percent (SD 9.8) of the tested animals were positive, as opposed to 11.3 percent (SD 
9.6) of finishers in positive herds. 
In 15 herds, it was possible to identify female breeding stock as gilts or sows. 
In this subsample of 437 animals, 8.5 percent of the gilts and 11.1 percent of the sows 
were positive. This rising percentage of reactors from finishers (4.8 %) to gilts (8.5 %) 
to sows (11.1 %) showed a pattern of increasing prevalence with age. 
Herd size Prevalence by herd size is shown in Tables 2 and 3. Size 
classifications in the 25 herds in which sows and gilts were tested were based on the 
total number of sows and gilts in the breeding herd. As shown in Table 2, 4 size 
categories were used: 1 - 99, 100 - 199, 200 - 399, and 400 or more sows and gilts. 
Coincidentally, this breakdown resulted in 5 herds in each category, with the exception 
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Table 1. Prevalence of toxoplasmosis; Summary data 
Animals Herds 
Animal type Test® Frequency Percent (95% CI") Frequency Percent 
Sows and gilts + 59 10.05 (7.62, 12.48) 17 68.00 
- 528 89.95 (87.52, 92.38) 8 32.00 
Finishers + 97 4.78 (3.85, 5.71) 43 47.25 
- 1932 95.22 (94.29, 96.15) 48 52.75 
Cumulative + 156 5.96 (5.06, 6.87) 53 50.96 
- 2460 94.04 (93.13, 94.94) 51 49.04 
^Seropositive = +; seronegative = 
^Confidence interval. 
Table 2. Prevalence of toxoplasmosis in sows and gilts by size of breeding herd 
Animals Herds 
Breeding herd size Test® Frequency Percent (95% CI^) Frequency Percent 
1 - 99 + 14 16.09 (8.37, 23.81) 5 100.00 
- 73 83.91 (76.19, 91.63) 0 0.00 
100 - 199 + 16 8.29 (4.40, 12.18) 6 60.00 
- 177 91.71 (87.82, 95.60) 4 40.00 
200 - 399 + 15 10.20 (5.31, 15.10) 3 60.00 
- 132 89.80 (84.90, 94.69) 2 40.00 
>399 + 14 8.75 (4.37, 13.13) 3 60.00 
- 146 91.25 (86.87, 95.63) 2 40.00 
^Seropositive = +; seronegative = 
^Confidence interval. 
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Table 3. Prevalence of toxoplasmosis in finishing animals by average total inventory 
Animals Herds 
Average inventory Test® Frequency Percent (95% CI^) Frequency Percent 
1 - 299 + 22 4.93 (2.92, 6.94) 9 42.86 
- 424 95.07 (93.06, 97.08) 12 57.14 
300 - 599 + 26 5.53 (3.47, 7.60) 9 45.00 
- 444 94.47 (92.40, 96.53) 11 55.00 
600 - 999 + 23 4.82 (2.90, 6.74) 10 52.63 
- 431 95.18 (93.26, 97.10) 9 47.37 
1000 - 1999 + 13 3.70 (1.73, 5.68) 8 50.00 
- 338 96.30 (94.32, 98.27) 8 50.00 
> 1999 + 12 3.90(1.74, 6.06) 7 46.67 
- 296 96.10 (93.94, 98.26) 8 53.33 
^Seropositive = +; seronegative = 
^Confidence interval. 
that category 2 had 10 herds. The prevalence by size category, going from smallest to 
largest, was 16.1 percent, 8.3 percent, 10.2 percent, and 8.8 percent. Because of the 
similarity in prevalence in categories 2 through 4, and because it was considered 
reasonable to assume that herds with fewer than 100 breeders may use a different 
management style and a different level of technology than larger herds, the statistical 
tests were done on a classification consisting of 2 herd sizes; herds with fewer than 100 
sows and gilts, and herds with 100 or more. The Yates corrected chi-square test of this 
2-tiered classification gave a value suggestive of a statistical difference (P=0.07); a 
comparison of proportions further supported a statistical difference in prevalence 
between the two groups (P<0.05) (Snedecor and Cochran, 1980). 
Under the 2-tiered classification, all 5 of the herds in the smallest category were 
roxop/flswfl-positive. In the other stratum, 60 percent of the herds were positive and 40 
percent of the herds were negative. Removing the negative herds, prevalence among 
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breeders in the positive herds was very similar between both strata; 16.1 percent of sows 
and gilts in positive herds in the smaller category and 14.0 percent in the larger. From 
these data it would appear that smaller herds were more likely to be infected, but 
prevalence within infected herds was approximately equal, regardless of size. 
Data on finishers were also evaluated for an association between herd size and 
prevalence. These results are listed in Table 3. Since finishers did not necessarily 
originate from a herd with breeding stock, size classifications were made on the basis of 
average total inventory. Five size categories were used in this analysis; 1 - 299, 300 -
599, 600 - 999, 1,000 - 1,999, and 2,000 or more swine. 
In finishers, seropositive animals were relatively uniformly distributed across the 
range of herd sizes, prevalence ranging from 3.7 percent to 5.5 percent. Unlike 
breeding herds. Toxoplasma positive finishing herds were distributed comparatively 
evenly among all herd size classifications. Between 15 and 21 herds were in each 
division and about one-half of the herds in each stratus were positive. In finishers, no 
association between herd size and prevalence was found, either on an animal basis or a 
herd basis. 
Facilities Herds were classified as using either "confined" or "not-confined" 
facilities. Confined facilities were defined as completely enclosed buildings equipped 
with power ventilation and slotted floors. Categories were exclusive, i.e., mixed 
classifications were disallowed. Thus, herds with a combination of confined and not-
confined facilities did not fit either group and were excluded from the analysis. This 
method of classification is less than ideal in that it does not include all types of 
confinement facilities. Also, it does not use all the available data. However, means of 
accurately classifying and evaluating the association of facilities and prevalence were not 
available using the data at hand. The results are given for breeders and finishers by 
animal type and facility type in Table 4. 
Among the 25 herds in which breeders were tested, 9 herds were defined as 
confined, 7 as not confined, and 9 herds as mixed confined and not-confined. The nine 
herds with mixed facilities were not included in the analysis. The prevalence of 
seropositive sows and gilts in confinement (9.3 %) as opposed to seropositive sows and 
gilts not in confinement (8.3 %) was not significantly different. 
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Table 4. Prevalence of toxoplasmosis by animal type and facility type 
Facility type Animals Herds 
(Animal type) Test® Frequency Percent (95% CI"') Frequency Percent 
Confined + 24 9.27 ( 5.74, 12.80) 6 66.67 
(Sows & gilts) - 235 90.73 (87.20, 94.26) 3 33.33 
Not confined + 11 8.33 ( 3.62, 13.05) 3 42.86 
(Sows & gilts) - 121 91.67 (86.95, 96.38) 4 57.14 
Confined + 2 1.60 ( 0.00,° 3.80) . 2 33.33 
(Finishers) - 123 98.40 (96.20, 100.00°) 4 66.67 
Not confined + 46 5.02 ( 3.61, 6.44) 18 45.00 
(Finishers) - 870 94.98 (93.56, 96.39) 22 55.00 
^Seropositive = +; seronegative = 
^Confidence interval. 
^Truncated at 0.00 %. 
^Truncated at 100.00 %. 
Among the 91 herds in which finishers were tested, 6 herds were contained in 
the confined category and 40 herds in the not-confined category. Among finishers, 1.6 
percent of the animals raised in confinement were seropositive, as compared to 5.0 
percent of the animals from the not-confined group. While the prevalence between the 
2 groups would intuitively appear to be highly influenced by facility type, the statistical 
support of a real difference between these two group was not definitive. Neither the 
Yates corrected chi-square (P=0.14) nor a comparison of the proportions (P=0.09) 
provided unequivocal support for a difference between the two groups. This lack of 
statistical support for a difference is primarily a function of the small confined sample 
size. The fact that the distribution observed in this study tends toward the extreme of 
the normal frequency distribution, in addition to a report in the literature of marked 
differences between confined and not-confined herds (Lubroth et al., 1983), lends 
support to an inference that facility type exerted some degree of influence on 
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seroprevalence within a herd. 
On a herd basis, 2/6 (33.3 %) of the herds finishing swine in confinement were 
roxop/flswû-positive. In the not-confined group, 18/46 herds (39.1 %) were 
seropositive. The small confinement sample size prohibited drawing clear conclusions 
from the data. Specifically, it could not be determined if the probability of an enclosed 
finishing herd becoming Toxoplasma-i[>os,iX\\Q was the same or different than a herd 
using other types of facilities. At the very least, it was evident that confinement 
facilities do not preclude infection. 
Seasonal effects A number of researchers have reported seasonal 
fluctuations in prevalence (Hugh-Jones et al., 1986; Kuzovkin, 1970; Lubroth et al., 
1983; Zimmermann, 1975). These data were examined for such trends. Only samples 
from finishers were used in order to reduce the observed effect of age on seropositivity. 
On a seasonal basis, seroprevalence showed a pattern of a slight rise from fall to 
summer. Prevalence was 4.3 percent in the fall, 4.6 percent in the winter, 4.8 percent in 
the spring, and 5.4 percent in the summer. 
True prevalence A method for calculating true prevalence is described in 
the literature (Thrushfield, 1986). The true prevalence of toxoplasmosis was calculated 
using the 88.2 percent sensitivity and 100 percent specificity reported for the percent 
ELISA (Waltman et al., 1984). The true prevalence of toxoplasmosis for all samples was 
calculated as 6.8 percent. The true prevalence among finishers was 5.4 percent and 11.4 
percent among sows and gilts. 
Discussion 
The results of this survey indicated that toxoplasmosis was more prevalent in 
breeding stock than finishers. This is consistent with other reports (Hugh-Jones et al., 
1986; Lubroth et al., 1983). Herd size was related to seropositivity in breeding stock but 
not in finishers. Herds with fewer than 100 breeders were more likely to be infected 
than herds with 100 or more breeders. However, within infected herds, the proportion 
of infection in breeding stock was approximately the same across all herd sizes. 
Finishers showed no herd size effects. Based on a small sample size and looking only at 
finishers, totally confined herds were approximately as likely to become infected as 
herds with other types of facilities. If infected, herds finishing animals in confinement 
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appeared to have a lower in-herd prevalence than herds utilizing other types of housing. 
The data inferred that toxoplasmosis is relatively independent of seasonal effects, 
prevalence being nearly constant the year around. 
The prevalence of toxoplasmosis in swine appears to be lower in Iowa than other 
areas of the United States surveyed within the past decade. A survey of swine in 
Louisiana showed a true prevalence of 20.7 percent in slaughter animals and 27.6 percent 
in breeding stock (Hugh-Jones et al., 1986). A survey of mature swine in Georgia 
showed 30.8 percent positives (Dreesen and Prestwood, 1980). Both of these surveys 
were extensive in size, each including more than 1,200 animals. 
Explanations for these differences in prevalence can only be conjectured. It is 
possible that these disparate rates are primarily related to climate and the survival of 
oocysts in the environment. It has been observed that toxoplasmosis is more prevalent in 
warm, moist areas than in cold or hot, dry areas (Jacobs, 1957). 
These data can also be compared with a survey of Iowa swine reported in 1964 
(McCulloch et al., 1964). In this study, 105 of a total of 750 swine sera collected during 
June, 1961 and stored at the State-Federal Brucellosis Testing Laboratory were tested for 
Toxoplasma antibodies by the Sabin-Feldman dye test. The 750 specimens originated 
from 66 of the 99 counties in the state. Seven of the 105 specimens (6.7 %) were 
positive. This figure lies within the 95 percent confidence interval (CI) for the 
cumulative estimate in the current study. Considering the changes that have occurred in 
the structure of the swine industry in Iowa (135,000 farms with swine in 1959 vs 36,670 
in 1987) (Christian et al., 1988; United States Department of Commerce, Bureau of the 
Census, 1989), average herd size (110 in 1959 vs 354 in 1987) (Christian et al., 1988), 
and technology (e.g. 26 % of current producers have confinement facilities) (Holden et 
al., 1988), the level of agreement is noteworthy. 
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GENERAL DISCUSSION 
In a small way, these studies have contibuted to the aggregate of knowledge on 
the role of infectious diseases and their relation to swine reproductive losses. Progress 
was made in the serologic diagnosis of encephalomyocarditis virus (EMCV) in swine. 
Building on this study, and using the resources of the National Animal Health 
Monitoring System, it was possible to make a meaningful estimate of the prevalence of 
EMCV in the Iowa herd. It is anticipated that these results will assist in assessing the 
role of EMCV as a pathogen of swine. 
In other areas, this work has served to reinforce established concepts. The 
definitive diagnosis of infectious diseases involved in reproductive losses is difficult 
under the best of cirucumstances. This results both from the instability of most 
microorganisms in nonviable tissues and from déficiences in serologic testing 
procedures. Leptospira is a prime example of both. And many of the "traditional" 
infectious agents that have historically caused reproductive inefficiency continue to do 
so, in particular, porcine parvovirus. 
New questions have emerged from these studies. EMCV appears to be 
ubiquitous in Iowa swine, but little is known about its epidemiology or the frequency 
with which clinical disease is associated with it. The same is true for Leptospira 
interrogans serovar bratislava. Further research, in the laboratory and in the field, will 
be required to discover the answers to these questions. 
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